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Abstract
A notable short-coming in the way radiotherapy is currently practised is that
patient-specific radiobiology is minimally and rarely accounted for in the treatment
planning process. If this is to be remedied, in silico radiobiological models of
radiotherapy will play an essential role. By increasing the complexity of such
models, greater accuracy and utility are gained, along with opportunities for
new radiobiological insights. A new computational model was developed called
“Stochastic Squared Radiotherapy” (S2RT). It is a spatio-temporal/four-dimensional
radiotherapy model for head and neck squamous cell carcinoma (HNSCC), that uses
stochastic modelling of tumour cells and Monte Carlo track structure simulations.
The four main components of the model are tumour growth, tumour irradiation,
DNA damage induction and cell death/survival.
The tumour growth module generates the initial multicellular tumour and
evolves it spatio-temporally in-between dose fractions. Ellipsoidal tumour cells
occupy randomised, non-overlapping locations. Cells are pushed outward and
fall inward following cell division and cell death, respectively. An epithelial cell
hierarchy of stem, transit and differentiated cells is modelled. A connected and
chaotic network of blood vessels grows interwoven between the cells. Chronic hypoxia
and necrotic cells are simulated at distances far from blood vessels. Hypoxic cells
divide slower and necrotic cells are gradually resorbed. Accelerated repopulation
may be simulated by increasing the symmetric division of cancer stem cells.
Dose fractions are delivered to the tumour in Monte Carlo simulations of
radiation tracks. The multicellular tumour is voxelised into nucleus, cytoplasm and
intercellular voxels of size 2 µm and imported into Geant4 to perform irradiation.
A Geant4 application was developed that uses Geant4-DNA to simulate low-energy
physical interactions and radiolytic chemical tracks to account for the indirect effect.
The tracks through cell nuclei are converted to DNA damage, including double-
strand breaks (DSBs). This was done by spatially clustering physical interactions
such as ionisations and excitations and hydroxyl radical interactions into simulated
DNA volumes, each of size 10 base pairs. The DNA damage was made dependent
upon the cellular pO2 by increasing the efficiency of DNA radical-to-strand break
conversion with increasing pO2.
In the model, complex DSBs (cDSBs) produced DNA free-ends that can misrejoin
with one another and produce exchange-type chromosome aberrations. Complete
exchanges are assumed. The misrejoining probability is modelled as an exponential
function of the initial distance between the two cDSBs involved. Cells die if they
contain an asymmetric chromosome aberration.
Notable findings from the S2RT model include: 1. Symmetric division of
cancer stem cells may be as high as 50% during accelerated repopulation. 2. The
decrease in the oxygen enhancement ratio for DSB induction with increasing LET
can be attributed to spatial clustering alone; i.e., at higher LET, the additional
strand breaks produced in the presence of oxygen seldom result in additional DSBs.
Instead, they increase DSB complexity. 3. For MV x-rays, misrejoinings between
cDSBs produced by the same primary x-ray (including its secondary electrons) do
not contribute appreciably to the linear components of chromosome aberration
production and cell killing. For HNSCC, which does have an appreciable linear
component of cell killing, unrejoined DNA ends (i.e. incomplete exchanges and
terminal deletions) may be important.
There is promise of accuracy and utility in S2RT because it is predicated on
simulating Monte Carlo tracks through a multicellular tumour and simulating
cellular tumour growth in-between dose fractions. DNA damage induction and
subsequent processes like DNA free-end misrejoining and cell death are modelled
stochastically using the track structure. Simulated tumours have realistic spatial
distributions of cellular pO2 in relation to the blood vessels, so one can carefully
investigate the effect of microscopic regions of tumour hypoxia on treatment efficacy.
Since tumour irradiation is performed with track structure, the radiation quality
modelled can easily be extended to high LET beams. Modelling a connected network
of blood vessels in the tumour also enables consideration of vascular damages. In
particular, the model may be used in the future to investigate the extent to which
wide-spread vascular damages are responsible for the efficacy of high dose per
fraction treatments such as stereotactic body radiotherapy.
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pO2 . . . . . . . Oxygen tension (mmHg).
PSA,dir . . . . . Probability that a direct event on DNA or its first hydration
layer produces a sugar radical [dimensionless].
PSA,•OH . . . . . Probability that an OH interaction with DNA is on the sugar
moiety, producing a sugar radical [dimensionless].
Symbols xxix
PSB,dir . . . . . Probability of a strand break from a direct event on DNA or its
first hydration layer [dimensionless].
PSB,•OH . . . . . Probability of a strand break from an •OH interaction with DNA
[dimensionless].
PSB,SR,dir . . . . Probability of a strand break from a sugar radical that was
produced by a direct event (e.g. ionisation or excitation) on
DNA or its first hydration layer [dimensionless].
PSB,SR,•OH . . . Probability of strand break from a sugar radical that was pro-
duced by an •OH interaction with DNA [dimensionless].
Psurv(mr) . . . . Probability of cell survival from DNA free-end misrejoining
[dimensionless].
r0 . . . . . . . . Characteristic interaction distance for DSBs (µm).
RV V . . . . . . Relative vascular volume (%).
RV V0 . . . . . . Target relative vascular volume (%).
S . . . . . . . . Surviving fraction (%).
SF2 . . . . . . . Surviving fraction after a dose of 2 Gy (%).
SF2(mr) . . . . . Surviving fraction after a dose of 2 Gy due to cell killing by DNA
free-end misrejoining (%).
S-phase . . . . . A cell cycle phase.
StO2 . . . . . . Microvascular oxygen saturation (%).
Slca . . . . . . . Surviving fraction from lethal chromosome aberrations (%).
SDP . . . . . . Symmetric division probability (referring to stem cells) (%).
t . . . . . . . . Virtual time in radiation track simulation [time].
tD . . . . . . . . Minimum encounter time in the chemical stage [time].
Thyd . . . . . . . Thickness of the first hydration layer of DNA (nm).
tlimit . . . . . . Minimum time step in the chemical stage [time].
xxx
Computational irreducibility is the idea [proposed by Stephen Wolfram
in [1]] that some systems can only be described by fully simulating them.
The only way to determine the answer to a computationally irreducible
question is to perform the computation. Thus it is not possible to know
the outcome to a system at a future state without computing all states in
between. These computations that cannot be reduced or sped up through
any kind of shortcut are called computationally irreducible.
— Complexity Labs [2]
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Introduction
Radiotherapy is a mainstay in the treatment of cancer. Delaney et al [3] estimated
that optimally 52% of all cancer patients in Australia should receive external beam
radiotherapy (the actual utilisation rate is unclear). The total cost of radiotherapy
to the Government of Australia is less than 9 cents in every dollar spent on cancer
[4], indicating that radiotherapy is cost-effective (assuming the actual utilisation
rate is comparable to the estimated optimal rate).
One type of cancer whose treatment relies heavily upon radiotherapy is head
and neck cancer (HNC). This chapter begins with general information about
HNCs and their treatment. An issue is then raised with the standard practice
of radiotherapy, which is not limited to radiotherapy of HNCs; namely, that
radiotherapy treatments could be further individualised to improve patient outcomes.
It is discussed how greater treatment individualisation could be achieved with use
of predictive biomarkers and computational modelling. The work in this thesis
is then introduced: the development of a new radiobiology-based computational
model of HNC radiotherapy. The motivation for this model is to assist in further
individualising HNC radiotherapy treatments, in particular to account for inter-
patient variable tumour hypoxia, which is the main reason radiotherapy sometimes
fails to cure HNCs.
1
2 1.1. Head and neck cancer
1.1 Head and neck cancer
HNCs are those that occur in the throat (pharynx and larynx), nose, sinuses and
mouth. More than 90% of these are squamous cell carcinomas (HNSCCs) [5]. For
the Australian population in 2017, HNCs made up 5.0% (3,625/72,169) of all cancers
diagnosed in men and 2.1% (1,330/62,005) in women [6]. They were responsible for
2.9% (777/27,076) of cancer deaths in men and 1.2% (249/20,677) in women. HNC
incidence in Australia increased from 2,475 in 1982 to 3,896 in 2009 (4,955 in 2017)
and deaths from HNC increased from 752 in 1982 to 944 in 2011 (1,026 in 2017) [7].
These increases were a reflection of Australia’s increasing and ageing population,
as age-standardised incidence and mortality rates decreased over the same periods.
5-year relative survival for HNC increased from 61.8% in 1982-87 to 68.2% (67.4%
for males and 70.4% for females) in 2006-10 [7] and was 68.4% for males in 2009-13
[6]. Tobacco use and alcohol consumption are the primary risk factors [8]. Human
papillomavirus (HPV) also contributes to HNCs, particularly of the oropharynx [9].
1.2 Treatment of head and neck cancer and the
role of radiotherapy
Early tumour-node-metastasis (TNM) stage (stage I or II) HNCs are treated
with either conservative surgery or radiotherapy (external beam radiotherapy or
brachytherapy) [10, 11]. The majority of HNCs are locally advanced (stage III or IV)
at the time of diagnosis [12]. Some locally advanced HNCs are treated with surgery,
including reconstruction, plus post-operative (adjuvant) radiotherapy or adjuvant
concurrent radiotherapy and chemotherapy (chemoradiotherapy). Here, the purpose
of adjuvant radiotherapy is to eliminate any residual cancer cells and reduce the
likelihood of recurrence, and adjuvant chemotherapy is necessary if there is distant
metastatic disease. Radiotherapy and/or chemotherapy can also be administered
before surgery (neoadjuvant) to shrink large tumours and make them easier to resect.
Some locally advanced HNCs are unresectable, or surgery will cause such great
morbidity, including organ loss, that it is not justified; especially if the prognosis
1. Introduction 3
is poor. In such cases, chemoradiotherapy is administered, either curatively or
palliatively. Most deaths from HNC are due to locoregional failure. Clearly
radiotherapy is an indispensable modality in the treatment of HNC.
For Australian men in 2014-15, HNC was the third most common cancer for
which a radiotherapy course was provided (2,152 out of 28,649 radiotherapy courses)
[6]. A study published in 2005 estimated that optimally 74% of all patients
with HNC should receive radiotherapy, and found lower than optimal rates of
radiotherapy utilisation in South Australia [3]. An advantage of radiotherapy over
other modalities is that it seldom requires hospitalisation, which is burdensome
for the patient, hospital and tax payer. In Australia in 2011-12, there were 3,725
surgery hospitalisations for HNC, 3,952 chemotherapy hospitalisations for HNC
and just 124 radiotherapy hospitalisations for HNC [7].
1.3 Radiotherapy basics
Radiotherapy treats cancer by exposing it to ionising radiation. This radiation is
conventionally in the form of an x-ray or electron beam, but there is also proton
therapy available in many countries. There are even carbon ion therapy facilities in
Japan, Germany, China and Italy. Protons and carbon ions may be advantageous
in some patient subsets [13]. A proton therapy facility is planned for Adelaide by
2022 (the first in Australia), with a focus on treating paediatric cancer [14].
The aim of currative radiotherapy is to insult the malignant tissue enough to
achieve a satisfactory tumour control probability (TCP) while minimising insult
to the surrounding healthy tissue. Damage to normal tissue is responsible for
side-effects, which can be particularly distressing when affecting organs in the
head and neck [15].
While normal tissue damage is inevitable, there are two general tactics employed
so that it is reduced. The first is dose conformation. The patient is imaged and a
clinical target volume (CTV) is outlined that contains the extent of gross tumour
plus a margin for microscopic disease. A treatment plan is devised that aims to
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deliver the prescribed, tumouricidal dose to the planning target volume (PTV)1 in
such a way that the dose drops off as fast as possible outside of the PTV. The most
basic way to achieve this conformal dose distribution is by varying the incident
beam angle during treatment and shielding, so that the beam always passes through
the PTV while passing through different volumes of healthy tissue. Technological
advancements in treatment planning systems [16, 17] along with the inventions
of image-guided radiotherapy, intensity-modulated radiotherapy and multi-leaf
collimators have greatly improved dose conformation [18–20].
The second main way healthy tissue is spared is by exploiting differences between
how tumours and healthy tissue respond to radiation. For this reason, the prescribed
total dose is typically delivered in small dose fractions. For example, a standard
course of radiotherapy for HNC consists of 33 fractions of 2 Gy each. One fraction
is delivered per day, 5 days a week from Monday to Friday. The time in-between
fractions allows both tumour and normal tissue time to repair some of the damage,
but for HNC at least, the normal tissue receives a greater benefit. The study
of the biological mechanisms underlying tumour and normal tissue response to
radiation defines the field of radiobiology.
1.4 Treatment individualisation with biomarkers
and computational modelling
Unlike the dose conformation in the treatment plan, which takes into account the
patient’s unique anatomy, the fractionation schedule is not individualised for the
patient’s unique radiobiology in current standard clinical practice. In standard
practice, the clinician refers to a one-size-fits-all, population-based schedule (where
population here refers to a type of cancer, e.g. HNC), like the one detailed above
for HNC. Yet there is large intra-population variation in patient response to any
fractionation schedule. For some patients, the standard total dose prescription
is higher than necessary to achieve a satisfactory TCP and, as a result, there is
1The PTV is larger than the CTV and ensures that the prescribed, tumouricidal dose is actually
delivered to the CTV, accounting for uncertainties in treatment planning and delivery.
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superfluous normal tissue damage. Conversely, some other patients require a higher
dose to achieve an adequate TCP. There are three main factors that affect the
tumour response to radiotherapy: the intrinsic radiosensitivity of tumour cells,
tumour hypoxia (volume and severity) and tumour repopulation [21].
Biomarkers have the potential to provide information about the effect of a
treatment. Such a biomarker is said to have predictive value for that particular
treatment.2 There are a large number of promising biomarkers for HNC, including
measurements of tumour hypoxia, HPV-status, gain-of-function in oncogenes (e.g.
epidermal growth factor receptor; EGFR) and loss-of-function in tumour supressor
genes (e.g. p53) [23–34]. Predictive value has been demonstrated for measurements
of tumour hypoxia [33, 35] and measurements of certain gene expression [25] with
respect to radiation-based therapies for HNC. Predictive biomarkers can also be
used to anticipate the severity of normal tissue toxicity [36].
In a more ideal clinical practice, each patient would be radiobiologically assessed
with multiple biomarkers prior to treatment in order to devise a more individualised,
optimised treatment. For example, if EGFR is overexpressed, the EGFR inhibitor
cetuximab may be beneficial in addition to chemoradiotherapy [26]. The radiother-
apy part of treatment can be optimised in many ways. In addition to prescribing
different total doses, the dose per fraction, number of fractions, total treatment time,
dose rate and timing of combined therapies can all be adjusted in the optimisation.
The issue with biomarkers is that they require clinical trials to establish their
predictive value. Without this evidence, it would not be worth the expense of using
biomarkers. It could also be irresponsible, negligent and unsafe to alter a patient’s
treatment on the basis of an unproven biomarker. Unfortunately, clinical trials are
expensive and time-consuming. Predictive value can also be difficult to demonstrate
[29, 37]. Furthermore, even if a clinical trial is successful in demonstrating predictive
value, it only demonstrates predictive value for one particular treatment. There
are many vying biomarkers and many different types of treatment, so it seems that
2Not to be confused with prognostic value, which means the biomarker provides information
about the overall cancer outcome [22]. Predictive biomarkers have greater utility.
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an overwhelming number of clinical trials will be necessary before a substantial
degree of biomarker-driven treatment optimisation can be achieved.
This is where radiobiological (computational) modelling can have an impact.
Models can be developed to simulate the response of a tumour (or normal tissue)
to different types of treatments, while taking into account those tumour properties
(intrinsic radiosensitivity, hypoxia and repopulation) that affect the response.
Accordingly, models can help to optimise treatments. While clinical trials are a
mainstay, modelling can perform a complimentary role, suggesting which biomarkers
could have the greatest impact and should be prioritised. Modelling is relatively
cheap, and once a model is developed it can often be applied to investigate many
different tumour properties and types of treatment simply by changing model
parameters or making small modifications.
Radiobiological models are challenging to develop because the interactions
between radiation and matter on the nanometre scale and the biological mechanisms
involved in the cellular response to radiation are incredibly complex. Simple models
exist that are accurate within a limited domain, but to increase the domain of
applicability the model must be made more complex, either by accounting for
more of the radiobiology involved or by simulating the radiobiology in a more
fundamental way. In the latter case, not only does this increase the model’s utility
as a predictive tool, it can also provide unique insights into radiobiological processes
that may be difficult to probe in experiment.
1.5 The current thesis
This thesis contains efforts in radiobiological modelling that build upon the im-
pressive body of existing work. In particular, a spatio-temporal/four-dimensional
(4D) model of HNC cellular kinetics and radiotherapy is developed, comprising
four main components:
1. 4D cellular HNC tumour growth with angiogenesis,3
3Angiogenesis is the formation of new blood vessels.
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2. Tumour irradiation using the Monte Carlo particle tracking toolkit Geant4
(version 10.4) [38–40], including simulation of the physicochemical and chemical
stages with Geant4-DNA [41–43],
3. Induction of DNA damage, including double-strand breaks (DSBs), by track
segments through cell nuclei, in a manner that takes into account the cellular
oxygenation (pO2), and
4. Simulation of DSB repair and misrepair and subsequent cell survival and
death.
The model can be used to simulate a whole fractionated radiotherapy treatment
by irradiating the tumour in multiple dose fractions and shrinking and regrowing
the tumour in the time between fractions (Figure 1.1).
The essential novelty of this radiotherapy model lies in the combination of
stochastic tumour cell modelling, meaning each cell is modelled individually with
stochastic elements (e.g. spatial coordinates of cells, cell cycle times, asymmetric vs
symmetric stem cell division), and modelling of the radiation effect starting from
Monte Carlo track structure simulations through the multicellular tumour volume.
For this reason, the model has been named “Stochastic Squared Radiotherapy”
(S2RT). It is hoped that this model foundation leads to greater accuracy and utility
and the possibility of new insights into radiobiology.
For historical background, this Ph.D comes out of a medical physics group with
members from the Royal Adelaide Hospital, University of Adelaide, University of
South Australia and Adelaide Radiotherapy Centre who are recognised as leaders
in radiobiological modelling and belonging to a laboratory with radiobiological
modelling as its niche. There was previously a Ph.D by Michael Douglass in
2014 [44] that developed a purely spatial model of Monte Carlo tracks through a
multicellular tumour. Before that, a Ph.D by Wendy Phillips in 2011 [45] developed
a purely temporal model of cellular tumour growth and radiotherapy. The current
work is a natural progression: an entirely new radiotherapy model is developed that































Figure 1.1: Schematic for the simulation of a fractionated radiotherapy treatment.
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simulates spatio-temporal cellular tumour growth, including tumour angiogenesis,
and irradiates the multicellular tumour with Monte Carlo tracks.
Other radiobiolgical models in the literature that simulate Monte Carlo tracks
have typically focussed on simulating them through increasingly complex DNA
geometries (nucleosome, chromatin and chromosome) within a single cell nucleus
[46–53] or mitochondria [54]. The current work applies Monte Carlo tracks in
a different context and at a different scale: to a multicellular tumour as part of
a spatio-temporal radiotherapy model.
The underlying motivation for the model is the endeavour to further individualise
HNC radiotherapy. Since locally advanced HNCs are often hypoxic [55] and
measurements of tumour hypoxia have predictive value for HNC radiotherapy
[33, 35], modelling tumour hypoxia and its effects are a central focus. To this end,
simulated tumours are grown with a connected and chaotic tumour vasculature, so
that realistic spatial distributions of cellular pO2 are produced in relation to the
blood vessels (chronic hypoxia). The simulated effects of hypoxia are i) the slowing
of cell division during tumour growth and ii) the reduction of DNA damage and
thus cell killing by radiation. To the authors’ knowledge, this work is the first to
model the latter effect at the level of DNA radical chemistry in the framework of a
radiation track structure model. DNA damage is simulated from both direct-type
effects (whereby radiation interacts directly with DNA or its primary hydration
layer) and the indirect effect (whereby radiation interacts with bulk water to
produce hydroxyl radicals which in turn interact with DNA). The indirect effect
is more sensitive to cellular pO2 and necessitated simulation of physicochemical
and chemical stages of irradiation.
The aim of this thesis is to develop and validate the four components of the
S2RT model (namely tumour growth, tumour irradiation, DNA damage induction
and cell death). The remainder of the thesis content is as follows:
Chapter 2 is a literature review regarding i) the development of tumour vasculature
and why hypoxia arises in some tumours and ii) quantitative data for the
amount of vascularisation measured in human HNCs.
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Chapter 3 contains a brief review of radiobiological modelling, focussing mainly
on Geant4-DNA and particularly its chemistry module.
Chapter 4 is a research paper describing the in-house development of a 4D cellular
HNC tumour growth model with angiogenesis. This includes a brief review of
other radiotherapy models in the literature.
Chapter 5 is a research paper that describes the behaviour of the developed
tumour growth model in more depth and provides results pertaining to HNC
tumour growth.
Chapter 6 is a research paper describing the in-house development of an algorithm
to predict DNA damage from Geant4-DNA physical and chemical tracks
through a nucleus, taking into account the cellular pO2. This includes a brief
literature review regarding the mechanisms of the oxygen enhancement effect.
Chapter 7 is a research paper describing an in-house developed Geant4 application
for irradiating a multicellular tumour with Monte Carlo tracks, followed by
translation of track segments through cell nuclei into DNA damage and
simulation of DNA-free end misrejoining and cell death. This includes a brief
literature review regarding the mechanisms of cell death from DNA damage.
Chapter 8 contains concluding remarks, including possible future directions.
2
A review of the development of tumor vas-
culature and its effects on the tumor mi-
croenvironment
The publication [56] forms the basis of this chapter:
Forster JC, Harriss-Phillips WM, Douglass MJ, Bezak E. A review of the
development of tumor vasculature and its effects on the tumor microenvironment.
Hypoxia (Auckl). 2017 Apr 11; 5:21-32. doi: 10.2147/HP.S133231.
2.1 Introduction and Motivation
A primary objective of this work was to model the growth of blood vessels in
the tumour (tumour angiogenesis). The tumour vasculature supplies the tumour
with oxygen and other nutrients. Accordingly, tumour hypoxia may be attributed
to deficiencies in the tumour vasculature. A literature review was conducted
to investigate what goes awry with the vasculature in tumours compared to in
normal tissue, as well as to compile quantitative data of the vasculature morphology
in human head and neck cancer. Insights were gained that were utilised in the
development of the tumour growth model with angiogenesis.
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2.2 Statement of Contribution
2.2.1 Conception
The idea to review tumour angiogenesis was from Eva Bezak. The specific scope
of the review and search methodology were conceptualised by Jake Forster with
input from Wendy Phillips, Michael Douglass and Eva Bezak.
2.2.2 Realisation
The review was conducted by Jake Forster, with general supervision and guidance
provided by Wendy Phillips, Michael Douglass and Eva Bezak. The manuscript was
evaluated by Eva Bezak, Wendy Phillips and Michael Douglass for data accuracy,
critical appraisal, conclusions reached and general structure and flow.
2.2.3 Documentation
The manuscript was primarily written by Jake Forster. Wendy Phillips, Michael
Douglass and Eva Bezak provided input, feedback and revisions.
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Background: The imbalance of angiogenic regulators in tumors drives tumor angiogenesis 
and causes the vasculature to develop much differently in tumors than in normal tissue. There 
are several cancer therapy techniques currently being used and developed that target the tumor 
vasculature for the treatment of solid tumors. This article reviews the aspects of the tumor vascu-
lature that are relevant to most cancer therapies but particularly to vascular targeting techniques.
Materials and methods: We conducted a review of identified experiments in which tumors 
were transplanted into animals to study the development of the tumor vasculature with tumor 
growth. Quantitative vasculature morphology data for spontaneous human head and neck cancers 
are reviewed. Parameters assessed include the highest microvascular density (h-MVD) and the 
relative vascular volume (RVV). The effects of the vasculature on the tumor microenvironment 
are discussed, including the distributions of hypoxia and proliferation.
Results: Data for the h-MVD and RVV in head and neck cancers are highly varied, partly due 
to methodological differences. However, it is clear that the cancers are typically more vascular-
ized than the corresponding normal tissue. The commonly observed chronic hypoxia and acute 
hypoxia in these tumors are due to high intratumor heterogeneity in MVD and lower than normal 
blood oxygenation levels through the abnormally developed tumor vasculature. Hypoxic regions 
are associated with decreased cell proliferation.
Conclusion: The morphology of the vasculature strongly influences the tumor microenviron-
ment, with important implications for tumor response to medical intervention such as radio-
therapy. Quantitative vasculature morphology data herein may be used to inform computational 
models that simulate the spatial tumor vasculature. Such models may play an important role in 
exploring and optimizing vascular targeting cancer therapies.
Keywords: cancer, head and neck, vasculature morphology, hypoxia, radiotherapy response
Introduction
In cancer therapy, techniques continue to be used and developed that target the tumor 
vasculature for the treatment of solid tumors. The tumor vasculature is essential for 
keeping the tumor alive and facilitating its growth. Tumor cells must be within a cer-
tain distance of a perfused blood vessel to receive sufficient oxygen and nutrients to 
survive and proliferate. It is for this reason that solid tumors must become angiogenic 
and recruit their own vasculature to grow beyond 1–2 mm in diameter.1
Various approaches of vascular targeting are currently being explored, including 
antiangiogenic agents that disrupt the formation of new blood vessels and vascular 
targeting agents that shut down the existing tumor blood flow.2 In the radiotherapy 
domain, the tumor response to high doses of radiation includes widespread damages 
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to the vasculature.3,4 High dose per fraction treatments such 
as stereotactic body radiation therapy (SBRT) are finding 
increasing clinical use worldwide for small- to medium-
sized primary and metastatic disease,5,6 although the extent 
to which vascular damage is responsible for the success of 
SBRT is not clear.7 There is also tumor antivascular alpha 
therapy (TAVAT), in which alpha-emitting radionuclides 
are delivered to the tumor vasculature to disrupt the tumor 
vessels.8
The tumor vasculature plays an indirect role in other 
cancer treatment modalities. In chemotherapy, the tumor 
vasculature is relied upon to deliver the drugs to the tumor 
cells. The tumor vasculature performs the same role in the 
technique of tumor radiosensitization using nanoparticles 
such as gold.9 There is also interest in radiosensitizing the 
tumor vessels themselves – as opposed to the tumor cells – by 
irradiating shortly after ingestion of nanoparticles while they 
are still concentrated in the tumor vasculature.10
With several treatment modalities currently being 
explored that target the tumor vasculature primarily or sec-
ondarily, a topical review is presented herein on the tumor 
vasculature, focusing on the aspects that are relevant to 
most cancer therapies and especially to vascular targeting 
techniques. The first part of this article is a review of the 
process of tumor vascularization and how the vasculature 
develops during tumor growth. Experiments are revisited in 
which tumors were transplanted into rats and mice for the 
purpose of studying the development of the tumor vascula-
ture. In some experiments, transparent chambers were used to 
observe changes to the tumor vasculature in real time, while 
others grew tumors to different sizes and then compared the 
vasculature between them. The vasculature morphology in 
tumors, like in normal tissue, can be described quantitatively 
with parameters such as the average vessel diameter, the 
vascular density, and the relative vascular volume (RVV). 
The second part of this article provides a compilation of 
tumor vasculature morphology data from the literature for 
spontaneous head and neck cancers in humans. Head and 
neck cancers were chosen because they are often poorly 
oxygenated.11 Finally, there is a review of the effects of the 
tumor vasculature on the tumor microenvironment. More 
recently, this has been explored by staining tumor sections 
with markers for blood vessels, perfusion, hypoxia, and pro-
liferation. Studies of head and neck cancers were exemplary.
The scope of the biology content in this review is intended 
for a medical physics audience. It is written from a historical 
perspective, discussing the key findings made. Quantitative 
vasculature morphology data are emphasized, which may be 
used to inform computational models that simulate the spatial 
tumor vasculature. Such models may play an important role in 
exploring and optimizing vascular targeting cancer therapies.
Materials and methods
The following search strategy and selection criteria were 
used. Three separate searches were performed using the 
PubMed database, one for each section of the review. Each 
search was across all years, and only publications in English 
were considered.
For the first section, studies of the development of the 
vasculature in tumor transplants were found by a search 
of the following keywords: “tumor AND vasculature AND 
transplant AND quantitative”. To be considered, publications 
had to present findings pertaining to the morphology or 
functionality of the vasculature at different stages of tumor 
growth. From the search results and references therein, 57 
such publications were found, 15 of which were deemed 
representative and were discussed in the review.
In the second section, to find vasculature morphology data 
for spontaneous human cancers of the head and neck, a search 
was conducted using the keywords: “tumor AND vasculature 
AND human AND (oral OR laryngeal OR tongue OR pha-
ryngeal OR salivary OR cheek) AND  ([vessel density] OR 
[vessel volume] OR [vessel diameter])”. Importantly, due to 
the large variation in measurements from using  different meth-
odologies, publications were only included if they reported 
measurements on the corresponding normal tissue and on the 
cancer. In addition, measurements had to be presented as mean 
± standard deviation, for vessel densities, there had to be suf-
ficient information to convert the value to mm-2 and finally a 
reasonable sample size was required. Of the 87 publications, 
9 met these criteria. The data were tabulated for comparison 
of measurements between  different groups.
For the third section regarding the effects of the tumor 
vasculature on the tumor microenvironment, a search was 
conducted using the following keywords: “tumor AND vas-
culature AND distance AND (proliferation OR hypoxia OR 
necrosis)”. Nine publications were selected for discussion 
from the search results and references therein. Aside from 
historically significant publications, the most insightful stud-
ies were those conducted on head and neck cancers.
Results and discussion
Development of tumor vasculature with 
tumor growth
The first group to quantitate changes in the tumor vascu-
lature morphology during tumor growth was Algire and 
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Chalkley.12 They transplanted tumors of mammary gland 
carcinoma and sarcoma 37 into transparent skin flap cham-
bers in mice to grow in the subcutaneous connective tissue. 
The tumors became vascularized by eliciting the sprouting 
of new capillaries from the vessels in the surrounding host 
tissue. This process is called angiogenesis.13 Angiogenesis 
also occurred with implants of subcutaneous tissue and at 
the site of a wound. However, for tumors, it occurred 3 days 
after implantation, whereas it began 6 days after implanta-
tion of subcutaneous tissue or the infliction of a wound. The 
tumors only increased in size once they became pervaded by 
capillaries. The tumor vascularity increased, and angiogenesis 
continued to occur at the tumor edge to facilitate the increas-
ing tumor size. The RVV, which was the relative proportion 
of the tumor area in the chamber covered by blood vessels, 
was measured daily using a method devised by Chalkley.14 
Briefly, an eyepiece graticule is randomly placed several 
times, and the proportion of coincidences with vessels 
yields the RVV. The RVV increased and reached 50% only 
7 days after implantation and maintained this level thereafter, 
which was twice the value in control chambers containing 
normal subcutaneous tissue. The tumor vasculature was a 
sinusoid-like plexus of vessels with large marginal draining 
vessels. There was no evidence that the new tumor vessels 
differentiated into venules or arterioles. They retained their 
capillary-like structure, having walls that contained only a 
single layer of endothelium, but their diameters were much 
larger than the capillaries in normal subcutaneous tissue. 
Such observations revealed that the vasculature in tumors is 
chaotic compared to that in normal tissue (Figure 1).
The formation of the tumor vasculature was described 
in more detail by Eddy and Casarett.16 They studied the 
development of the vasculature in tumors of a malignant 
neurilemmoma of the Syrian hamster as they grew in a trans-
parent cheek pouch chamber. After tumor implantation, the 
veins and venules in the surrounding host tissue dilated and 
become tortuous. The arterial vessels were largely unaffected 
in comparison. The capillary sprouts of angiogenesis were 
seen to originate from the host venous vessels, although the 
magnitude of this activity may have obscured a similar activ-
ity in the host capillary bed. The capillary sprouts elongated 
and anastomosed with each other to establish a capillary-like 
network in the tumor. As soon as a tumor capillary anasto-
mosed with the arterial end of a host capillary, the direction 
of blood flow changed so that the host arterial supply flowed 
through the tumor capillary network to the host venous sys-
tem. Anastomoses between the tumor capillaries and the host 
arterioles were seemingly random and occasionally resulted 
in inefficient blood distribution. For example, a single short 
capillary could conduct blood from a host arteriole directly 
to a wide capillary-like vessel, which drained to the tumor 
perimeter. As the tumor increased in size, the host venous 
vessels were remodeled and pushed away until finally being 
incorporated into the tumor. In contrast, the host arterial ves-
sels remained in about the same location as the tumor grew 
around them. The tumor vessels maintained a capillary-like 
structure, including a number that progressively dilated and 
reached diameters as large as 200 µm in some cases (capil-
laries normally have diameters less than 12 µm). In the later 
stages of tumor growth, it was apparent that some vessels had 
become occluded. Blood flow was restored if the chamber 
walls were separated by even a fraction of a millimeter.
Yamaura and Sato17 further quantitated the development 
of the tumor vasculature morphology in tumors of rat ascites 
hepatoma growing in transparent chambers. At various days 
after tumor implantation, they measured the frequency dis-
tribution of vessel diameters and the RVV using Chalkley’s 
method in the whole chamber. They also used these measure-
ments to calculate the vascular length and surface area per 
unit volume of tissue. Tumor angiogenesis began after 3 to 
5 days. The sprouting of capillaries resulted in an increase 
in the proportion of vessels with diameters less than 10 µm 
Normal tissue Tumor
Figure 1 Organized vasculature in normal tissue contrasted with chaotic vasculature in tumors.
Note: Adapted with permission from Macmillan Publishers Ltd.: Nature Medicine, Jain RK, Molecular regulation of vessel maturation, 2003;9(6):685–693,15 copyright (2003). 





from 40 to 70%. The vascular length increased from 30 to 
160 cm/mm3, the vascular surface area increased from 20 to 
63 mm2/mm3, and the RVV increased from 20 to 50%. On 
day 10, the tumor capillaries began to dilate, causing the 
frequency distribution of vessel diameters to become low 
and wide. This was associated with decreases in the vascular 
length and surface area, but the RVV was unchanged. There 
were changes to the host arterial vessels around this time. 
Their walls became thin and ragged, their lumina widened at 
branching sites, they took on a zigzag pattern and vasomotion 
eventually disappeared. After 14 days, necrosis appeared near 
the center of the tumor and spread outward, seemingly due to 
prolonged vessel occlusion. The smallest vessels were the first 
to close, resulting in cords of viable tissue surrounding the 
remaining larger vessels, beyond which there was necrosis. 
Eventually, even the widest vessels were forced shut and the 
tumor became completely necrotic. Necrosis was associated 
with the disappearance of blood vessels and thus coincided 
with decreases in the vascular length, vascular surface area, 
and RVV to zero.
It is worth briefly mentioning the findings of a few other 
experiments in which tumors were grown in transparent 
chambers. Peters et al18 observed that in normal tissue, the 
capillary perfusion was uniform and orderly. Conversely, 
in a mammary adenocarcinoma, red blood cells were often 
densely packed and slowly squeezed single file through windy 
capillaries. Capillaries could alternate between very fast and 
very slow perfusion. Boucher et al19 demonstrated that the 
interstitial fluid pressure increased over time in human colon 
adenocarcinoma and mouse mammary adenocarcinoma 
growing in a skin fold chamber in mice. Endrich et al20 
found that the mean blood flow to amelantotic melanoma 
growing in a chamber decreased from 40.4 mL/min/100 g 
on day 4 to 21.1 mL/min/100 g on day 12. Central necrosis 
appeared in these tumors after just 5 days. Vajkoczy et al21 
showed for gliomas growing in a skin fold chamber in mice 
that the onset of central necrosis on day 22 coincided with 
a significant decrease in the vessel perfusion index in the 
central region of the tumor compared to that in the marginal 
region. Each of these findings suggests that blood vessels 
may become occluded during tumor growth in chambers, 
which if prolonged could cause necrosis from blood stasis.
The transparent chamber technique allowed for observa-
tion of the development of the tumor vasculature in real time. 
In particular, it provided unique insight into the process of 
tumor vascularization as discussed earlier. However, this 
technique has limitations. Recall in the experiment by Eddy 
and Casarett,16 it was shown that permanent and widespread 
vessel occlusion can occur in tumors that grow within the 
confines of a chamber due to pressure from the chamber 
itself. This quickly leads to massive necrosis, making it dif-
ficult to study the development of the tumor vasculature after 
the earliest stages of growth. Therefore, the discussion now 
moves to experiments that grew tumor transplants to different 
sizes without being confined to a chamber, then internally 
examined them to view the state of the tumor vasculature at 
various stages of growth.
Although prolonged vessel occlusion and thus necrosis 
may be produced artificially in chamber experiments, these 
processes occur naturally in tumors as well. Large intersti-
tial pressures develop in tumors due to a combination of 
the high tumor cell density (108–109 cells/cm3), high blood 
vessel permeability, and poor lymphatics.22 Goldacre and 
Sylven23 found that for various unicentric mouse and rat 
tumors transplanted subcutaneously or intramuscularly, 
central necrosis appeared when tumors reached a diameter 
of 1 cm. It was found by injection of a dye that there was no 
blood flow to the necrotic zone, but there were blood vessels 
in the necrotic zone that contained undamaged red blood 
cells. These findings indicated that vessel occlusion result-
ing in blood stasis was responsible for the central necrosis. 
For tumor transplants of rat fibrosarcoma in which necrosis 
tended to develop centrally, Tozer et al24 showed that the 
mean blood flow (mL/min/100 g) decreased with increasing 
tumor size. Furthermore, the blood flow was constant in the 
tumor periphery, it was in the center that it decreased. In all 
but the smallest tumors, blood flow was lower in the center 
than the periphery, even when only considering viable tissue.
Tannock and Steel25 found that the relative necrotic vol-
ume (the relative proportion of the tumor section covered by 
necrosis, measured using Chalkley’s method) in equatorial 
sections of transplanted rat mammary tumors increased with 
tumor weight from 0% at 0.5 g to 50% at 10 g. By labeling 
red blood cells with chromium-51 and observing that only a 
small fraction of the red blood cells in necrotic regions were 
labeled compared to that in viable regions, it was concluded 
that the cause of necrosis was again stasis in tumor blood 
vessels caused by vessel occlusion.
Fallowfield26 reported that for murine melanoma B16 and 
human melanoma Mel-mo transplanted subcutaneously in 
mice, the relative perfused vascular volume (as determined 
by staining with Hoechst 33342) in all tumor tissue, both 
viable and necrotic, decreased with the logarithm of tumor 
weight, while the relative necrotic volume increased with the 
logarithm of tumor weight. These relationships suggest that 
necrosis appeared when the blood vessels became occluded. 
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In Mel-mo tumors weighing between 37 and 2050 mg, the 
relative perfused vascular volume decreased from 12.6 to 
4.1% and the relative necrotic volume increased from 24 to 
48.8%. In B16 tumors weighing between 80 and 3612 mg, the 
relative perfused vascular volume decreased from 20 to 8.7% 
and the relative necrotic volume increased from 2.8 to 30%.
Different tumor types can elicit entirely different patterns 
of vasculature from the host subcutaneous tissue. Rubin 
and Casarett27 used angiography to study the development 
of the vasculature in tumors of Walker carcinosarcoma and 
Murphy lymphosarcoma transplanted into rats. Walker car-
cinosarcoma induced “peripheral vascularization”, which 
consisted of vessels corkscrewing radially into the tumor. 
Once these tumors reached 1.5 to 3 cm in diameter, central 
necrosis appeared and the radial vessels abruptly terminated 
at the necrotic edge. Murphy lymphosarcoma induced a con-
trasting pattern of “central vascularization”. Major vessels 
penetrated into the tumor center and formed an axial trunk 
from which smaller vessels branched out to the periphery in 
an arborescent fashion. Central necrosis did not develop in 
these tumors.
Gliomas induce a distinct vasculature that differs system-
atically from the tumor center to periphery. The development 
of the glioma vasculature was best described by Deane and 
Lantos28 who induced gliomas in rats by intracerebral injec-
tion of neoplastic glial cells, but similar findings have been 
reported for gliomas growing subcutaneously.21 The gliomas 
remained avascular to sizes up to 1 mm in diameter. In larger 
tumors up to 4 mm in diameter, the core remained avascular 
and occasionally developed necrosis, while at the tumor 
periphery, there were capillary buds and capillaries up to 
5 µm in diameter corresponding to early angiogenesis. In 
tumors larger than 4 mm, there was a third zone in between 
the central avascular necrotic zone and the peripheral zone of 
early angiogenesis. This intermediate zone contained tortuous 
vessels with diameters ranging from 3 to 40 µm. The wider 
vessels were unusually large sinusoidal capillaries lined by 
up to 15 endothelial cells. It was deemed that the vasculature 
in the intermediate zone was in the “late vascular stage”.
Perhaps the most quantitative study of the develop-
ment of tumor vasculature morphology was conducted by 
Vogel.29 Tumors of mammary adenocarcinoma 72j were 
transplanted subcutaneously in mice and permitted to grow 
for 6, 17, or 23 days to produce a range of tumor weights 
from 5 to 2700 mg. Necrotic regions were randomly scat-
tered throughout tumors weighing more than 300 mg and 
occupied between 5 and 15% of the tumor cross section. Ves-
sels were stained by injection of India ink so the  vasculature 
 morphology was only measured in viable regions. The 
vasculature morphology was quantitated by measuring the 
frequency distribution of vessel diameters and the RVV using 
Chalkley’s method. The vascular length and surface area per 
unit volume of tissue were also calculated. Viable regions in 
the center showed no significant differences in vasculature 
morphology compared to viable regions in the periphery. In 
the smallest tumors between 5 and 30 mg, vascular length 
was 820 mm/mm3 and vascular surface area was 34 mm2/
mm3. In the largest tumors weighing between 1.1 and 2.7 g, 
the vascular length and surface area in viable tissue were 
drastically reduced. The vascular length was 47 mm/mm3, 
and the vascular surface area was 7 mm2/mm3. The RVV 
increased only slightly from 16 to 18% in the viable tissue 
from the smallest tumors to the largest. The frequency dis-
tribution of vessel diameters revealed that 70% of vessels 
had a diameter less than 12 µm for tumors weighing between 
5 and 30 mg, but as the tumors increased in size, there was 
a familiar widening and flattening of the distribution. In 
tumors weighing between 1.1 and 2.7 g, only 27% of the 
vessels had a diameter less than 12 µm. Vogel reported that 
tumor growth was accompanied by an increase in sinusoidal 
areas compared to capillary areas. Typical capillary areas had 
97% of vessel diameters less than 12 µm, an RVV of 12%, 
an average vessel diameter of 6.7 µm, a vascular length of 
1700 mm/mm2, and a vascular surface area of 45 mm2/mm3. 
Contrastingly, sinusoidal areas had 11% of vessel diameters 
less than 12 µm, an RVV of 32%, an average vessel diameter 
of 53 µm, a vascular length of 50 mm/mm3, and a vascular 
surface area of 11 mm2/mm3.
A similar experiment was conducted by Hilmas and 
Gillette30 on mouse mammary carcinoma grown in gas-
trocnemius muscle. Tumors ranged between 4 mm in 
diameter (volume 35 mm3) and 14 mm in diameter (volume 
1500 mm3). Again vessels were stained by injection of a con-
trast agent, in this case colloidal carbon, and the vasculature 
morphology was quantitated in the viable tissue. The vascular 
length decreased rapidly from 850 to 350 mm/mm3 with 
increasing tumor volume between 35 and 100 mm3. In tumors 
larger than 500 mm3, the vascular length was 150 mm/mm3 
or less. The vascular surface area was 26.5 mm2/mm3 in the 
smallest tumors and 15 mm2/mm3 or less for tumor volumes 
of 500 mm3 or greater. An increase in the average vessel 
diameter was again observed with increasing tumor size. The 
RVV in viable tissue was a constant 17% for all tumor sizes. 
The relative necrotic volume was less than 5% for tumor 
volumes of 35 mm3 and increased to over 40% in tumors 
with volumes over 1500 mm3.





In summary, tumors become vascularized by inducing 
angiogenesis in the veins, venules, and capillaries of the host 
tissue. Capillaries sprout toward the tumor and anastomose 
with each other and the host vessels to form a capillary net-
work through the tumor. Angiogenesis continues to occur 
beyond the tumor periphery to facilitate its increase in size. 
The host venous vessels are pushed away and remodeled 
before being incorporating into the growing tumor, while 
the patterns of the arterial vessels are unchanged as they are 
incorporated. The tumor capillaries develop abnormally. They 
dilate and become tortuous while retaining their capillary-like 
structure and not properly differentiating into arterials and 
venules. Associated with these changes are decreases in the 
vascular length and vascular surface area per unit volume of 
tissue but the RVV remains about the same. The host vessels 
that become incorporated in the tumor become disfigured too. 
They dilate and the arterial vessels become thin and ragged 
and eventually lose vasomotion. The tortuosity of tumor 
vessels causes vessel perfusion to fluctuate. When tumors 
become larger, the interstitial fluid pressure can become so 
great that small vessels become permanently occluded. This 
leads to blood stasis and the formation of necrotic regions, 
typically near the tumor center.
It must be noted that these observations are from tumors 
growing in rats and mice (and generally in the subcutaneous 
tissue), since only in such animal models has the develop-
ment of tumor vasculature been closely observed (for ethical 
and practical reasons). However, it is reasonable to assume 
that the development of vasculature in spontaneous human 
tumors shares similarities with the development in animal 
models.
Vasculature morphology in spontaneous 
human tumors
In the past few decades, the vasculature morphology has 
been quantitated in spontaneous tumors presenting in human 
patients. This has typically been done by staining the blood 
vessels in resected specimens using a marker such as von 
 Willebrand factor (vWF), CD34, or CD31. A compilation of 
the vasculature morphology data from the literature for various 
head and neck cancers is presented in Table 1. There are six 
publications for squamous cell carcinoma (SCC) of the oral 
cavity, two for laryngeal SCC and one for mucoepidermoid 
carcinoma of the salivary glands. Vasculature morphol-
ogy parameters include the highest microvascular density 
(h-MVD), the RVV, and the mean vessel diameter. For every 
measurement on carcinoma, the measurement on the corre-
sponding normal tissue is also presented. Measurements on 
dysplasia were included too. The table contains a description 
of the method used for each measurement.
There is usually large intratumoral heterogeneity in the 
MVD. For example, Wijffels et al31 found that for various 
human head and neck SCCs, the values for h-MVD were 
a factor of 1.5 to 6 times higher than the vascular density 
across the whole tumor section, referred to as the average 
MVD (a-MVD). Most groups32–39 report on the h-MVD. 
They do so by staining vessels and measuring the vascular 
density in the most vascularized areas or “hotspots” in the 
tumor, an approach pioneered by Weidner et al.40 The find-
ings in the table demonstrate that for oral SCC, laryngeal 
SCC, and mucoepidermoid carcinoma of salivary glands, 
the h-MVD is significantly higher in carcinoma than in the 
corresponding normal tissue, i.e., tumors contain regions that 
are more vascularized than anywhere in the normal tissue. 
Further, a significant increase from normal to dysplasia was 
found by Pazouki et al,32 Pignataro et al,34 Shieh et al,35 and 
Mohtasham et al39 but not by Li et al.36 From dysplasia to 
cancer, Li et al36 and Mohtasham et al39 found a significant 
increase, while Pazouki et al,32 Pignataro et al,34 and Shieh 
et al35 did not.
There is enormous variation in the values of h-MVD 
for oral SCC presented by different groups. On oppo-
site extremes, Mohtasham et al39 reported a value of 
57.8±10.8 mm-2, while Sharma et al38 found it to be 
240.53±92.3 mm-2. Elsewhere, Davey et al41 reported 
a median h-MVD of over 1000 mm-2 (and a median of 
~400 mm-2 for normal tissue). Schor et al42 demonstrated that 
measurements of h-MVD are highly subject to the method-
ology used, including the staining factor, the pretreatment, 
and the size of the subset area. There is also variation due 
to interobserver bias. For this reason, it was essential that 
normal tissue values be provided to serve as a reference 
point for the measurement on cancer.
The data also indicate that progression of oral SCC is 
accompanied by increasing RVV, which means tumors are 
overall more vascularized than normal tissue. This should 
also be reflected in the parameter a-MVD, but unfortunately 
there are limited data available. Davey et al41 reported that 
the a-MVD was significantly higher (p=0.01) in oral SCC 
than in normal oral mucosa for six specimens when stain-
ing vessels with vWF. Nevertheless, given the high degree 
of intratumor heterogeneity in vascularity, there can still be 
regions of a tumor, in which the vascularity is comparable 
to or even less than that in normal tissue.
Li et al36 commented that for oral SCC, high concentra-
tions of vascularization were most commonly found at the 
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margins of invasive regions. The same has been reported 
elsewhere.43 Li et al also noted that the vessels in normal oral 
mucosa were regularly distributed and had regular courses 
and cross-sectional shapes, whereas at the margin of oral 
SCC, the vessels had irregular courses and elongated cross-
sectional shapes.
The method of differential path length spectroscopy 
used by Amelink et al44 also enabled measurement of the 
microvascular oxygen saturation (StO
2
). They reported that 
the vessels were significantly less oxygenated in oral SCC 
than that in normal oral mucosa (p<0.05), with StO
2
 values 
of 81±21 and 95±5%, respectively. They also found that 
this was the case for bronchial carcinoma compared with 
normal bronchial mucosa.45 These findings suggest that the 
tumors contained poorly perfused vessels and thus blood 
depleted of oxygen.
Table 1 Vasculature morphology data for spontaneous human head and neck cancers
Reference (year) Cancer type Number of specimens Method Measurements
Pazouki et al32 (1997) Oral SCC 16 of normal oral 
mucosa, 30 of dysplasia 
(10 mild, 9 moderate, 
and 11 severe), and 
30 of cancer (14 
early and 16 late)
Vessels were stained 
for vWF, h-MVD was 
measured using the 
hotspot method and 
RVV was measured 
using Chalkley’s 
method
h-MVD (mm-2): normal 88±35, 
severe dysplasia 164±58,* and late 
SCC 148±53*
RVV (%): normal 3.7%±0.5%, 
increased linearly with severity of 
dysplasia, and SCC to 10.0%±2.5% 
for late SCC* (values for RVV were 
taken by reading off a graph)
Sawatsubashi et al33 
(2000)
Laryngeal SCC 10 of normal, 54 of 
invasive cancer
Vessels were stained 
for CD34, and h-MVD 
was measured using 
the hotspot method
h-MVD (mm-2): normal 21.67±3.00 
and cancer 37.34±2.64*
Pignataro et al34 (2001) Laryngeal SCC 20 of normal mucosa, 
20 of dysplasia, and 
20 of infiltrating 
carcinoma
Vessels were stained 
for CD34, and h-MVD 
was measured using 
the hotspot method
h-MVD (mm-2): normal 35.1±11.5, 
dysplasia 60.9±19.8,* and cancer 
74.8±19.0*
Shieh et al35 (2004) Oral SCC 12 of normal mucosa, 
28 of dysplasia, and 
50 of T2 cancer
Vessels were stained 
for CD34, and h-MVD 
was measured using 
the hotspot method
h-MVD (mm-2): normal 84±21, 
dysplasia 212±56,* cancer 
intratumoral 226±50,* and cancer 
peritumoral 240±58*
Li et al36 (2005) Oral SCC 12 of normal mucosa, 
26 of mild dysplasia, 
16 of moderate dysplasia, 
10 of severe dysplasia, 
and 98 of cancer
Vessels were stained 
for CD31, and h-MVD 
was measured using 
the hotspot method
h-MVD (mm-2): normal 31.0±13.4, 
mild dysplasia 37.4±10.8, moderate 
dysplasia 42.1±23.8, severe dysplasia 
48.1±19.6, and cancer 79.6±38.2*
Amelink et al44 (2008) Oral SCC 16+ of normal mucosa 




Mean vessel diameter (µm): normal 
24±14 and cancer 25±12
RVV (%): normal 1.0±0.9 and cancer 
2.2±2.3*
Shieh et al37 (2009) Mucoepidermoid 
carcinoma of 
salivary glands
35 of normal tissue and 
35 of cancer
Vessels were stained 
for CD34, and 
h-MVD was measured 
using the hotspot 
method
h-MVD (mm-2): normal 18.7±5.2 and 
cancer intratumoral 63.9±23.2*
Sharma et al38 (2010) Oral SCC 10 of normal mucosa and 
30 of cancer
Vessels were stained 
for vWF, and h-MVD 
was measured using 
the hotspot method
h-MVD (mm-2): normal 64.4±13.53 
and cancer 240.53±92.3*
Mohtasham et al39 
(2010)
Oral SCC 6 of normal mucosa, 
22 of dysplasia, and 42 of 
cancer
Vessels were stained 
for CD34, and h-MVD 
was measured using 
the hotspot method
h-MVD (mm-2): normal 27.5 ± 12.5, 
dysplasia 41.5±8.5,* and cancer 
57.8±10.8*
Note: *Significantly different to normal tissue (p<0.05).
Abbreviations: SCC, squamous cell carcinoma; h-MVD, highest microvascular density; RVV, relative vascular volume; vWF, von Willebrand factor.





Effects of the tumor vasculature on the 
tumor microenvironment
Ultimately, the tumor vasculature must be judged by how well 
it nourishes the tumor cells. In a study of surgical resections 
of human bronchial carcinoma, Thomlinson and Gray46 dis-
covered how the vasculature in spontaneous human tumors 
sometimes fails in this sense. They found that the tumor 
cells were located in cords, where each cord had a single 
blood vessel along its axis and outside of the cords there was 
necrosis. The obvious explanation for their discovery was 
that the availability of oxygen and nutrients decreases with 
increasing distance from the blood vessels and only tumor 
cells within the cords were close enough to a blood vessel to 
survive. A similar corded structure was observed in Yamaura 
and Sato’s chamber experiment,17 which was discussed in 
the first section of this review, but in that instance the cords 
appeared because only the largest vessels were still perfused 
after all of the smaller vessels had become occluded from 
the high interstitial pressure. In the present case, all of the 
vessels were perfused but apparently the vessel density was 
insufficient for the amount of oxygen available in the blood. 
Thomlinson and Gray recognized that there must be a large 
fraction of hypoxic cells in corded tumors, particularly in 
the outer regions of the cords bordering necrosis. Hypoxia 
of this nature is called “chronic hypoxia”. It is sometimes 
misleadingly referred to as “diffusion limited”. “Consump-
tion limited” would be a more accurate term.
An example of an animal tumor that has an innate corded 
structure is the mouse mammary tumor BICR/SA1 studied by 
Tannock.47 Necrosis and cords of viable tissue were evident 
even in the smallest tumors examined weighing 0.1 g. For 
tumors weighing between 0.5 and 3 g, the relative necrotic 
volume was 60 to 70% and increased slightly with tumor 
weight. Tumor cords had radii in the range 60 to 120 µm, and 
there was no systematic variation in the mean cord radius 
with tumor weight. It was found that for animals breathing 
only 10% oxygen, the mean tumor cord radius decreased 
from 85.1±2.2 to 75.5±8.8 µm. Tannock also investigated 
the patterns of cell proliferation in this tumor using tritiated 
thymidine. He found that proliferation in the tumor cords 
decreased with increasing distance from the blood vessels. 
He reported that this was due to a decrease in the fraction 
of cycling cells and that the cell cycle time did not vary. 
The growth fraction was 100% in the inner zone, 80% in 
the middle zone, and 50% in the outer zone of the cords. He 
noted that tumor cells must migrate centrifugally through 
the tumor cords. When a tumor cell divides, its daughter 
displaces neighboring cells further toward the cord  periphery 
and finally into the necrotic zone. He suggested that for every 
tumor cell produced by mitosis, on average one tumor cell 
becomes necrotic (neglecting longitudinal cord growth). 
Therefore in tumor cords, there is constant cell renewal. It 
was estimated that cells in the inner and middle zones took 
36 and 16 hours, respectively, to migrate to the outer zone.
A similar experiment was conducted by Hirst and 
Denekamp48 on the corded tumors of another transplant-
able mouse mammary carcinoma KHH. They reported that 
proliferation in this tumor did not vary between center and 
periphery, it only decreased with increasing distance from 
blood vessels. Unlike Tannock, they found that the cell 
cycle time did increase with increasing distance from the 
vessel, mainly due to the duration of the G
1
 phase, which 
was 7.2 hours in the inner zone, 11.8 hours in the middle 
zone, and 17.1 hours in the outer zone. The growth fraction 
decreased from 100% in the inner and middle zones to 58% 
in the outer zone of the cords. They too estimated that a cell 
labeled next to a vessel transversed the 90 µm to the outer 
zone in ~36 hours. In both this study and Tannock’s study, it 
was estimated that the growth fraction in the outer zone of the 
cord, which neighbored the necrotic region and presumably 
contained hypoxic cells, was over 50%. This large popula-
tion of radioresistant cells with the ability to repopulate the 
tumor would make these tumors difficult to eradicate with 
radiotherapy.
More recently, the effects of the vasculature on the tumor 
microenvironment have been explored in human tumors, par-
ticularly those of head and neck cancers, by staining tumor 
sections with markers for blood vessels and hypoxia. Wijffels 
et al31 studied the spatial relationship between hypoxia and 
blood vessels in 22 specimens of human SCC of the orophar-
ynx, larynx, and hypopharynx. Blood vessels were stained by 
Pathologische Anatomie Leiden-Endothelium (PAL-E), and 
hypoxia was stained by pimonidazole. Pimonidazole bind-
ing occurs at oxygen tensions less than 10 mmHg.49,50 The 
fraction of the tumor section stained by pimonidazole, called 
the hypoxic fraction, varied between 2 and 29% across the 
entire tumor surface. Of the 22 tumors, 16 had a total hypoxic 
fraction above 5%. For these tumors, to quantitate the distri-
bution of hypoxia in relation to the vasculature, the hypoxic 
fraction was calculated in zones at increasing distance from 
the nearest blood vessel (0–50, 50–100, 100–150 µm, etc.). 
Accordingly, tumors were separated into three categories. 
One category of tumors had hypoxia between 50 and 200 µm 
from vessels and small areas of necrosis beyond 150–200 µm. 
These tumors possessed a typical corded structure (Figure 2). 
Another category of tumors had very little hypoxia within 
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100 µm of vessels and significant amounts of viable, hypoxic 
tissue at distances greater than 200 µm. The stark contrast 
between these categories suggests that oxygen consumption 
and delivery varied considerably between tumors. In the last 
category, tumors had considerable amounts of hypoxia within 
50 µm of blood vessels, where there are ordinarily normoxic 
cells. Hypoxia this close to blood vessels is caused by a 
temporary absence of vessel perfusion and is termed “acute 
hypoxia” to distinguish it from consumption-limited, chronic 
hypoxia. In each category, the tumors showed an increase 
in the hypoxic fraction in zones at increasing distance from 
blood vessels (at least before the onset of necrosis).
An alternative hypoxia marker to pimonidazole is car-
bonic anhydrase 9 (CA9). CA9 is typically expressed at 
oxygen tensions less than 20 mmHg.51 Since it has a higher 
threshold than pimonidazole, it should stain closer to blood 
vessels. Hoogsteen et al52 found this was the case in a study 
of 103 human biopsies of laryngeal SCC. For 18 tumors of 
assorted human head and neck SCCs, Beasley et al53 found 
that the distance from blood vessels (stained by CD34) to the 
start of CA9 expression was between 40 and 140 µm (median 
80 µm) and the distance from blood vessels to the onset of 
necrosis was between 80 and 200 µm (median 130 µm).
Further insights have been gained from staining tumor 
sections with markers for perfusion and proliferation in con-
junction with markers for vessels and hypoxia. By staining 
vessels with 9F1, perfusion with Hoechst 33342, and prolif-
eration with S-phase marker BrdUrd, Bussink et al54 showed 
that proliferation staining decreased in zones at increasing 
distance from both perfused and nonperfused vessels in 
xenografts of human laryngeal SCC grown subcutaneously 
in mice. Proliferation was higher near perfused than nonper-
fused vessels, but proliferation close to nonperfused vessels 
was comparable to or greater than it was at larger distances 
from perfused vessels. This indicated that the nonperfused 
vessels were recently perfused and thus vessel perfusion 
fluctuated in these tumors.
In a study of xenografts of human head and neck SCCs 
grown subcutaneously in mice, Ljungkvist et al55 found that 
different vasculature structures give rise to different distri-
butions of hypoxia. By staining blood vessels with 9F1 and 
hypoxia with pimonidazole, two distinct patterns of hypoxia 
were identified. Patchy hypoxia was associated with a typical 
tumor cord structure. Ribbon-like hypoxia occurred when 
the vessels were in sheet structures that formed concentric 
lobe shapes. In both cases, the hypoxic fraction increased 
and proliferation staining with BrdUrd decreased in zones at 
increasing distance from blood vessels. They found that there 
was considerable overlap between hypoxia and proliferation, 
particularly at 100–150 µm from vessels.
Some human head and neck cancers are well oxygenated. 
Wijffels et al56 conducted a study of eight specimens of human 
salivary gland carcinoma and found that none contained any 
hypoxia according to staining with pimonidazole and CA9. 
They also stained blood vessels with PAL-E, and it was 
apparent that the MVD was high across the entire tumor 
sections. The a-MVD varied from 209 to 546 mm-2 (median 
285 mm-2). There were no measurements on normal tissue 
to compare with, but they reported in the aforementioned 
study of oropharyngeal, laryngeal, and hypopharyngeal SCCs 
(again staining vessels with PAL-E) that the a-MVD varied 
between 11 and 67 mm-2 (median 42 mm-2). Assuming they 
used similar methodologies between studies, it is safe to 
conclude that these salivary gland carcinomas were extremely 
vascularized. Along with the lack of hypoxia, there was no 
clear spatial relationship between proliferation staining with 
IdUrd (another S-phase marker) and vessel structures.
Conclusion
Studies of tumor transplants growing subcutaneously in 
rats and mice reveal that the tumor vasculature develops 
inefficiently under the imbalance of angiogenic regulators. 
The tumor vessels are unorganized and become increasingly 
tortuous and disfigured, hindering vessel perfusion. When 
tumors become large, high interstitial fluid pressures can 
develop, which cause vessels in the tumor to permanently 
shut, resulting in blood stasis and the development of mac-
roscopic necrosis.
Figure 2 Fluorescence microscopic image of a tumor section after staining for 
hypoxia (green) and vessels (red).
Notes: A typical corded structure is recognizable. There are well-oxygenated 
areas directly adjacent to vessels, further out there is hypoxia and at even greater 
distances there is necrosis (white arrow). Adapted with permission from Macmillan 
Publishers Ltd on behalf of Cancer Research UK: British Journal of Cancer, Wijffels 
KIEM, Kaanders JHAM, Rijken PFJW, et al, Vascular architecture and hypoxic 
profiles in human head and neck squamous cell carcinomas, 2000;83(5):674–683,31 
copyright 2000. 





Data from spontaneous human head and neck cancers 
show that there are typically regions in the tumor that are 
more vascularized than any region in the normal tissue. 
Although the data are limited, it seems that tumors are also 
more vascularized overall. This is not trivial – the opposite 
has been reported for esophageal SCC57 and lung cancer.58 
However, tumor vascularity is highly heterogeneous, and 
there can still be regions of head and neck cancers, in which 
the vascularity is comparable to or even less than that in nor-
mal tissue. Vascular hotspots are most commonly observed 
in invasive regions of the carcinoma. Like in animal models, 
the vessels in spontaneous human carcinomas are observed 
to be irregular and tortuous compared to those in the normal 
tissue, thus hindering perfusion and reducing the oxygenation 
levels in the blood, as evidenced by StO
2
 measurements.
By staining tumor sections of head and neck cancers with 
markers for vessels, perfusion, hypoxia, and proliferation, 
it becomes apparent that the tumor vasculature intimately 
shapes the microenvironment. Acute hypoxia is observed 
near vessels that were not recently perfused (though perfu-
sion fluctuates and the acute hypoxia soon moves elsewhere), 
and chronic hypoxia is observed at a distance from perfused 
blood vessels. Chronic hypoxia according to staining of 
pimonidazole began at distances between 75 and 125 µm 
from vessels, while chronic hypoxia according to CA9 
expression began at distances between 40 and 140 µm from 
vessels, with the difference largely reflecting their different 
oxygen tension thresholds for binding and expression. The 
distance from blood vessels to the onset of necrosis varied 
from 80 to 300 µm. The distance from blood vessels to the 
onset of chronic hypoxia, observed by staining or expression 
of a hypoxic marker, depends on the blood oxygenation and 
the metabolic demands of the tumor cells. The distance from 
blood vessels to the onset of necrosis depends on these fac-
tors and the tolerance of the tumor cells to hypoxia. Chronic 
hypoxia and necrosis are observed closer to vessels in tumors 
than in normal tissue because the blood oxygenation is less 
in tumors, and tumor cells typically have increased metabolic 
demands. Thus, the vascular density in the tumor does not 
need to be less than that in normal tissue for chronic hypoxia 
to occur.
In practice, acute hypoxia and chronic hypoxia are limited 
to the least vascularized regions of tumors for head and neck 
cancers. In these regions, there was an increase in staining 
of hypoxia markers and a corresponding decrease in staining 
of proliferation markers with increasing distance from the 
vessels. Microscopic regions of necrosis were also observed 
at large distances from vessels. The decrease in proliferation 
may possibly be attributed to a decreasing growth fraction 
(as hypoxic cells are held up at cell cycle checkpoints) and 
lengthening of the duration of the G
1
 phase of the cell cycle. 
Thus, tumor cells become more radioresistant further from the 
vessels as more of them are hypoxic and more are found in the 
relatively radioresistant G
1
 phase. Contrastingly, in vascular 
hotspots, there was little hypoxia staining and no clear spatial 
relationship between proliferation staining and the vessels.
Since the morphology of the tumor vasculature strongly 
affects the tumor microenvironment, the tumor vasculature 
should ideally be included in models that simulate tumor 
growth and tumor response to irradiation. This is especially 
necessary when modeling poorly oxygenated tumors like 
those of head and neck cancers. Such radiotherapy models 
are highly valuable for their insight, utility, and predictive 
powers. They may be used to determine the most effective 
radiotherapy treatment schedule for a given set of tumor 
properties. It is hoped they will lead to better customization 
of radiotherapy treatment plans on an individual patient basis 
by accounting for interpatient variations in tumor properties. 
Indeed, some radiotherapy models have been developed that 
include a basic representation of the tumor vasculature,59,60 
but since the vasculature can have such a strong effect, it 
is important that it be modeled as realistically as possible. 
Accurate simulation of the tumor vasculature will also be 
important in exploring and optimizing vascular targeting 
treatment techniques. It is hoped that the quantitative vas-
culature morphology data compiled within will assist with 
the modeling efforts to come.
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2.3 Discussion and Conclusion
It was interesting to find that hypoxia does not typically arise in tumours of HNSCC
due to a diminished vessel density; conversely, the vessel density is usually greater
in tumours than in normal tissue. Rather, it is due to decreased oxygen levels in
the blood (chronic hypoxia) and temporally inhibited blood flow (acute hypoxia).
This occurs because there are imbalanced factors (e.g. vascular endothelial growth
factor), producing immature and deformed vessels, with no proper system of flow
through artery→arteriole→capillary→venule→vein, and there are high interstitial
pressures that squash and occlude vessels. The tumour growth model developed in
Chapter 4 makes particular use of the findings that, in tumours of HNSCC, the
relative vascular volume (RV V ) varies from 2 to 10% and the distance from vessels
to the onset of necrosis (necrosis distance; ND) varies from 80 to 300 µm.
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Background on radiobiological modelling
and the Geant4 Monte Carlo toolkit
3.1 Introduction
This chapter provides background for the computational models developed in
this thesis, with which we aim to predict the response of a tumour to a course
of radiotherapy, taking into account properties of the tumour (e.g. hypoxia)
and details of the treatment (e.g. fractionation schedule). Since the modelling
must incorporate radiobiological mechanisms, a glossary of the most important
radiobiological effects is provided for completeness. Justification is then given for
a transition from deterministic to stochastic models of radiotherapy. One way to
incorporate a stochastic element is by performing the irradiation using Monte Carlo
track structure simulations. This was done in the current work (see Chapters 6
and 7) using the Geant4 toolkit. Relevant background is provided on Geant4
and its low-energy extension Geant4-DNA. Particular attention is paid to the
chemistry module of Geant4-DNA, which was used to simulate water radiolysis
and the indirect effect of ionising radiation.
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3.2 The Rs of radiobiology
Predicting clinical outcomes of radiotherapy treatments is a challenging endeavour
that implores the simulation of many complicated physical, chemical and biological
mechanisms. The principle biological mechanisms involved in the radiation response
are captured in the “Rs of radiobiology” [57–60]:
• Repair of sub-lethal DNA damage in tumour stem cells (and normal stem
cells).
• Repopulation as surviving stem cells divide and regrow the tumour (and
normal tissue), e.g., by loss of asymmetry in stem cell division.
• Redistribution of cells in the cell cycle. In tumour cells, genes, such as p53,
that regulate cell cycle checkpoints may be mutated and the checkpoints absent.
This, combined with the phase of the cell cycle affecting radiosensitivity,
may give rise to different distributions of cell cycle phases between tumour
and normal cell populations. This may affect tumour and normal tissue
radiosensitivities to a subsequent fractional dose.
• Reoxygenation of the tumour after irradiation. The tumour shrinks and
surviving (radioresistant) hypoxic cells gain better access to the oxygen and
other nutrients in the blood.
• Radiosensitivity of cells, which is dictated by exogenous factors such as
pO2 as well as endogenous factors pertaining to the genome (e.g. mutated
DNA repair pathways, cell cycle checkpoints, signal transduction) and the
cell cycle phase (cells in S-phase are more radioresistant than cells in G2 or
mitosis).
Additional Rs have also been proposed, including [61, 62]:
• Dose-rate effect, which denotes the increase in isoeffective dose with de-
creasing dose rate. This is because at low dose rates, repair of DNA damage
(and other biological processes; the first four Rs) occurs during irradiation.
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• (Remote) bystander effects, referring to the observation that cells can die
from irradiation of neighbouring cells, possibly because irradiated cells secrete
factors and transfer harmful molecules (long-lived reactive oxygen species) via
gap-junctions.
3.3 Deterministic versus stochastic
radiobiological models
Radiobiological models may broadly be categorised as deterministic or stochastic.
Deterministic models (a.k.a. analytic models) solve for a set of equations and are
typically fast. Stochastic models take a different approach that involves sampling
from one or more random probability distributions. A stochastic approach is more
appropriate when the process being modelled is itself stochastic in nature, as is the
case for radiation interactions with matter, for example. While stochastic models of
stochastic phenomena can achieve greater accuracy and utility than deterministic
models, it is at the expense of increased computation time.
The most renowned radiobiological model, the Linear Quadratic (LQ) model, is
deterministic. It relates the surviving fraction of cells, S, to the dose delivered, D:
S = e−αD−βD2 (3.1)
The LQ model often provides a good fit to experimental data of clonogenic cell
survival for certain values of the α and β parameters. Note that this is a macroscopic
model that arose from curve fitting [63], but there can be radiobiological meaning
attached to it relating to microscopic processes (see Chapter 7). It overestimates
the effect at high doses (& 10 Gy), where the true response becomes linear (possibly
associated with vasculature damage, immunological effects or breakdown of the
Poisson assumption) [64–68].
If the dose is delivered in n fractions, each of dose d (D = nd), the LQ
model becomes:
S = e−n(αd+nβd2) (3.2)
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This allows for tentative comparison between different fractionation schedules, but
noting that repopulation between dose fractions is neglected. Improvements have
been suggested in the form of a time parameter and additional terms to account for
repair, repopulation, redistribution and reoxygenation [45, 69]. However, a purely
deterministic model may be too restrictive and inappropriate for tackling the highly
complex and inherently stochastic processes in radiotherapy.
A radiobiological model of radiotherapy is an excellent candidate for stochastic
methods. In this thesis, such a model is developed that is stochastic in tumour
cell modelling, meaning each cell is modelled individually with stochastic elements
(e.g. spatial coordinates of cells, cell cycle times, asymmetric vs symmetric stem
cell division), and uses Monte Carlo track structure simulations for modelling
the radiation effect. The remainder of this chapter describes how Monte Carlo
(stochastic) track structure is simulated in Geant4.
3.4 The Geant4 Monte Carlo toolkit
Simulating the passage of a particle (e.g. an electron) through matter (e.g. water)
using Monte Carlo methods generally consists of calculating the probability of
interaction for all of the possible physics processes available to it given the material
it is in (e.g. electron ionisation in water), and then selecting one of these processes
to occur based on randomly sampling the interaction probabilities [44]. This is
repeated for the next physics process and so on, tracking the particle until it stops or
leaves the simulation volume. Some physics processes generate secondary particles
and these are tracked in the same way.
The prototypical code for Monte Carlo track structure simulation in the low-
energy domain of radiobiology/medical physics is Friedland et al’s PARTRAC
(Particle Tracks) [46, 54, 70, 71]. However, this code is not publically available.
Another excellent code in the field of radiobiology is RITRACKS (Relativistic Ion
Tracks), developed by I. Plante [72, 73], which can be used but not developed.1
1RITRACKS may be obtained in black box form from NASA upon request: https://software.
nasa.gov
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The (private) KUBEC code is also eminent in the radiobiological domain [74].
Other codes include PITS [75], NOREC [76], MC4 [77], TRIOL [78], CPA100 [79],
MOCA [80], PROTON and DELTA [81].
The track structure simulations in this project were performed using the Monte
Carlo toolkit Geant4 [38–40, 82]. Geant4 is open-source (all of its code is accessible),
free to download, regularly updated and routinely verified. It is written in C++
and, thanks to its object-oriented modular structure, it is easy for users to develop
their own unique applications to meet their specific needs. While it was originally
developed for high energy physics, it has found application in other fields including
space radiation and medical physics.
The basic structure of Geant4 is as follows. Please refer to the user and developer
guides available on the official Geant4 website [82] for more comprehensive details.
Note that names of C++ classes will be written in purple and names of C++ functions
will be written in orange. A Geant4 application requires, at minimum, the following
classes (in addition to the main() function):
• DetectorConstruction: Constructs the simulation geometry by placing
volumes of different shapes and materials in different positions and orientations.
Geometries from atomistic DNA structure to a high energy physics detector
can be achieved in this way (Figure 3.1).
• PhysicsList: Defines the physics processes to mediate particle interactions
with materials. For each process (e.g. electron ionisation in water), there are
multiple models to choose from; some alternative and some complementary
(e.g. Moller-Bhabha, Livermore, Penelope, Born, Emfietzoglou and CPA100
ionisation models). The physics list can be constructed piece-wise from scratch
or there are pre-made physics lists to choose from depending on the application
(the energy range).
• PrimaryGeneratorAction: Specifies the source(s) of particles, including
the particle type, energy distribution, position, direction and shape.
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(a) (b)
Figure 3.1: Examples of geometries simulated in Geant4. (a) Atomistic chromatin fibre
loop. Reprinted from Nuclear Instruments and Methods in Physics Research B, 346, Tajik
M, Rozatian ASH, Semsarha F, Calculation of direct effects of 60Co gamma rays on the
different DNA structural levels: A simulation study using the Geant4-DNA toolkit, pp
53-60, Copyright 2015 [50], with permission from Elsevier. (b) ATLAS detector at the
Large Hadron Collider, CERN [83].
• ActionInitialization: Defines the user action classes (see below) to be
invoked during the simulation (including the mandatory PrimaryGeneratorAc-
tion).
As alluded to, there are several optional user action classes, which are useful
for extracting information about the simulation. They include:
• RunAction: The “run” refers to the sum of all the primary particles,
i.e., the whole simulation. The RunAction class has member functions
PreUserRunAction and PostUserRunAction. They enable user actions before
and after the run, respectively (e.g. initialise a data analysis tool in Pre and
write the data to a file in Post).
• EventAction: Each primary particle is called an “event”. The Pre &
PostUserEventAction functions enable user actions before and after each
event (e.g. query the state of the random number generator engine for the
upcoming event in Pre).
• TrackingAction: A “track” stores the current information of a particle,
including dynamic quantities (energy, momentum, position, time, etc.) and
static quantities (charge, mass, etc.). The Pre & PostUserTrackingAction
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functions enable user actions at the beginning and end of tracks (e.g. accessing
the initial and final energies of particles).
• SteppingAction: A track can only be changed by a process and each
change occurs in a “step”. A step contains information about which process
is responsible for it, the coordinates and volumes at the beginning and
the end of the step and the changes in energy and momentum in the step.
The UserSteppingAction function enables user actions during each step (e.g.
accessing any of the above information about steps).
The free-to-download Geant4 software includes a large number of example
applications. These range from beginner to advanced level and perform different
tasks. They demonstrate the impressive capabilities of Geant4 and how to make
use of them in your own application. The examples often include visualisation,
achieved with software such as OpenGL [84] and DAWN [85]. Note that names
of example applications will be written as example.
3.5 The low energy extension Geant4-DNA
Geant4-DNA is the low energy extension of Geant4, developed for modelling early
biological damage induced by ionising radiation at the DNA scale [41–43, 86]. It uses
many of the same interaction cross sections as PARTRAC and similar simulation
techniques. Geant4-DNA is divided into physics and chemistry compartments.
3.5.1 Geant4-DNA physics
Geant4-DNA physics is unique (compared to the other physics lists in Geant4) in
that it uses discrete, step-by-step (a.k.a event-by-event) processes, as opposed to
condensed history processes, and electrons are tracked in this manner down to eV
energies. Figure 3.2 illustrates the difference between the Livermore physics list
(which is relatively low energy) and Geant4-DNA physics. The difference is critical,
as there is biological effect at the end of the electron track (the “sting in the tail” [87]).
A limitation of Geant4-DNA, however, is that it currently only simulates interactions





Figure 3.2: Comparison of Livermore versus Geant4-DNA physics lists for tracking an
electron (red) in water, with initial energy 1 keV and initial direction up the page. The
three scale bars are mutually orthogonal and each 50 nm long.
in liquid water (of variable density). In other words, real biological molecules and
proteins, such as DNA, cannot yet be modelled. Instead, geometries representing
these molecules and proteins but containing liquid water are typically modelled.
Geant4-DNA physics can be used to simulate ionisations and excitations of water
molecules in a DNA geometry (the so-called “direct effect” of ionising radiation)
and of bound water molecules in the first hydration layer of DNA (the “quasi-direct
effect”). The direct and quasi-direct effects are collectively termed “direct-type
effects”. There is also the “indirect effect”, whereby radiation interacts with water
to produce radical2 species that in turn react with DNA (more in Chapter 6).
The chemistry module of Geant4-DNA simulates water radiolysis, allowing for
consideration of the indirect effect.
3.5.2 Geant4-DNA chemistry
Water radiolysis is simulated in Geant4-DNA in temporal stages [88]. Virtual
time is denoted by t.
2A radical is an atom or molecule with an unpaired electron and is highly reactive.
3. Radiobiological modelling and Geant4 37
Physical stage (t < 10−16 s)
Electrons are tracked through the water medium as they undergo physical inter-
actions including elastic scattering, ionisation (H2O −−→ H2O+ + e– ), electronic
excitation (H2O −−→ H2O*) and dissociative attachment (H2O+ e– −−→ H2O– ).
The result is a spatial distribution of H2O+, H2O*, H2O– and e– as spheres or
point-like objects along the electron track.
Physicochemical stage (10−16 < t < 10−12 s)
Disocciation or relaxation of water ions and molecules (process name
“H2O_DNAMolecularDecay” of class G4DNAMolecularDecay) produces various
radical species, e.g.:
H2O+ −−→ H3O+ + •OH (3.3)
H2O∗ −−→ •OH + H• (3.4)
H2O− −−→ •OH + OH− + H2 (3.5)
H2O* and H2O+ may also undergo electron hole recombination (process class
G4DNAElectronHoleRecombination). Each e– is surrounded by a cage of water
(e– +H2O −−→ e–aq) becoming a “solvated” or “aqueous” (aq) electron. The result is
a spatial distribution of •OH, e–aq, H•, OH– , H3O+ and H2 as spheres or point-like
objects along the electron track.
Chemical stage (10−12 < t < 10−6 s)
The various chemical species diffuse away from the initial electron track under
Brownian motion (process class G4DNABrownianTransportation) (Figure 3.3). For




where D is the diffusion coefficient. The diffusion coefficients used in Geant4-DNA
for the various chemical species are shown in Table 3.1. If two molecules are potential
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Table 3.1: Difussion coefficients in Geant4-DNA [88].








reactants and the distance between them becomes less than the reaction radius, a
chemical reaction occurs. The possible reactions modelled in Geant4-DNA are:
•OH + •OH −−→ H2O2 (3.7)
•OH + e−aq −−→ OH− (3.8)
•OH + H• −−→ no product (3.9)
H3O+ + e−aq −−→ H• (3.10)
e−aq + e−aq −−→ OH− + OH− + H2 (3.11)
e−aq + H• −−→ OH− + H2 (3.12)
H• + H• −−→ H2 (3.13)
H3O+ + OH− −−→ no product (3.14)
e−aq + H2O2 −−→ OH− + •OH (3.15)
Note that these reactions tend to decrease the number of radicals over time.
Colliaux et al [89], using a different code, also simulated molecules of O2 and
reactions involving O2.
The simulation technique for the chemical stage
As mentioned above, molecules diffuse during the chemical stage according to
Brownian motion. The transportation method implemented in Geant4-DNA is [90]:







2Dτ ·N(0, 1) +O(τ 2) (3.16)
where:
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50 nm
(a) t = 2 ps
50 nm
(b) t = 100 ps
50 nm
(c) t = 1 ns
500 nm
(d) t = 1 µs
Figure 3.3: Time evolution of the chemical stage in Geant4-DNA for a 1 keV electron
track (red) in water. The chemical species diffuse away from the electron track as virtual
time progresses. Chemical species shown: •OH (magenta), H3O+ (yellow), e–aq (blue),
H2O2 (green), H• (cyan) and H2 (brown) (OH– not shown).
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• t0 is the initial time,
• τ is the time interval,
• x0 is the initial position,
• F is the external force,
• m is the mass,
• γ is the friction constant,
• D is the diffusion coefficient, and
• N(0, 1) is a random number described by a Gaussian distribution of mean 0
and variance 1.
The simulation of the chemical stage uses the Step-By-Step (SBS) method. Using
this method, all chemical species are stepped (with randomised Brownian transport)
in the same (virtual) time steps. After a time step, if two reactants are separated
by less than the reaction radius, a reaction occurs.
The question then arises as to what time steps to use? With larger time steps,
there is more chance of missing reactions, while smaller time steps require more
computation time (and the Smoluchowski equation is not valid if the time step is
less than the relaxation time of velocity - see [90]). The developers of PARTRAC
noted that the molecules are closest together at the beginning of the chemical
stage and move further apart as time goes on, so reactions become less likely
over time [71]. Accordingly, they proposed time steps that start small and get
larger as the virtual time progresses.
To improve upon this approach of static time steps, a method of dynamic time
steps was developed. A time step, tD, is defined for a given pair of reactants as the
time during which no reaction will occur, with 95% confidence. This is referred
to as the “maximum diffusion time without reaction” or the “minimum encounter
time”. The minimum encounter time is calculated for each possible reaction using
the closest pair of reactants, and the smallest tD is used for the time step. With
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Table 3.2: Conventional minimum time steps for the chemical stage in Geant4-DNA.
Virtual time (ps) Minimum time step (ps)
1− 10 0.1
10− 102 1
102 − 103 3
103 − 104 10
104 − 106 102
this approach of dynamic time steps, the time steps should naturally become larger
as virtual time goes on and it is unlikely that reactions will be missed.
The downside of dynamic time steps is that before a reaction occurs, there
will be smaller and smaller time steps as the pair of reactants move closer and
closer together, thus increasing the computation time. To overcome this limitation,
Geant4-DNA uses a combination of dynamic and static time steps, as follows. It
introduces a minimum time step, tlimit, which is a function of the virtual time
(Table 3.2). If the smallest tD is less than tlimit, all pairs of reactants with tD < tlimit
are recorded and then all molecules are diffused for a time step of tlimit. For
those pairs of reactants that previously had tD < tlimit, if after the time step their
separation distance is (again) greater than the reaction radius, there is a possibility
that their separation distance was less than the reaction radius for some time
during the time step. The likelihood of this is calculated using the Brownian bridge
technique (see [90] for details) and a reaction may be simulated in retrospect.
The Independent Reaction Time (IRT) method is an alternative to the Step-By-
Step method. It is an event-driven simulation in which a reaction occurs at every
time step. Reactions are decided at the creation of molecules, without modelling
diffusion. RITRACKS offers both SBS and IRT [72].
3.5.3 How to implement Geant4-DNA
To use DNA physics and chemistry in a Geant4 application requires the following
(as demonstrated in example chem1):
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1. Register DNA physics and chemistry in the PhysicsList.cc file, as shown in
Listing 3.1.
Listing 3.1: Registering Geant4-DNA physics and chemistry in PhysicsList.cc
(C++).
#include <Phys i c sL i s t . hh>
#include <G4EmDNAPhysics . hh>
#include <G4EmDNAChemistry . hh>
. . .
Phys i c sL i s t : : Phys i c sL i s t ( )
: G4VModularPhysicsList ( )
{
. . .
Reg i s t e rPhys i c s (new G4EmDNAPhysics ( ) ) ;
Reg i s t e rPhys i c s (new G4EmDNAChemistry ( ) ) ;
}
Alternatively, activate DNA physics and chemistry only in a given G4Region
using the member function AddDNA of class G4EmParameters (see example
neuron).
2. Implement a StackingAction that instructs the program to begin simulating
chemistry (the physicochemical and chemical stages) when the physical stage
ends, as shown in Listing 3.2.
Listing 3.2: The necessary StackingAction.cc to use Geant4-DNA chemistry
(C++).
#include <StackingAct ion . hh>
#include <G4StackManager . hh>
#include <G4DNAChemistryManager . hh>
. . .
void StackingAct ion : : NewStage ( )
{
i f ( stackManager−>GetNTotalTrack ( ) == 0) // a l l phy s i c a l t r a ck s
have been proces sed
{
G4DNAChemistryManager : : In s tance ( )−>Run( ) ; // begin chemistry
}
}
3. Notify your program of the StackingAction by including it in your ActionIni-
tialization (Listing 3.3).
Listing 3.3: Modifying the ActionInitialization.cc to use Geant4-DNA chemistry
(C++).
#include <Ac t i o n I n i t i a l i z a t i o n . hh>
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#include <StackingAct ion . hh>
. . .
void Ac t i o n I n i t i a l i z a t i o n : : Bui ld ( ) const
{
. . .
SetUserAction (new StackingAct ion ( ) ) ;
. . .
}
The user may change the minimum time steps used in the chemical stage in
a TimeStepAction.cc file (Listing 3.4).
Listing 3.4: Setting the minimum time steps for the chemical stage in TimeStepAction.cc
(Geant4-DNA) (C++).
#include <TimeStepAction . hh>
. . .
TimeStepAction : : TimeStepAction ( ) : G4UserTimeStepAction ( )
{
AddTimeStep (1∗ picosecond , 0 .1∗ picosecond ) ;
AddTimeStep (10∗ picosecond , 1∗ picosecond ) ;
AddTimeStep (100∗ picosecond , 3∗ picosecond ) ;
AddTimeStep (1000∗ picosecond , 10∗ picosecond ) ;
AddTimeStep (10000∗ picosecond , 100∗ picosecond ) ;
/∗
∗ E. g . from 1 picosecond to 10 picosecond , the minimum time
∗ s tep i s 0 . 1 p icosecond .
∗/
}
The user can also change the duration of the chemical stage in the ActionIni-
tialization (Listing 3.5):
Listing 3.5: Adjusting the duration of the chemical stage in ActionInitialization.cc
(Geant4-DNA) (C++).
#include <Ac t i o n I n i t i a l i z a t i o n . hh>
#include <G4DNAChemistryManager . hh>
#include <G4Scheduler . hh>
. . .
void Ac t i o n I n i t i a l i z a t i o n : : Bui ld ( ) const
{
. . .
i f (G4DNAChemistryManager : : I sAct iva ted ( ) )
{
. . .
// Uncomment to stop the chemical s tage a f t e r
// . . . a g iven number o f time s t ep s :
//G4Scheduler : : In s tance ( )−>SetMaxNbSteps (50) ;
// . . . or r each ing t h i s v i r t u a l time :
G4Scheduler : : In s tance ( )−>SetEndTime (1∗ nanosecond ) ;
}
}
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The example chem3 demonstrates user interactivity with the chemical tracks
via TimeStepAction.cc, ITTrackingAction.cc and ITSteppingAction.cc files. The
TimeStepAction class permits user interaction in-between time steps and after
chemical reactions with its member functions UserPostTimeStepAction and User-
ReactionAction, respectively. The ITTrackingAction and ITSteppingAction classes
are analogous to TrackingAction and SteppingAction for chemical tracks rather
than physical tracks.
Finally, some miscellaneous pieces of advice relating to Geant4-DNA chemistry:
• If the user wishes to unnaturally kill a chemical track (e.g., to simulate
additional scavenging), they may do so in the ITTrackingAction or ITSteppin-
gAction. It was this user’s experience (using Geant4 version 10.4) that chemical
tracks are best killed in the PreUserTrackingAction of ITTrackingAction to
avoid a G4Exception or segmentation fault, as demonstrated in Listing 3.6.
Listing 3.6: Safely killing a chemical track in ITTrackingAction.cc (Geant4-DNA)
(C++).
#include <ITTrackingAction . hh>




PreUserTrackingAction ( const G4Track∗ t rack )
{
// i f ( /∗some cond i t i on i s met∗/ )
//{
G4Track∗ t r = (G4Track∗) t rack ;
tr−>SetTrackStatus ( fKi l lTrackAndSecondar ies ) ;
//}
}
• Energy deposition should be scored in the (physical) SteppingAction or via
a primitive scorer (like in example RE02). These two methods give the
same result and they do not receive a contribution from DNA chemistry.
Energy deposition should not be scored in the ITSteppingAction, where there
will very rarely be energy deposited due to non-dissociative relaxation of H2O.
• Colleagues and I have had issues with a G4Exception occasionally occurring
called “Outside of mother volume”. It reports that a “Product has been
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placed outside of the volume containing the mother molecule”. This can
be commented out in G4DNAMolecularDisssociation.cc, seemingly without
detriment.
3.6 Summary
The current chapter has provided an overview of the radiobiological principles and
software tools employed in the computational models that follow. The principal
radiobiological effects described were carefully considered in the development of the
cellular tumour growth model, described in Chapters 4 and 5, and impacted the DNA
damage and radiation-induced cell kill modelling in Chapters 6 and 7. Background
was provided on the simulation of ionising radiation from first principles with Monte
Carlo track structure. The elegant structure of Geant4 was described, along with
the sophisticated simulation of physical tracks and radiolytic chemical tracks in
Geant4-DNA. These technical details should assist the reader in Chapters 6 and 7,
where the Geant4-DNA software is applied.
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Development of an in silico stochastic 4D
model of tumor growth with angiogenesis
The publication [91] forms the basis of this chapter:
Forster JC, Douglass MJ, Harriss-Phillips WM, Bezak E. Development of an
in silico stochastic 4D model of tumor growth with angiogenesis. Med Phys. 2017
Apr; 44(4):1563-1576. doi: 10.1002/mp.12130.
4.1 Introduction and Motivation
This is the first of two publications on the HNSCC tumour growth model. The
model is spatio-temporal, multicellular and includes tumour angiogenesis. This
paper describes the development of the model, including a detailed description of the
computational methods. Other tumour growth models in the literature are briefly
reviewed in the Introduction. The main goals for the model were: randomised cell
positions, tumour growth by cell division (including an epithelial cell hierarchy),
and growth of a connected network of blood vessels interwoven between the cells.
Chronic hypoxia and necrosis were simulated in the tumour.
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48 4.2. Statement of Contribution
4.2 Statement of Contribution
4.2.1 Conception
The model methods were conceived by Jake Forster under the supervision of Michael
Douglass, Wendy Phillips and Eva Bezak, based on their previous work and the
idea of a spatial-temporal multicellular tumour model.
4.2.2 Realisation
Jake Forster developed the model (i.e. wrote the code), wrote the code to run
the simulations to acquire data, wrote the code to run the simulations on a
supercomputer, ran the simulations on a supercomputer, analysed the data and made
the plots for visualising data. The manuscript was evaluated by Eva Bezak, Wendy
Phillips and Michael Douglass for data accuracy, critical appraisal, conclusions
reached and general structure and flow.
4.2.3 Documentation
The manuscript was primarily written by Jake Forster, who also prepared the




Development of an in silico stochastic 4D model of tumor growth with
angiogenesis
Jake C. Forster,a) Michael J.J. Douglass, and Wendy M. Harriss-Phillips
Department of Physics, University of Adelaide, North Terrace, Adelaide, South Australia 5005, Australia
Department of Medical Physics, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000, Australia
Eva Bezak
Sansom Institute for Health Research and School of Health Sciences, Division of Health Sciences, University of South Australia,
Adelaide, South Australia 5001, Australia
Department of Physics, University of Adelaide, North Terrace, Adelaide, South Australia 5005, Australia
(Received 4 October 2016; revised 10 December 2016; accepted for publication 18 January 2017;
published 22 March 2017)
Purpose: A stochastic computer model of tumour growth with spatial and temporal components that
includes tumour angiogenesis was developed. In the current work it was used to simulate head and neck
tumour growth. The model also provides the foundation for a 4D cellular radiotherapy simulation tool.
Methods: The model, developed in Matlab, contains cell positions randomised in 3D space without
overlap. Blood vessels are represented by strings of blood vessel units which branch outwards to
achieve the desired tumour relative vascular volume. Hypoxic cells have an increased cell cycle time
and become quiescent at oxygen tensions less than 1 mmHg. Necrotic cells are resorbed. A hierarchy
of stem cells, transit cells and differentiated cells is considered along with differentiated cell loss.
Model parameters include the relative vascular volume (2–10%), blood oxygenation (20–
100 mmHg), distance from vessels to the onset of necrosis (80–300 lm) and probability for stem
cells to undergo symmetric division (2%). Simulations were performed to observe the effects of
hypoxia on tumour growth rate for head and neck cancers. Simulations were run on a supercomputer
with eligible parts running in parallel on 12 cores.
Results: Using biologically plausible model parameters for head and neck cancers, the tumour vol-
ume doubling time varied from 45  5 days (n = 3) for well oxygenated tumours to 87  5 days
(n = 3) for severely hypoxic tumours.
Conclusions: The main achievements of the current model were randomised cell positions and the
connected vasculature structure between the cells. These developments will also be beneficial when
irradiating the simulated tumours using Monte Carlo track structure methods. © 2017 American
Association of Physicists in Medicine [https://doi.org/10.1002/mp.12130]
Key words: cancer, cancer stem cell, doubling time, head and neck, hypoxia, stochastic
1. INTRODUCTION
Models of tumor growth can be broadly classified as analytic
or stochastic. Analytic models1–3 are relatively fast computa-
tionally, but have limitations when modeling inherently
stochastic processes. Stochastic models typically treat each
cell in the tumor individually and the tumor grows by cell
division. Stochastic models have been the models of choice
in the last two decades following advancements in computing
power.
Stochastic models of tumor growth may be purely tempo-
ral, i.e., without a spatial component. This can save greatly
on computation time while still enabling important features
of tumor growth to be simulated. For example, the stochastic
temporal model of head and neck squamous cell carcinoma
(HNSCC) by Harriss-Phillips et al.4–6 featured a hierarchy of
different cell types including stem cells, transit cells, and dif-
ferentiated cells and a sophisticated system of transitions to
progress cells through the hierarchy. It simulated both sym-
metric and asymmetric division of stem cells and loss of
differentiated cells from the tumor. The model also simulated
each phase of the cell cycle as well as quiescence due to
hypoxia. The model by Appleton et al.7 is another example
of a purely temporal stochastic growth model that simulated
the phases of the cell cycle and a hierarchy of cell types for
the mouse oral epithelium.
Spatial stochastic models, on the other hand, generate a
tumor composed of a two-dimensional (2D) or three-dimen-
sional (3D) spatial distribution of tumor cells. The simplest
form of distribution is a regular cubic lattice of cell positions.
This approach has been common in tumor growth models.8–15
However, the lattice method produces artificial anisotropies in
space. For example, there are straight line paths from one end
of the geometry to the other that pass through practically no
cellular material. This could be a limitation for certain applica-
tions. For example, it could produce artifacts if the simulated
tumors are spatially irradiated in Monte Carlo particle tracking
simulations. A purely spatial and spatially isotropic tumor
model was developed by Douglass et al.16–18 which modeled
ellipsoid shaped cells of different sizes randomly distributed in
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3D space without overlap. Another spatially isotropic approach
was employed in the tumor growth model by Kansal et al.,19 in
which the tumor was partitioned into cells according to a
Voronoi diagram.
Additional properties of tumors that tumor growth models
have endeavored to incorporate are hypoxia and necrosis.
Hypoxia has been observed to reduce cell proliferation in
tumors by decreasing the proportion of cycling cells and
increasing the cell cycle time (CCT).20,21 Severely hypoxic
cells become necrotic and are eventually resorbed. The previ-
ously mentioned temporal model by Harriss-Phillips et al.4–6
included the simulation of hypoxia. It adjusted the CCT for
hypoxic cells and induced cell quiescence below a threshold
cellular oxygenation (pO2). However, it is desirable for tumor
models to be spatial in order to model hypoxia and necrosis
from a more fundamental standpoint.
In living tissue, hypoxic cells are typically located beyond
some distance from the blood vessels and necrotic cells are
located further again. Accordingly, tumor cell pO2 is often
treated in models as a function of distance from the nearest
blood vessel.22–25 Therefore to model tumor growth with
hypoxia and necrosis, models should ideally possess both
temporal and spatial components (i.e., spatio-temporal mod-
els) and include tumor angiogenesis to dynamically generate
a spatial tumor vasculature.
For example, a stochastic spatio-temporal tumor growth
model with angiogenesis was developed by Kocher et al.,10
with tumor cells and blood vessel units confined to posi-
tions in a regular 3D lattice. Hypoxia was simulated
100 lm from the vessels. New vessel units formed by angio-
genesis from existing ones in order to maintain a certain
vessel density in the tumor. However, the vessel units were
scattered incoherently rather than forming continuous vessel
structures in the tumor. One limitation this presents is that
the degree of vascularity in the tumor does not relate to the
amount of hypoxia in the same way as it would if the vessel
units were in a connected vasculature structure, like in real
tumors.
Another spatio-temporal model with angiogenesis was
developed by Borkenstein et al.13 and later adapted by Hart-
ing et al.14 This model had similar limitations as the Kocher
et al. model, namely cell and vessel units were in a regular
lattice and the vessel units were randomly scattered. But
rather than angiogenesis occurring in response to diminished
vessel density, it occurred in response to hypoxia. Hypoxic
cells excreted vascular endothelial growth factor and angio-
genesis occurred after a certain amount of factor accumulated
at a vessel unit.
Cai et al.15 developed a model that likewise simulated
angiogenesis in response to hypoxia. In addition, the vessel
units formed continuous vessels in a connected vasculature
structure. However, the tumor cells and the vasculature were
generated in two different spaces and were effectively overlaid
as if they were transparent. This is a limitation for certain
applications (e.g., if the intention is to irradiate the simulated
tumors using Monte Carlo track structure methods). Cells and
vessel units were also confined to regular lattice positions.
In this work, we describe the development of a new
stochastic spatio-temporal tumor growth model with a novel
approach to angiogenesis. The model is designed to simulate
HNSCC. It extends the work of previous models26,27 and
addresses some of the limitations of existing spatio-temporal
models. In particular, in this work, ellipsoid-shaped cells
occupy randomized positions in 3D and a connected vascula-
ture structure grows between the cells. These developments
will also be beneficial in future work when the tumors gener-
ated are spatially irradiated using Monte Carlo track structure
methods. Herein we describe the computational methods
employed in the model and present its first results, including
tumor doubling times for well-oxygenated and severely
hypoxic tumors of HNSCC.
2. MATERIALS AND METHODS
2.A. Model features and biological background
The tumor growth model presented in this work was
developed in Matlab and is designed to model HNSCC.
While some features of the model are specific to HNSCC,
the model is capable of simulating other cancer types after
making appropriate parameter modifications. The flow
chart in Fig. 1 outlines the various spatial and temporal fea-
tures of the model and how they are interconnected. In this
section, each of these features are described and justified
with the relevant biological background. The details of how
they were implemented in the tumor growth algorithm are
described in the computational methods section (Section 2)
that follows.
2.A.1. 3D placement of cells
In the model, 3D tumor cells are packed into randomized
positions in 3D space without overlap. Ellipsoids are used for
the cell shape, consistent with the shape of squamous cells.
Cells have major axis sizes ranging from 14 to 20 lm (FaDu
HNSCC cell line28) and contain internal structures including
the cytoplasm and nucleus, as shown in Fig. 2. The ellip-
soidal cells have randomized orientations. The internal struc-
tures are coaxial with the cell and their sizes are fixed
proportions of the cell size. The nucleus volume is 8% of the
cell volume.29
2.A.2. Cell division and cell hierarchy
Tumor growth is simulated through cell division. Each cell
is allocated a CCTwhich is the time between divisions. Upon
division, one daughter cell occupies the position of the parent
cell and the other daughter cell occupies an adjacent position,
which usually involves pushing neighboring cells outwards
towards the tumor periphery. Cell division is typically accom-
panied by cellular differentiation, whereby cells become more
specialized in their functionality but lose proliferative poten-
tial. A basic epithelial cell hierarchy is implemented consist-
ing of stem cells (S), three generations of transit cells
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(T1, T2, and T3), and differentiated cells (D).26 An S may
either divide into two Ss (symmetric division) or one S and
one T1 (asymmetric division). The probability for stem cells
to undergo symmetric division is set to 2%,26 but this may
become higher than 50% for HNSCCs regrowing after irradi-
ation during accelerated repopulation.30–32 A T1 divides into
two T2s, a T2 into two T3s and a T3 into two Ds (Fig. 3).
This is at present a basic system of cell hierarchy. With
HNSCC, the loss of differentiated cells due to cell death (nat-
ural sloughing or apoptosis) is simulated using an in vivo
reported differentiated cell loss factor of 80%.26,33,34 This
means that after a time equivalent to the CCT, a differentiated
cell has an 80% chance of dying and being removed from the
tumor. If it survives, it has the same likelihood of dying after
another CCT passes.
2.A.3. 3D placement of blood vessels
The simulated tumor contains a network of blood vessels
growing between the tumor cells. Vessels are represented by
“strings” of discrete spherical vessel units. The diameter of
the vessel units ranges from 14 to 20 lm, in line with the
diameters of the dilated capillary-like vessels observed in
tumors.35,36 The vasculature structure that develops is chao-
tic, as is the case in real tumors, in contrast with the spa-
tially regular, organized, and efficient vasculature found in
normal tissue.37 Various degrees of tumor vascularity may
be simulated, i.e., different amounts of vessel branching.
The relative vascular volume (RVV) in the tumor is manipu-
lated via the model parameter RVV0. Measurements of the
RVV in human HNSCC have yielded values between 2 and
10%.36,38
2.A.4. Hypoxia and its effect on the CCT
Chronic hypoxia is simulated beyond a certain distance
from the blood vessels as follows. The cellular pO2 is taken
to be the oxygen tension at the center of the cell. The oxygen














where p0 is the oxygen tension at the vessel wall, the necrosis
distance, ND, is the distance between vessels and the onset of
necrosis and R0 is a constant defined by:
FIG. 1. Main features of the newly developed HNSCC tumour growth model. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 2. Tumor cells are modeled as ellipsoids to represent squamous cells.
The cells contain internal structures with different chemical compositions.27
[Color figure can be viewed at wileyonlinelibrary.com]
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The parameter a is the vessel radius and is set to 10 lm (the
maximum radius of vessel units). Studies of HNSCC have
reported observing values of ND from 80 to 300 lm.24,39
Values of blood oxygenation, p0, from 20 to 100 mmHg are
considered, noting that the oxygenations of healthy artery and
venule blood are 100 and 40 mmHg, respectively,40 and
blood vessels in tumors can suffer from sluggish flow result-
ing in lower than normal blood oxygenation.35,36
Hypoxic cells have an increased CCT in the model.41–44
For HNSCC, the CCT under normoxic conditions follows the
Gaussian distribution:26,34
CCT0 ¼ 33 5:9 h (3)
The CCT is increased for hypoxic cells according to the fol-
lowing adjustment factor y, which is a function of the cellular
pO2:
21,26,45
yðpO2Þ ¼ 1þ 1:8 e
0:2pO
2 (4)
where the cellular pO2 is in units of mmHg. That is, the CCT
is:
CCTðpO2Þ ¼ CCT0  yðpO2Þ (5)
Studies have also shown that cells may enter the quiescent G0
phase under severely hypoxic conditions, e.g., below
1 mmHg.46–48 This is accounted for in the model by making
the CCT infinite at cellular pO2\1 mmHg. The CCT adjust-
ment factor then becomes:
yðpO2Þ ¼




Note that a cell in a quiescent position with infinite CCT does
not stay there for long before being pushed into a different
position, often moving further from vessels and becoming
necrotic (see Section 4). Fig. 4 illustrates the cellular pO2 and
CCT adjustment factor as a function of distance from the
nearest blood vessel, calculated using Eqs. (1)–(6).
Before tumor growth is simulated by cell division, the
structure of the vasculature that will grow out during tumor
growth is established (with a unique randomized vasculature
structure generated in each simulation). That is, the tumor cells
move positions during the simulation but the vessel units do
not. Thus, it is possible to precalculate the oxygen tension at
each cell position and, in turn, the CCT at each cell position.
When a cell moves positions relative to the blood vessels, its
pO2 changes and its CCTchanges accordingly, but it retains its
age. So the time remaining before it divides (= CCTage) will
have changed. In this way, cells have a dynamic CCT in the
model that reflects their instantaneous pO2.
2.A.5. Necrotic cells
If during the tumor growth simulation a cell is pushed to a
distance beyond ND from a blood vessel to where the oxygen
tension is insufficient to keep it alive, the cell becomes necro-
tic. After a time, the necrotic cell is resorbed by the tumor.
The time taken for the necrotic cell to be resorbed depends
on the local necrotic volume, defined as the proportion of the
cell positions within a 28 lm radius that are likewise occu-
pied by necrotic cells (i.e., the number of necrotic cells within
FIG. 3. Cell division and progression through the cell hierarchy. S denotes a stem cell, T1, T2, and T3 are three generations of transit cells and D denotes a differ-
entiated cell. [Color figure can be viewed at wileyonlinelibrary.com]
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FIG. 4. Cellular pO2 decreases and CCT increases with increasing distance
from the nearest blood vessel. In this example using p0 ¼ 40 mmHg and
ND = 180 lm, the increase in CCT becomes noticeable when cells are fur-
ther than 65 lm from a vessel and cells become quiescent beyond 140 lm.
Cells in the region labeled “hypoxia" are viable but have pO2\ 10 mmHg
and would likely stain positive for the hypoxia marker pimonidazole.49,50
[Color figure can be viewed at wileyonlinelibrary.com]
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28 lm divided by the number of cell positions within 28 lm
9 100%). The necrotic cell resoprtion time follows Gaussian
distributions with means of 3, 4, 5, and 6 days for local
necrotic volumes between 0–25%, 25–50%, 50–75%, and
75–100% respectively, and in each case, the standard devia-
tion is an eighth of the mean.13,14 This means that necrotic
cells in large volumes of necrosis take longer to be resorbed
than those interspersed among living cells. When a necrotic
cell moves positions during tumor growth (e.g., it may be
pushed outwards due to cell division), its resorption time is
recalculated based on the new local necrotic volume but it
retains its age.
The model parameters and their values for HNSCC are
summarized in Table I.
2.B. Computational methods
This section describes the computational methods
employed in the model to achieve spatial and temporal cellu-
lar tumor growth with angiogenesis. The layout of the pro-
gram is shown in Fig. 5.
2.B.1. Generate 3D mesh
To begin, a 3D coordinate mesh containing all posi-
tions that tumor cells and blood vessel units may occupy
is established. During the tumor growth simulation, the
tumor grows larger as more positions in the mesh
become occupied by cells and vessel units. Rather than
confining mesh positions to a regular lattice, they are
randomized while ensuring that cells and vessel units do
not overlap with one another.
The following algorithm was developed to fill a given
volume with nonoverlapping cell/vessel unit positions:
1. X, Y and Z coordinates are randomly chosen within the
volume to be filled.
2. If a sphere of radius Rcell;min ¼ 7 lm could be placed at
that position without overlapping with the spheres at
positions already placed, this is a successful place-
ment.
3. If the placement has been successful, the sphere radius is
then increased in increments of 0.1lm up to a maximum
radius of Rcell;max ¼ 10lm. After each increment, it is
checked whether the sphere now overlaps with any of the
spheres at positions already placed. If overlap has
occurred, the sphere radius is reduced to its previous
value at which there is no overlap. The final sphere
radius is then stored along with the position coordinates.
4. Steps 1–3 are repeated until there fails to be a success-
ful placement for a certain number of consecutive
attempts (see below), indicating that a sufficient den-
sity has been reached.
The computation time for this algorithm increases dramat-
ically with the size of the volume being filled. Consequently,
the total spherical tumor volume of radius Rtum;max is divided
into shells of thickness:
DRshell ¼ 2Rcell;max þ 1 ¼ 21lm (7)
Shells are filled with cell/vessel unit positions one at a time
from the origin outward. This shell thickness is chosen so
that when placing a position in the shell, overlap need only
be checked with existing positions in the current shell and in
the previous shell. As the shell volume grows larger further
from the origin, shells are further divided into increments of
polar angle, h, and azimuthal angle, /, such that the outer arc
lengths are Dl = 11 lm, as shown in Fig. 6. Thus ultimately
cell/vessel unit positions are placed in subvolumes of size:
V.DRshellDl
2 ¼ 2541 lm3 (8)
The following formula is used to set the maximum number of
consecutive failed position placements before moving on to
the next subvolume:













where ceil is the ceiling function.
TABLE I. Model input parameters and values for HNSCC.
Input parameter Values Type References
Cell (and blood vessel) diameter 14–20 lm Distribution [28]
RVV 2–10% Single value [36,38]











p0 20–100 mmHg Single value [36,40]
ND 80–300 lm Single value [24,39]
CCTunder normoxia 33  5.9 h (Gaussian) Distribution [26,34]
CCT adjustment factor with hypoxia yðpO2Þ ¼ 1þ 1:8 e
0:2pO
2 Distribution [21,26,45]
Hypoxia-induced quiescence <1 mmHg Single value [46–48]
Necrotic cell resorption time 3–6 d depending on local necrotic volume Distribution [13,14]
S symmetric division probability  2% before irrad., possibly > 50% after Single value [26]
Differentiated cell loss factor 80% Single value [26,34]
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The result is a 3D mesh of randomized cell/vessel unit
positions, each with an assigned cell/vessel unit radius which
limits the size of the ellipsoidal cell or spherical vessel unit
that occupies that position, thereby ensuring no overlap
occurs (Fig. 7). For ellipsoidal cells the semimajor axis of the
ellipsoid is equal to the radius assigned to that position and
the other semi-axes lengths are randomly assigned between
7 lm and the semimajor axis length.
FIG. 5. Overview of the program structure. [Color figure can be viewed at wileyonlinelibrary.com]
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2.B.2. Identify neighborhoods
For each mesh position, nearby mesh positions are identi-
fied. In later stages of the program, this information is used
to perform vessel branching and to shift cells out to make
room when a cell divides. Mesh positions within a distance
of 4Rcell;min ¼ 28lm are considered to be in the “neighbor-
hood”. This distance is chosen to ensure no more than one
position would be included in the neighborhood along the
same direction in space.
2.B.3. Grow vasculature
The structure of the tumor vasculature that grows out dur-
ing tumor growth is established before tumor growth is simu-
lated. To achieve this, all mesh positions are initially grouped
into curvy “pathways” that start at different distances from
the center and extend out to the periphery of the tumor vol-
ume. The total spherical tumor volume is divided into shells
of thickness DRshell ¼ 21 lm, then a curvy pathway is formed
by starting at one shell and taking one position per shell out
to the periphery. Positions are chosen that have the most simi-
lar h and / coordinates to the previous position in the path-
way after both h and / are offset by an amount
corresponding to an arc length of DRshell ¼ 21 lm, which is
slightly larger than the diameter of a cell. This has the effect
of moving to the next position across in the shell and thus
produces curvature in the pathway (Fig. 8). The offset in h
and / is in the same direction (the same sign + or ) for the
whole pathway, so the pathway has a consistent curvature.
Pathways that begin in one shell are made to have the oppo-
site curvature to pathways beginning in the previous shell.
A small number of these curvy pathways are then
selected to be “vessel pathways”, which blood vessels will
grow along during tumor growth. That is, the mesh posi-
tions in these pathways will become occupied by blood
vessel units. First, six curvy pathways are chosen to be
the initial vessels growing in 3D. These curvy pathways
are selected from those that begin in either the first or
second shell, so that they roughly emanate from the ori-
gin, and on the basis that the last position in the pathway
lies the closest to one of the positive or negative Cartesian
axes, thereby ensuring the tumor grows in all directions
even in the absence of vessel branching.
Next, additional curvy pathways are chosen to be vessel
pathways on the basis that the new vessels appear to branch
from existing ones. The amount of vessel branching that
FIG. 6. A 2D representation of the placement subvolumes for the first 10
shells. The spherical tumor volume is divided into subvolumes of approxi-
mately equal size, which are filled with cell/vessel unit positions one at a
time.
FIG. 7. A 3D mesh of cell/vessel unit positions filled with ellipsoids repre-
senting tumor cells.
FIG. 8. Examples of radial pathways (blue) and curvy pathways (red). Radial
pathways are used to shift cells along to make room for an additional daugh-
ter cell when a cell divides, while curvy pathways are used to direct the
growth of blood vessels. [Color figure can be viewed at wileyonlinelibrary.
com]
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occurs is dictated by the model parameter RVV0. Starting
with the third shell, the RVV in the previous shell is calcu-
lated. The RVV is calculated by the ratio of the number of
positions occupied by blood vessel units to the total number
of positions in that shell. If the RVV in the previous shell is
less than the desired value for the tumor (RVV0), an attempt
is made to branch new vessels from existing ones at the cur-
rent shell as follows. For each vessel pathway, the position in
the pathway in the current shell has its neighborhood
searched. If any of the neighboring positions is the first posi-
tion in its own pathway, that pathway is selected as a new ves-
sel pathway. The result is vessel branching as illustrated in
Fig. 9. This is repeated for the next shell and so on to estab-
lish the complete tumor vasculature and achieve approxi-
mately the desired tumor RVV.
The remaining mesh positions that are not in vessel path-
ways are cell positions, meaning that cells may occupy them
during tumor growth.
2.B.4. Assign oxygen type & CCT
With the structure of the vasculature predetermined, the
distance from each cell position to the nearest blood vessel unit
is calculated. If this distance is less than ND, the cell position
is viable, otherwise it is a necrotic position. For viable cell
positions, the distance is used to calculate the cellular pO2
using Eq. (1). Each viable cell position is then assigned a CCT
which cells will adopt while occupying that position. To obtain
the CCT, a normoxic CCT is randomly sampled from the dis-
tribution in Eq. (3) and multiplied by the CCT adjustment fac-
tor in Eq. (6) which is a function of the cellular pO2.
2.B.5. Group cell pathways
Cell positions are grouped into radial “cell pathways”
which cells will shift along when a cell divides, a
differentiated cell dies, or a necrotic cell is resorbed. The total
spherical tumor volume is divided into shells of thickness
DRshell ¼ 21 lm, then a pathway is formed by starting at one
shell and taking one position per shell out to the periphery.
Positions are chosen that have the most similar h and / coor-
dinates to the previous position in the pathway (Fig. 8).
During the tumor growth simulation, when a cell divides
giving rise to two daughter cells, one daughter cell occupies
the parent cell’s position and the other daughter cell occupies
an adjacent position. When there are no vacant positions adja-
cent to the parent cell, cells are shifted out along the cell path-
way to make room (Fig. 10). Similarly, when a differentiated
cell dies or a necrotic cell is resorbed, cells are shifted inward
along the cell pathway to fill the vacant position left behind.
The tumor growth simulation is terminated when a cell
position at the end of a cell pathway becomes occupied, as it
means that soon there will be no vacancies available when a
cell in that pathway next divides. If cells divide more rapidly
in one pathway than in others (e.g., as a result of pO2), an
irregular tumor shape develops rather than a spherical one.
2.B.6. Grow tumor
The initial tumor size is set by the number of 21 lm shells
that tumor cells occupy to begin with. The user sets the initial
proportions of each cell type (S, T1, T2, T3, and D). Each
cell starts with an age that is a random fraction of its CCT.
Vessel units in the preestablished vessel pathways are acti-
vated out to two shells beyond the tumor cells and this rela-
tive lead is maintained throughout the tumor growth
simulation. Thus, vessel branching occurs just beyond the
FIG. 9. Illustration of four initial blood vessels (red) emanating from the ori-
gin in opposite directions and three additional blood vessels (blue) branching
from them. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 10. Tumor growth: placement of daughter cells after a cell divides.
[Color figure can be viewed at wileyonlinelibrary.com]
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tumor margin before cells move into the space, simulating
new tumor vessels originating from the surrounding normal
tissue vasculature.51,52
Simulation time is progressed until the first action is to be
taken. Action is taken when a cell’s age reaches its CCT or a
necrotic cell’s age reaches its resorption time. If a cell’s age
reaches its CCT and it is an S, T1, T2, or T3, the action taken
is cell division. When a differentiated cell’s age reaches its
CCT, it either dies (80% chance) or survives for at least one
more CCT. When a necrotic cell’s age reaches its resorption
time it is resorbed.
If the action taken involves a shift of cells and/or necrotic
cells, the cells and necrotic cells involved in the shift will be
affected and this may trigger further action. For example, the
shift may cause a cell to move to a necrotic position and there-
fore become a necrotic cell. A cell shifted to another viable
position will adopt the CCT at the new position and a necrotic
cell shifted will have its resorption time recalculated. In each
case, the age of the (necrotic) cell is retained. If a cell moves to
a viable position with a shorter CCT and its age now exceeds its
CCT, it immediately divides, or in the case of a differentiated
cell, it has a chance to die. Likewise, if the resorption time of a
necrotic cell becomes less than its age, the necrotic cell is
resorbed. These actions and consequent shifts may themselves
trigger more actions, and so on. Once there are no more actions
to perform at this instant, simulation time is progressed until
the next action is due to be performed, and so on.
2.B.7. Simulations performed
Tumor growth simulations were performed varying key input
parameters RVV0, p0 and ND between biologically plausible
limits (Table I) to observe the effects of different amounts of
hypoxia on the tumor growth rate. Hypoxia was assessed by the
hypoxic fractions HF10, HF5, HF2, and HF1 (the fractions of
cells with pO2\10, 5, 2, and 1 mmHg, respectively). The stem
cell symmetric division probability was also varied. Computa-
tion times were reported. The segments of code “IDENTIFY
NEIGHBORHOODS” and “ASSIGN OXYGEN TYPE &
CCT” were eligible to run in parallel on multiple cores. Simula-
tions were performed on the Phoenix supercomputer53 using as
many as 12 cores and 4 GB of memory.
3. RESULTS
3.A. Visualization of tumor growth simulation
A tumor growth simulation is visualized in Fig. 11. As
cells divided, the tumor margin expanded and new vessels
branched from existing ones to maintain the desired RVV
(set by the model parameter RVV0). Cells near vessels were
normoxic, whereas cells pushed further out were hypoxic
with longer CCTs and cells pushed further than ND from a
vessel became necrotic. Note that vessels only appear open-
ended because the surrounding normal tissue is not modeled.
In reality, these vessels connect with the normal tissue vascu-
lature. Vessel branching occurs just beyond the tumor margin
to simulate new vessels originating from the normal tissue
vasculature.
3.B. Variation of tumor oxygenation
The amount of hypoxia and necrosis in the simulated
tumor depends on the model parameters RVV0, p0 and ND.
Figure 12 compares sections of tumors with the same RVV
but different p0 and ND. The tumor oxygenation can be
described quantitatively by the distribution of cellular pO2, as
shown in Fig. 13.
3.C. Tumor volume doubling times for HNSCC
The tumor growth rate was reduced by the presence of
hypoxia and necrosis (Fig. 14). With a stem cell symmetric
division probability of 2% and differentiated cell loss factor
of 80%, well-oxygenated tumors (RVV0 ¼ 10%;
p0 ¼ 100 mmHg;ND ¼ 300 lm) had a volume doubling
time of 455 days (n = 3 simulations). Conversely, the vol-
ume doubling time for severely hypoxic tumors
(RVV0 ¼ 2%; p0 ¼ 20 mmHg;ND ¼ 80 lm) was 875
days (n = 3 simulations). Well-oxygenated tumors contained
no hypoxia or necrosis and had a median cellular pO2 of
691 mmHg and a mean cellular pO2 of 671 mmHg, while
severely hypoxic tumors contained hypoxic fractions of
HF10 = 0.790.01, HF5 = 0.540.01, HF2 = 0.310.01,
and HF1 = 0.210.01 (also the quiescent fraction), a necro-
tic volume of 4.50.5%, a median cellular pO2 of 4.40.2
mmHg, and a mean cellular pO2 of 5.60.1 mmHg. The
composition of the tumor rapidly equilibrated to 6% S, 6%
T1, 11% T2, 22% T3, and 55% D for both oxic and hypoxic
cases. The reduction in the stem cell proportion from 100%
to 6%, as a result of cell differentiation during tumor growth,
is responsible for the shoulder in both curves in Fig. 14.
With the stem cell symmetric division probability
increased from 2% to 50% to simulate possible conditions
during accelerated repopulation, the tumor volume doubling
time decreased to 2.20.1 days (n = 3 simulations) for well-
oxygenated tumors and 4.00.4 days (n = 3 simulations) for
severely hypoxic tumors.
3.D. Computation time
The computation time for simulations beginning with the
first two 21 lm shells filled with stem cells and ending in a
final tumor diameter of 1.5 mm, containing 33 105 cell/
vessel unit positions, is shown in Table II. 4 GB of memory
was sufficient for all parts.
4. DISCUSSION
A spatio-temporal stochastic tumor growth model with
angiogenesis has been developed. One of the main achieve-
ments of the current model was to position cells and vessel
units into randomized positions in 3D, whereas most spatio-
temporal models in the past have used a regular lattice.8–15
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This was an important development because a lattice can pro-
duce artifacts in certain applications (e.g., in Monte Carlo
particle tracking simulations). With randomized cell posi-
tions, to implement cell division (and differentiated cell loss
and necrotic cell resorption), the concept of the cell pathway
was devised. One drawback of randomized cell positions was
having to accept a slightly lower cell density. The cell density
obtained was 2 108 positions/cm3 (cells and vessels).
While 109 cells/cm3 is the textbook standard tumor density, it
is becoming recognized that 108 cells/cm3 may be more accu-
rate after accounting for the vasculature and the extracellular
matrix.54
Another achievement was having the vessel units con-
nected to form a coherent vasculature structure in the tumor.
This had been done previously by Cai et al.,15 but in their
model, the tumor cells and blood vessels were generated in
two separate spaces and then coupled. In the current model,
the vessels coexist with the tumor cells, extending between
them without overlapping. One advantage of having a con-
nected vasculature as opposed to scattered vessel units is that
the tumor vascularity will relate to the amount of hypoxia in
a similar way as it does in real tumors.
The model also achieved a dynamic CCT for the cells.
This was made possible by preventing the vessel units from
moving around during tumor growth (even though the vessels
grew and branched). Thus, it was possible to predetermine
the oxygen tension at each cell position and, in turn, the CCT
that cells would have while occupying that position.
Angiogenesis was simulated to maintain the desired tumor
vascularity (RVV between 2 and 10%) via the model parame-
ter RVV0. A similar criteria for triggering angiogenesis was
used in the model by Kocher et al.10 Some models instead
simulated angiogenesis in response to hypoxia, i.e., hypoxic
cells released factors that were received by vessel units and
(a) (b)
(c) (d)
FIG. 11. Snapshots during a tumor growth simulation. Blood vessel units are shown in red, normoxic cells in black, hypoxic cells (pO2\ 10 mmHg) in green,
and necrotic cells in brown. The simulation began with approximately 70 stem cells occupying the first two 21 lm shells of the tumor volume. The different ini-
tial vessels are easily distinguishable in (b), these vessels recently underwent branching in (c), and in (d), some cells had necrosed. The tumor RVV was only
0.5% and the simulation used p0 = 40 mmHg, ND = 180lm, stem cell symmetric division probability = 2%, and differentiated cell loss factor = 80%. [Color fig-
ure can be viewed at wileyonlinelibrary.com]
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stimulated angiogenesis.13–15 This approach was not imple-
mented in the current model because it would require that
vessel units have access to the same positions as cells and
thus be capable of moving around during the simulation
(e.g., in response to cell division). If vessel units were permit-
ted to move around, it would be difficult to keep them con-
nected to form whole vessels and a coherent vasculature
structure. It would also mean regularly recalculating the oxy-
gen tension and CCT at each cell position, which would make
the model far more computationally intensive. While angio-
genesis is not driven by cell signaling in the current model,
realistic vasculature structures, cellular pO2 distributions and
tumor growth rates are achieved, which are the most impor-
tant factors for future applications in radiotherapy simula-
tions.
The vessel density did not vary systematically between
central and peripheral regions of the tumor. There are many
tumor types for which this is accurate, including some
HNSCCs.55–57 If a tumor with a necrotic or hypoxic core and
a well-oxygenated rim is desired, multiple tumor growths
with different vessel densities could be spatially pieced
together. Note that the model does not currently simulate
(a) (b)
FIG. 12. Sections of tumors with the same vasculature structure but different p0 and ND. Blood vessel units are shown in red, normoxic cells in black, hypoxic
cells (pO2\ 10 mmHg) in green, and necrotic cells in brown. [Color figure can be viewed at wileyonlinelibrary.com]
(a) (b)
FIG. 13. Distributions of cellular pO2 for tumors with the same vasculature structure but different p0 and ND. [Color figure can be viewed at wileyonlinelibrary.
com]
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acute (transient) hypoxia, which can be important in some
tumors.39
The model parameters that determine the oxygenation of
the simulated tumor are RVV0, p0, and ND. A strength of the
model is that there is clinical data available for each of these
parameters, enabling tumors to be generated with realistic
oxygenations. Note that the simulated tumor will only have
RVV=RVV0 if it is spherical. In the simulation, the tumor
naturally grows asymmetrically, with cells preferentially
growing along the blood vessels. Thus, the tumor RVV is
typically a percentage or so larger than RVV0.
For HNSCC, there are wide ranges of biologically plausi-
ble RVV0, p0, and ND values, producing tumors ranging
from well oxygenated to severely hypoxic. The presence of
hypoxia and necrosis in the tumor markedly slowed the
growth rate in simulated tumors. The doubling times obtained
for well-oxygenated tumors were consistent with values in
the literature for HNSCC, which average 45 days.58 The pro-
portion of stem cells in the tumor population was 6%, in
agreement with clinical studies of HNSCC. These typically
report cancer stem cell proportions less than 10%.59–61
A limitation of the current model is the large computation
time, particularly for the “GROW TUMOR” section of the
code which can only be run sequentially. Ideally, the tumor
growth simulation would begin with a tumor size of approxi-
mately 1 mm3, which is the size at which a tumor acquires its
own vasculature,62 and end with a clinically detectable vol-
ume of 1 cm3. The issue of computation time has been a
common problem for spatio-temporal models. For some mod-
els, it meant limiting the tumor to a subclinical size.8,11
Others have used strategies to reach clinical tumor sizes. For
example, Kansal et al.19 and Antipas et al.12 developed mod-
els in which the tumor was divided into geometrical cells,
each of which represented a large number of real cells. For
the current model, future work may involve conducting multi-
ple tumor growth simulations in parallel and then piecing
them together to form a clinically relevant tumor size. The
computation time is less of a concern when simulating tumor
growth during a course of radiotherapy, as accelerated repop-
ulation occurs and a high stem cell symmetric division proba-
bility (possibly 50%) is favorable.30–32 Furthermore, in this
case only several weeks of tumor growth (equal to the total
treatment time) need to be simulated.
5. CONCLUSIONS
A 4D computational tumor growth model with angiogene-
sis was developed. It was used to evaluate the tumor volume
doubling time for well-oxygenated and hypoxic tumors of
HNSCC. The model is unique in that it features randomized
cell positions and grows a connected vasculature structure in
the tumor. The doubling times and cancer stem cell propor-
tions obtained are consistent with clinical data for HNSCC.
In future work, the tumor growth model will be used to
generate 3D tumors that will be spatially irradiated using
Monte Carlo track structure methods. The DNA damage to
each cell will be determined by clustering the ionization
events that occur in the cell nucleus to estimate the number
of DNA double-strand breaks. The cellular pO2 will affect
the amount of damage incurred and the cell’s ability to
repair the damage. The current tumor model provides accu-
rate localization of hypoxic cells and therefore cellular
radiosensitivity to microscopic regions beyond some dis-
tance from the blood vessels, as well as accurate amounts of
hypoxia in relation to the degree of tumor vascularity. As
the blood vessels are modeled as serial structures, damages
to the tumor vasculature can be studied, which are consider-
able in high-dose treatments such as stereotactic body radia-
tion therapy.63,64 Ultimately, the tumor growth model will be
used in conjunction with the tumor irradiation model to sim-
ulate fractionated external beam radiotherapy for HNSCC.
Early results presented herein of tumor doubling times indi-
cate that the amount of hypoxia and necrosis as well as the
stem cell symmetric division probability will have a large
effect on the rate at which tumors regrow during a course of
radiotherapy.




















 = 10%, p
0
 = 100 mmHg, ND = 300 m)
Severely hypoxic (RVV
0
 = 2%, p
0
 = 20 mmHg, ND = 80 m)
FIG. 14. Growth rates of well-oxygenated and severely hypoxic tumors. The
stem cell symmetric division probability was 2% and the differentiated cell
loss factor was 80%. Each simulation began with approximately 70 stem cells
occupying the first two 21 lm shells of the tumor volume. [Color figure can
be viewed at wileyonlinelibrary.com]
TABLE II. Computation times for a tumor growth simulation with a final
tumor diameter of 1.5 mm.
Code segment Cores Run time
Generate 3D mesh 1 2.5 h
Identify neighborhoods 12 10 min
Grow vasculature + group cell pathways 1 15 min
Assign oxygen type & CCT 12 15 min
Grow tumor
i) Stem cell symmetric division
probability 2% and oxic (hypoxic)
1 190 (328) tumor days
simulated in
316 (320) h
ii) Stem cell symmetric division
probability 50% and oxic (hypoxic)
1 21 (32) tumor days
simulated in 93 (40) h
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4. Development of an in silico stochastic 4D model of tumor growth with
angiogenesis 65
Table 4.1: Revised computation times for a tumour growth simulation with a final
tumour diameter of 1.5 mm.
Code segment Cores Run time Memory (GB)1
Generate 3D mesh 1 2 h 0.5
Identify neighbourhoods 12 5 min 9
Grow vasculature and
group cell pathways 1 11 min 0.4
Assign oxygen type
and CCT 12 6 min 6
Grow tumour






in 44 (37) h
1 (0.9)






in 80 (40) min
0.6 (0.6)
1total memory shared between cores if multicore
2symmetric division probability
4.3 Discussion and Conclusion
The tumour growth model was developed after conceiving of a method based on
“pathways”. The stochastic, randomised cell/vessel unit positions were grouped
into “curvy” pathways, some of which were selected to become blood vessels (and
the positions in the pathways were assigned to blood vessel units), such that a
connected, branching and chaotic vasculature was generated in the tumour. The
remaining positions were cell positions and were grouped into radial pathways.
After a cell division, cells were transported outward along their radial pathway
to make room for the additional daughter cell. Similarly, after a cell death (e.g.
differentiated or necrotic cell death), cells were transported inward along their
radial pathway to fill the gap.
Shortly after this article was accepted for publication, a more efficient way of
running Matlab code on Phoenix was discovered (see Appendix - previously the
Matlab compiler mcc was used to generated an executable). Revised computation
times are shown in Table 4.1.
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5
Simulation of head and neck cancer oxy-
genation and doubling time in a 4D cellular
model with angiogenesis
The publication [92] forms the basis of this chapter:
Forster JC, Douglass MJJ, Harriss-Phillips WM, Bezak E. Simulation of head and
neck cancer oxygenation and doubling time in a 4D cellular model with angiogenesis.
Sci Rep. 2017 Sep 8; 7(1):11037. doi: 10.1038/s41598-017-11444-1.
5.1 Introduction and Motivation
This paper explores the behaviour of the tumour growth model in more detail.
For example, how do the model parameters {RV V , p0, ND} map to the hypoxic
proportions and necrotic volume in the tumour? How do the stem cell symmetric
division probability and tumour oxygenation affect the tumour doubling time and
proportion of cancer stem cells in the tumour? What combinations of {RV V , p0,
ND} give a typical HNSCC tumour oxygenation?
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68 5.2. Statement of Contribution
5.2 Statement of Contribution
5.2.1 Conception
All authors felt it necessary to rigorously explore the tumour growth model behaviour.
The study methodology was conceived by Jake Forster under the supervision of
Michael Douglass, Wendy Phillips and Eva Bezak.
5.2.2 Realisation
Jake Forster wrote the code to run the simulations to acquire data, wrote the code
to run the simulations on a supercomputer, ran the simulations on a supercomputer,
analysed the data and made the plots for visualising data. The manuscript was
evaluated by Eva Bezak, Wendy Phillips and Michael Douglass for data accuracy,
critical appraisal, conclusions reached and general structure and flow.
5.2.3 Documentation
The manuscript was primarily written by Jake Forster, who also prepared the
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Simulation of head and neck 
cancer oxygenation and doubling 
time in a 4D cellular model with 
angiogenesis
Jake C. Forster  1,2, Michael J. J. Douglass1,2, Wendy M. Harriss-Phillips1,2 & Eva Bezak1,3
Tumor oxygenation has been correlated with treatment outcome for radiotherapy. In this work, the 
dependence of tumor oxygenation on tumor vascularity and blood oxygenation was determined 
quantitatively in a 4D stochastic computational model of head and neck squamous cell carcinoma 
(HNSCC) tumor growth and angiogenesis. Additionally, the impacts of the tumor oxygenation and 
the cancer stem cell (CSC) symmetric division probability on the tumor volume doubling time and 
the proportion of CSCs in the tumor were also quantified. Clinically relevant vascularities and blood 
oxygenations for HNSCC yielded tumor oxygenations in agreement with clinical data for HNSCC. The 
doubling time varied by a factor of 3 from well oxygenated tumors to the most severely hypoxic tumors 
of HNSCC. To obtain the doubling times and CSC proportions clinically observed in HNSCC, the model 
predicts a CSC symmetric division probability of approximately 2% before treatment. To obtain the 
doubling times clinically observed during treatment when accelerated repopulation is occurring, the 
model predicts a CSC symmetric division probability of approximately 50%, which also results in CSC 
proportions of 30–35% during this time.
While tumors are typically more vascularized than normal tissue, hypoxia will still arise in many tumors due to 
heterogeneity in the vascularity and depleted levels of blood oxygenation that occur when blood moves slug-
gishly through constricted and malformed vessels1, 2. Radiotherapy is a primary treatment modality for head 
and neck squamous cell carcinoma (HNSCC) and tumor oxygenation has been correlated with treatment out-
come3–5. Another key factor influencing the treatment outcome is the rate of tumor regrowth during treatment. 
Radiotherapy is typically delivered over several weeks (an example of a conventional fractionation schedule for 
the treatment of HNSCC with X-rays is 2 Gy fractions, 5 days/week over 6 weeks), and after a certain time (the 
“kick-off time”) the tumor initiates accelerated repopulation6–8. One of the key mechanisms responsible for accel-
erated repopulation is reportedly an increase in the symmetric division of cancer stem cells (CSCs). CSCs make 
up only a small proportion of the tumor cells9, but each has the potential to regenerate the tumor and must be 
inactivated to achieve 100% local tumor control probability.
In previous work, a computational model was developed that simulates HNSCC tumor growth10. This is a 
4D cellular model that includes the simulation of tumor angiogenesis. In the first part of the current work, this 
model was used to quantitatively map tumor properties, such as vascularity and blood oxygenation, to tumor 
oxygenation descriptors, such as the proportion of hypoxic cells, the mean cellular pO2 and the necrotic volume. 
By constraining the vascularity and blood oxygenation to values that have been clinically observed in HNSCC, 
values of tumor oxygenation descriptors were obtained for HNSCC and compared with clinical data.
In the second part of the work presented here, the effect of tumor oxygenation on the tumor volume doubling 
time for HNSCC was quantitatively assessed. The effect of the CSC symmetric division probability on the dou-
bling time was also explored. The CSC symmetric division probability also affects the proportion of CSCs in the 
tumor and this relationship was investigated. Finally, doubling times and CSC proportions were compared with 
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clinical data for HNSCC. While tumor irradiation was not simulated, tumor growth kinetics during accelerated 
repopulation were obtained by increasing the CSC symmetric division probability.
Methods
The tumor growth model. Simulations of HNSCC tumor growth were performed using a computational 
model that was developed in-house using Matlab (version R2017a, The MathWorks, Inc.) and has been previously 
described10. The flow chart in Fig. 1 outlines the spatial and temporal features of the model and how they are 
related. Briefly, each tumor cell is modeled as an ellipsoid and packed into randomized positions in 3D space with-
out overlap (Fig. 2a). The tumor grows over time by cell division, wherein a cell upon reaching the end of its cell 
cycle time (CCT) divides into two daughter cells, consequently pushing neighbouring cells outward towards the 
tumor periphery. A hierarchy of cell types is simulated, including CSCs, three generations of transit cells (T1-3) 
and differentiated cells (Fig. 2b). The probability for CSCs to undergo symmetric division (i.e., divide into two 
CSCs as opposed to one CSC and one transit cell) is set by the user. The sloughing of differentiated cells, which is 
characteristic of epithelial tissue, is also simulated.
Angiogenesis is modeled reflecting a connected and chaotic tumor vasculature that grows out with the cells 
(Fig. 2c,d), with blood vessels represented by consecutive discrete vessel units. Tumors can be grown with differ-
ent vascularities which are quantified by the relative vascular volume, RVV. Cellular pO2 is modeled dynamically 
as a function of distance from the nearest vessel using a diffusion equation (Table 1), with key parameters being 
the blood oxygenation, p0, and the distance from vessels to the onset of necrosis (the necrosis distance, ND). 
The tumor vascularity (RVV) and the blood oxygenation (p0 and ND) affect the amount of hypoxia in the tumor 
(Fig. 2e,f). Hypoxic cells have longer CCTs and cells that become necrotic are gradually resorbed by the tumor. 
Table 1 summarises the main parameters of the model and their values for HNSCC.
Simulations entail the following. First, a unique 3D mesh of non-overlapping cell/vessel unit positions is gen-
erated using Monte Carlo methods. The cell density reached is 2 × 108 cells/cm3. A connected network of blood 
vessels is then generated. As a result, a selection of the mesh positions are designated as vessel unit positions. A 
unique vasculature is generated each time using Monte Carlo methods. The vasculature is chaotic and tortuous, 
representative of tumor vasculature1, 2. As the tumor grows larger, the vasculature grows out by activating more of 
the vessel unit positions. Mesh positions that are not designated as vessel unit positions are cell positions, mean-
ing tumor cells may occupy them during tumor growth simulation.
Once a blood vessel network has been generated and prior to tumor growth simulation, the oxygen tension 
at each cell position is determined and used to calculate the CCT. Cells push one another around when a cell 
divides, a differentiated cell is lost or a necrotic cell is resorbed. When a cell changes position, it retains its age 
(the time since it last divided), but its CCT changes to the CCT at its new position. When the age of the cell equals 
its position dependent CCT, it divides. When a cell divides, it pushes a neighbouring cell outward towards the 
tumor periphery, causing a chain of cell movement outward, making room for the additional daughter cell. Thus, 
one daughter cell occupies the position where the parent cell used to be, and the other daughter cell occupies an 
adjacent position.
The daughter cells are always one generation more differentiated than the parent cell (CSC → T1 → T2 → 
T3 → differentiated), except in the case of CSC symmetric division. A differentiated cell loss frequency of 80% is 
simulated to model the natural cell death of these cells, i.e., apoptosis. When a cell becomes differentiated, after 
a time equal to the CCT, there is an 80% likelihood that the differentiated cell is removed from the tumor. If it is 
not removed, it remains for another period of time equal to the CCT, then there is again an 80% likelihood that 
Figure 1. Main features of the HNSCC tumor growth model. Adapted with permission from ref. 10.
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it is removed, and so on. When a differentiated cell is removed, there is a chain of cell movement inward to fill 
the vacant position. The same occurs when a necrotic cell is resorbed from the tumor, which occurs when its age 
reaches the necrotic cell resorption time (Table 1).
For a more in-depth description of the computational model methods, please refer to ref. 10.
Figure 2. HNSCC tumor growth model. (a) Tumor cells are modeled as non-overlapping ellipsoids in 
randomized positions in 3D. (b) Cell kinetics for the different types of cells in an example simulation. (c,d) The 
tumor in the example simulation after 3 days and 202 days of growth. Vessel units are shown in red, normoxic 
cells in black, hypoxic cells (pO2 < 10 mmHg) in green and necrotic cells in brown. Vessel units “string” together 
to form whole vessels that undergo branching in a chaotic fashion. Tumor cells close to vessels are normoxic, 
cells further from vessels are hypoxic and cells pushed further than ND from a vessel become necrotic. This 
example simulation started with approximately 70 CSCs and ended with RVV = 0.4%, using p0 = 40 mmHg, 
ND = 180 µm and CSC symmetric division probability = 2%. (e,f) Sections of tumors with the same 
vasculature structure but different blood oxygenation (via p0 and ND) ((e) p0 = 60 mmHg and ND = 220 µm; (f) 
p0 = 30 mmHg and ND = 120 µm). (e,f) were adapted with permission from ref. 10.
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Study of tumor oxygenation. The HNSCC tumor model was used in this work to quantify how the vas-
cularity (RVV) and the blood oxygenation (p0 and ND) affect the tumor oxygenation. Noting that HNSCC exhibit 
RVV from 2–10%11, 12, p0 from 20–100 mmHg11, 13 and ND from 80–300 µm14, 15, three combinations of (p0, ND) 
were considered, namely (20 mmHg, 80 µm), (40 mmHg, 180 µm) and (100 mmHg, 300 µm), depicting scenar-
ios of poor, moderate and high blood oxygenation, respectively. In each case, the model input parameter RVV0 
(which would be equal to the tumor RVV if the tumor grew with spherical symmetry, but due to preferential 
growth along the vessels, RVV ends up larger than RVV0) was varied from 0–10% in 1% increments (for the 
(20 mmHg, 80 µm) combination, RVV0 values of 0.25% and 0.5% were also used), yielding values of tumor RVV 
from 0–16%. The tumor RVV was determined at the end of the growth simulation as the ratio of the number of 
vessel units to the number of living cells + necrotic cells + vessel units (×100%). Tumor growth simulations 
began with approximately 70 CSCs and ended with a final tumor diameter of 1 mm (104–105 cells). A CSC sym-
metric division probability of 50% was used in the tumor oxygenation study for fast computations, since this 
affects the doubling time and CSC proportion but does not greatly affect the tumor oxygenation.
The tumor oxygenation at the end of the growth simulation was evaluated using several different descriptors. 
The hypoxic proportions HP10, HP5, HP2.5 and HP1 were determined, which were the proportions of living cells 
with pO2 <10, 5, 2.5 and 1 mmHg, respectively. The mean and median cellular pO2 in living cells were also calcu-
lated. The volume proportion of necrosis (necrotic volume) was evaluated as the ratio of the number of necrotic 
cells to the number of living cells + necrotic cells + vessel units (×100%).
Study of tumor growth rate and CSC proportion. The HNSCC tumor model was then used to explore 
the effects of tumor oxygenation and CSC symmetric division on the doubling time and the CSC proportion. The 
doubling time, Td, in the final days (in “tumor time”) of the tumor growth simulation was evaluated as follows. Let 
N(t) denote the number of living and necrotic cells in the tumor at time t. Then the average slope, k, of the curve 
lnN vs t in the final few days of the simulation was used to calculate the final doubling time according to:
=T kln2/d
The effect of tumor hypoxia and necrosis on doubling time was observed in the simulations from the tumor 
oxygenation study. Since these simulations all used a CSC symmetric division probability of 50%, the relative 
variation in the doubling time was reported.
To investigate the effects of the CSC symmetric division probability on the doubling time and the CSC pro-
portion, CSC symmetric division probabilities of 2%, 5%, 10%, 25%, 50%, 75% and 100% were simulated for the 
two extremes of HNSCC tumor oxygenation. The most oxygenated case was RVV = 10%, p0 = 100 mmHg and 
ND = 300 µm and the most hypoxic case was RVV = 2%, p0 = 20 mmHg and ND = 80 µm. In order to achieve 
approximately these RVVs, the model parameter RVV0 was set to 8.2% and 0.75% respectively. Again, the sim-
ulations began with approximately 70 CSCs and ended with a final tumor diameter of 1 mm. Three simula-
tions (n = 3) were conducted for each value of CSC symmetric division probability for both well oxygenated and 
severely hypoxic cases (with the exception of the severely hypoxic case with CSC symmetric division probability 
10%, for which n = 4 was used). The CSC proportion was calculated as the ratio of the number of CSCs to the 
number of living cells (×100%). The doubling times and CSC proportions were plotted using the mean value of 
the 3 (or 4) simulation runs and with error bars corresponding to the standard error of the mean (SEM). Prism 
(version 7, GraphPad Software, Inc.) was used to determine whether statistical significance had been reached.
Equipment. Simulations were performed on the Phoenix cluster at the University of Adelaide16 using as many 
as 12 cores and 10 GB of RAM.
Data availability. The data that support the finding of this study are available from the corresponding author 
upon reasonable request.
Input parameter Values Type References
Cell (and blood vessel) diameter 14–20 µm Distribution 11, 36, 37












2  where, 
a = 10 µm
Distribution 38, 39
p0 20–100 mmHg Single value 11, 13
ND 80–300 µm Single value 14, 15
CCT under normoxia 33 ± 5.9 h (Gaussian) Distribution 40, 41
CCT adjustment factor with hypoxia y e(pO ) 1 1 82
0 2pO2= + . − . Distribution 40, 42, 43
Hypoxia-induced quiescence pO2 < 1 mmHg Single value 44–46
Necrotic cell resorption time 3–6 days depending on local necrotic volume Distribution 47, 48
CSC symmetric division probability ~2% pre-treatment, possibly >50% during accelerated repopulation Single value 6–8, 30, 40
Differentiated cell loss frequency 80% Single value 40, 41
Table 1. Tumor growth model input parameters and values for HNSCC.
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Code availability. The code used to analyze the data is available from the corresponding author upon rea-
sonable request. The code used to perform tumor growth simulations has not been made publicly available at this 
time.
Results
The effects of tumor vascularity and blood oxygenation on tumor oxygenation. With increasing 
tumor vascularity (RVV) and increasing blood oxygenation (p0 and ND), the hypoxic proportions and necrotic 
volume decreased, while the mean and median cellular pO2 increased (Figs 3 and 4). According to clinical data, 
HNSCC exhibit RVV from 2–10%11, 12, p0 from 20–100 mmHg11, 13 and ND from 80–300 µm14, 15. With these con-
straints, the tumor growth model predicted values of HP1 from 0–29%, HP2.5 from 0–42%, HP5 from 0–65%, HP10 
Figure 3. Variation of hypoxic proportions with tumor vascularity for (a) poor blood oxygenation 
(p0 = 20 mmHg and ND = 80 µm), (b) moderate blood oxygenation (p0 = 40 mmHg and ND = 180 µm) and (c) 
high blood oxygenation (p0 = 100 mmHg and ND = 300 µm).
www.nature.com/scientificreports/
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from 0–86%, mean cellular pO2 from 4.4–65.2 mmHg, median cellular pO2 from 2.9–67.5 mmHg and necrotic 
volume from 0–15% for HNSCC.
For poor blood oxygenation (p0 = 20 mmHg and ND = 80 µm), there was necrosis present even at 10% RVV. 
Note that the same hypoxic proportion could arise from different combinations of RVV, p0 and ND. For example, 
(RVV, p0, ND) combinations of (11.8%, 20 mmHg, 80 µm), (2.7%, 40 mmHg, 180 µm) and (0.4%, 100 mmHg, 
300 µm) each yielded a HP5 of 20%.
The effects of hypoxia and CSC symmetric division on the tumor growth rate and the CSC pro-
portion. The doubling time decreased with increasing tumor vascularity (RVV) and increasing blood oxygen-
ation (p0 and ND) (Fig. 5a). For HNSCC (RVV = 2–10%, p0 = 20–100 mmHg, ND = 80–300 µm), the doubling 
time increased by a factor of 3 from well oxygenated tumors to the most hypoxic tumors. The doubling time was 
considerably affected, even without the presence of necrosis, by low cellular pO2 effects such as increased CCTs 
and cell quiescence (Fig. 5b,c).
The doubling time decreased with increasing probability of CSC symmetric division probability (Fig. 6a). The 
mean doubling time was 2.6–3.3 times larger for the most hypoxic tumors than for well oxygenated tumors of 
HNSCC across all values of CSC symmetric division probability. The difference in doubling time between severely 
hypoxic and well oxygenated conditions was significant (p-value < 0.05 using unpaired t-test with Welch’s correc-
tion) at every value of CSC symmetric division probability.
The CSC proportion increased with CSC symmetric division probability (Fig. 6b). The mean CSC proportion 
was 1–1.14 times larger for the most hypoxic tumors than for well oxygenated tumors across all values of CSC 
symmetric division probability. The difference in CSC proportion between severely hypoxic and well oxygenated 
conditions was significant (p-value <0.05 using unpaired t-test with Welch’s correction) at every value of CSC 
symmetric division probability except 2%.
A CSC symmetric division probability of 2% yielded a mean ± SEM doubling time of 44.5 ± 0.8 days (n = 3) 
for well oxygenated tumors and 129 ± 16 days (n = 3) for the most hypoxic tumors. The CSC proportion was 
approximately 6% in each case (6.11 ± 0.01% (n = 3) and 6.3 ± 0.2% (n = 3) respectively). An increase in the CSC 
symmetric division probability to 50% yielded a doubling time of 2.28 ± 0.03 days (n = 3) for well oxygenated 
tumors and 6.3 ± 0.6 days (n = 3) for the most hypoxic tumors. The CSC proportions were 30.49 ± 0.06% (n = 3) 
and 34.8 ± 0.3% (n = 3) respectively.
Figure 4. Variation of (a) mean cellular pO2 and (b) necrotic volume with tumor vascularity for poor, moderate 
and high blood oxygenation.
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Discussion
Several studies have reported pO2 measurements in human HNSCC using invasive polarographic needle elec-
trodes. The results from some of these studies are collated in Table 2. Since accessing a tissue block from the 
HNSCC primary tumor can be difficult, these studies often took measurements from sufficiently large lymph 
node metastases originating from a primary HNSCC. The table also lists measurements of necrotic volume in 
HNSCCs, as assessed by CT scan or MRI. The results from the current study are included at the bottom for 
comparison.
The values of median pO2, mean pO2, HP2.5, HP5 and HP10 produced by the tumor growth model using RVV 
from 2–10%, p0 from 20–100 mmHg and ND from 80–300 µm are in line with these clinical measurements. This 
assists in model validation since these values for RVV, p0 and ND are based on clinical data for HNSCC. The 
clinical tumor oxygenation data overall indicate well oxygenated tumors are rare and lower values of RVV, p0 and 
ND are typical.
Figure 5. Relative variation in the doubling time with (a) tumor vascularity and (b) HP10. (c) Variation in the 
necrotic volume with HP10.
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The clinical studies sometimes reported large values of necrotic volume outside the range produced by 
the tumor growth model. This is likely because the clinical studies observed macroscopic regions of necrosis. 
Macroscopic necrosis occurs when tumors become large and whole macroscopic regions of the tumor lose blood 
supply. The tumor growth model only produced necrosis at the microscopic scale (between distant blood vessels) 
in the sub-clinical sized tumors used in this study.
Pre-treatment doubling times of HNSCC have been obtained in studies that measured tumor growth while 
patients waited for treatment. Jensen et al.17 found that in the time between diagnostic scan (MR or CT) and 
treatment planning CT scan (median 28 days, range 5–95 days), the median doubling time was 99 days (range 
15 to > 234 days) for 61 patients with HNSCC. Waaijer et al.18 found that in the time between diagnostic and 
treatment planning CT scans (mean 34 days), the mean doubling time was 96 days (range 21–256 days) in 13 
patients with oropharyngeal SCC. Murphy et al.19 found that in the time between diagnostic (MRI or CT) and 
planning or interval CT scan (median 35 days, range 8–314 days), the median doubling time was 94 days (range 
16–6931 days) in 85 oropharyngeal SCC. These average clinically measured pre-treatment doubling times are 
similar to those produced by the presented tumor growth model under moderately hypoxic conditions and with 
a CSC symmetric division probability of approximately 2% (recall the doubling times obtained with the tumor 
model using 2% CSC symmetric division averaged 45 days for well oxygenated tumors and 130 days for severely 
hypoxic tumors).
In the current work, a CSC symmetric division probability of 2% yielded a proportion of CSCs in the tumor 
of approximately 6% for all HNSCC tumor oxygenation levels. Methods have been established for identifying 
CSCs in HNSCC. For example, cells that express markers such as ALDH1, CD133 and CD44 exhibit CSC-like 
properties, while others do not9, 20–24. Cells that efficiently efflux Hoechst 33342 dye, termed side-population (SP) 
cells, are also CSC-like25, 26. Chinn et al.27 reported a mean CD44high content of 10.8% (range 0–84.5%) for 40 
patient-derived primary HNSCCs. In 10 human oral SCC tissue samples, Zhang et al.28 found CD133+ content 
of 1–3%. Lu et al.29 identified approximately 2.1% SP cells in 7 human primary HNSCC samples, and all SP cells 
were also CD133+. The CSC proportion of 6% obtained by the tumor growth model using 2% CSC symmetric 
division, is close to these clinical estimates for HNSCC pre-treatment and results from other models (e.g. 5.9% 
from Marcu & Marcu30).
Figure 6. Variation of (a) doubling time and (b) CSC proportion with CSC symmetric division probability for 
severely hypoxic tumors (mean ± SD RVV = 2.2 ± 0.2% (n = 22), p0 = 20 mmHg, ND = 80 μm) (blue) and well 
oxygenated tumors (mean ± SD RVV = 10.5 ± 0.6% (n = 21), p0 = 100 mmHg, ND = 300 μm) (red) of HNSCC.
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Tumors respond to treatment by undergoing accelerated repopulation. In an analysis of 5 clinical trials con-
taining a total of 2653 patients, Pedicini et al.31 using an analytical/graphical method arrived at a best estimate of 
3.5 days (95% CI 3.1–3.9 days) for the doubling time of HNSCC during radiotherapy. The loss of asymmetric divi-
sion by CSCs is believed to be a key mechanism behind accelerated repopulation6–8, 30, 32, 33. In the tumor growth 
model, a CSC symmetric division probability of 50% yielded doubling times from 2.3 to 6.1 days, depending 
on the tumor oxygenation, which are in line with the estimate by Pedicini et al. A 50% CSC symmetric division 
probability yielded CSC proportions from 30–35% in the current work. To the authors’ knowledge, there are no 
clinical studies in the literature that measured the CSC proportion in HNSCC in patients during accelerated 
repopulation. In the model by Marcu & Marcu30, the CSC proportions obtained were higher than in the current 
work for the same CSC symmetric division probability. For example, in their work, 10%, 20% and 30% symmet-
ric division yielded 25%, 35% and 45% CSCs, respectively (recall in the current work, 10% and 25% symmetric 
division yielded approximately 9% and 15% CSCs, respectively). Conversely, the CSC proportions were slightly 
lower in the HYP-RT model by Harriss-Phillips et al.33 than in the current work. In that model, 30% symmetric 
division yielded just 10% CSCs. Most in vitro studies of various cancer types show a 3–5 times increase in CSCs 
post single irradiation24.
Conclusion
The current work established how the tumor oxygenation varies with vascularity and blood oxygenation, how the 
doubling time varies with tumor oxygenation and CSC symmetric division probability, and how the CSC propor-
tion varies with CSC symmetric division probability in a 4D cellular model of HNSCC tumor growth. The dou-
bling time varied by a factor of ~3 from well oxygenated tumors to the most severely hypoxic tumors of HNSCC. 
A CSC symmetric division probability of 2% yielded clinically relevant doubling times and CSC proportions for 
HNSCC before treatment, while a value of 50% produced the doubling times observed in the clinic for HNSCC 
undergoing accelerated repopulation. This 50% probability yielded CSC proportions from 30–35%.
In future work, the tumor growth model will be extended to a radiotherapy simulation tool for both low 
and high LET beams. The cellular geometry will be imported into Geant434 and irradiated in Monte Carlo track 
structure simulations. Radiolysis will be simulated along the particle tracks. Ionisation events and generated •OH 
species will be clustered in the cell nuclei to predict the complexity and extent of DNA damage to each cell. The 
cellular pO2 will affect how efficiently •OH attack to the base of DNA is translated to strand breakage35. Irradiation 
will be simulated in fractions separated by time intervals, during which the tumor growth model will translate 
DNA damage to cell death while also regrowing the tumor.
Tumor site
Median pO2 
(mmHg) in the 
tumor
Mean pO2 (mmHg) in 
the tumor HP2.5 (%) HP5 (%) HP10 (%) Necrotic volume (%)
King et al.49 Metastastic cervical nodes from HNSCC — — — — —
mean ± SD 
19.09 ± 13.94 
(n = 106)
Kong et al.50 Primary HNSCC mean 14.0 (n = 82) — — — — —
Gagel et al.51 lymph node metastases from HNSCC
mean ± SD 
12.5 ± 10.3; range 
0.1–41.1 (n = 38)
mean ± SD 17.6 ± 7.3; 
range 8.8–36.0 
(n = 38)
mean ± SD 
29.3 ± 18.4; range 
0.0–58.5 (n = 38)
mean ± SD 
38.4 ± 18.1; range 
7.0–73.6 (n = 38)
mean ± SD 
48.9 ± 18.2; range 




Neck node metastases 
from HNSCC or primary 
HNSCC
median 9; range 
0–62 (n = 397) —
median 19; range 0–97 
(n = 397)
median 38; range 
0–100 (n = 397) — —
Kuhnt et al.52 Primary HNSCC — — — — — mean ± SD 18 ± 30 (n = 51)*
Gagel et al.53 neck lymph node metastases from HNSCC
mean 10.7; 95% CI 
of mean 5.2–16.1; 
range 0.4–22.4 
(n = 16)
mean 16.3; 95% CI of 
mean 12.1–20.5; range 
9.0–27.4 (n = 16)
mean 35.9; 95% CI of 
mean 24.1–47.6; range 
0.5–58.1 (n = 16)
mean 44.3; 95% CI 
of mean 34.0–54.5; 
range 27.6–66.5 
(n = 16)
mean 52.5; 95% CI of 
mean 42.2–62.9; range 
33.7–77.5 (n = 16)
—
Terris et al.54 cervical lymph node metastases from HNSCC —
mean ± SD 20.8 ± 13.7 
(n = 50)*
mean ± SD 20.8 ± 25.7 
(n = 42) — —
mean ± SD 
14.5 ± 11.2 (n = 42)
Brizel et al.55
Primary HNSCC or 
cervical lymph node from 
HNSCC
mean 4.5; range 
0–60 (n = 63)* — — — — —
Brizel et al.5
Primary HNSCC or neck 
node metastases from 
HNSCC
mean 11.2; range 
0.4–60 (n = 28) — — — — —
Nordsmark 
et al.4
Lymph node metastases 
from HNSCC (n = 34) or 
primary HNSCC (n = 1)
mean ± SD 
14.7 ± 10.8; 
median 14; range 
1–35 (n = 35)
—
mean ± SD 22 ± 24; 
median 15; range 0–95 
(n = 35)
mean ± SD 
35 ± 29; median 




work range 2.9–67.5 range 4.4–65.2 range 0–42 range 0–65 range 0–86 range 0–15
Table 2. Clinical data for tissue pO2 and necrotic volume in human HNSCC. *Mean ± SD of two or more sub-
groups were combined with appropriate error propagation.
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5.3 Discussion and Conclusion
The behaviour of the tumour growth model was documented comprehensively.
While HNSCC tumours can have RV V from 2 to 10%, p0 from 20 to 100 mmHg
and ND from 80 to 300 µm [56], they are typically very hypoxic, requiring these
parameters to take values near their lower limits. Our attention now turns to
the dose fraction module of the S2RT model.
5.3.1 Erratum
• In the legend of Figure 4(a), the first and third entries were accidentally
reversed.
6
Monte Carlo Simulation of the Oxygen Ef-
fect in DNA Damage Induction by Ionizing
Radiation
The publication [93] forms the basis of this chapter:
Forster JC, Douglass MJJ, Phillips WM, Bezak E. Monte Carlo Simulation of
the Oxygen Effect in DNA Damage Induction by Ionizing Radiation. Radiat Res.
2018 Sep; 190(3):248-261. doi: 10.1667/RR15050.1.
6.1 Introduction and Motivation
The aim was to deliver dose to the multicellular tumour via Monte Carlo tracks,
so that DNA damage could be simulated from track segments through cell nuclei.
For this to be possible, the tracks must be accurate down to eV electron energies.
It is also important to simulate the indirect effect of ionising radiation, so the
chemical tracks from water radiolysis should also be simulated. These were achieved
using Geant4-DNA.
First, an algorithm was developed to predict DNA damage from physical and
chemical tracks simulated in Geant4-DNA. This is presented in the publication that
proceeds. The algorithm incorporates the oxygen (enhancement) effect, modelling
the influence of pO2 on the conversion of DNA radicals to strand breaks. This was
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important to include, since tumour hypoxia is a focus and strength of the model
(a connected vasculature was modelled, obtaining realistic spatial distributions
of chronic hypoxia).
6.2 Statement of Contribution
6.2.1 Conception
The idea to develop an algorithm to predict DNA damage from Monte Carlo tracks
originated from Michael Douglass and Eva Bezak. This model and its methods,
including the way the indirect effect and the oxygen effect were modelled, were
conceived by Jake Forster under the supervision of Eva Bezak, Wendy Phillips
and Michael Douglass.
6.2.2 Realisation
Jake Forster developed the model (i.e. wrote the code), wrote the code to run
the simulations to acquire data, wrote the code to run the simulations on a
supercomputer, ran the simulations on a supercomputer, analysed the data and made
the plots for visualising data. The manuscript was evaluated by Eva Bezak, Wendy
Phillips and Michael Douglass for data accuracy, critical appraisal, conclusions
reached and general structure and flow.
6.2.3 Documentation
The manuscript was primarily written by Jake Forster, who also prepared the
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Forster, J. C., Douglass, M. J. J., Phillips, W. M. and Bezak,
E. Monte Carlo Simulation of the Oxygen Effect in DNA
Damage Induction by Ionizing Radiation. Radiat. Res. 190,
248–261 (2018).
DNA damage induced by ionizing radiation exposure is
enhanced in the presence of oxygen (the ‘‘oxygen effect’’).
Despite its practical importance in radiotherapy, the oxygen
effect has largely been excluded from models that predict DNA
damage from radiation tracks. A Monte Carlo-based algo-
rithm was developed in MATLAB software to predict DNA
damage from physical and chemical tracks through a cell
nucleus simulated in Geant4-DNA, taking into account the
effects of cellular oxygenation (pO2) on DNA radical chemistry
processes. An initial spatial distribution of DNA base and
sugar radicals was determined by spatially clustering direct
events (that deposited at least 10.79 eV) and hydroxyl radical
(

OH) interactions. The oxygen effect was modeled by
increasing the efficiency with which sugar radicals from
direct-type effects were converted to strand breaks from 0.6 to
1, the efficiency with which sugar radicals from the indirect
effect were converted to strand breaks from 0.28 to 1 and the
efficiency of base-to-sugar radical transfer from

OH-mediated
base radicals from 0 to 0.03 with increasing pO2 from 0 to 760
mmHg. The DNA damage induction algorithm was applied to
tracks from electrons, protons and alphas with LET values
from 0.2 to 150 keV/lm under different pO2 conditions. The
oxygen enhancement ratio for double-strand break induction
was 3.0 for low-LET radiation up to approximately 15 keV/lm,
after which it gradually decreased to a value of 1.3 at 150 keV/
lm. These values were consistent with a range of experimental
data published in the literature. The DNA damage yields were
verified using experimental data in the literature and results
from other theoretical models. The spatial clustering approach
developed in this work has low memory requirements and may
be suitable for particle tracking simulations with a large
number of cells.  2018 by Radiation Research Society
INTRODUCTION
Ionizing radiation can damage DNA through direct-type
effects and the indirect effect (1, 2). Direct-type effects
refer to ionizations and excitations of DNA (direct effect)
and water in its first hydration layer (quasi-direct effect)
that produce radical anions/cations (electrons/holes).
Electron/hole transfer can occur from the water to DNA
or from one DNA component to another before the
electrons/holes are trapped by protonation/deprotonation,
producing neutral DNA radicals (3–6). DNA radicals
ultimately give rise to various forms of DNA damage
including single- and double-strand breaks (SSBs and
DSBs), oxidized bases, abasic sites and crosslinks (DNA-
protein, inter- and intra-strand) (1, 7–11). The indirect
effect refers to the interaction of radiation with bulk water,
producing radical species that in turn react with DNA. Of
the radical species generated, the hydroxyl radical (

OH) is
the most reactive with DNA (8).

OH reacts with DNA by
hydrogen atom abstraction, forming a DNA radical with an

OH-adduct.
The ‘‘oxygen effect’’ is the increase in radiation-induced
cell killing under oxic conditions compared to anoxic
conditions. This occurs because, through reactions with
oxygen, the initial DNA radicals are more likely to follow
chemical pathways that end in strand breaks (SBs) (1, 12–
15). Oxygen reacts with base radicals to form base peroxyl
radicals and reacts with sugar (20-deoxyribose) radicals to
produce sugar peroxyl radicals (2). Noting that a sugar
radical is required to produce a strand break (2), there are
thought to be two primary mechanisms driving the oxygen
effect (15). The first is that sugar peroxyl radicals convert to
strand breaks with greater efficiency than the native sugar
radicals (14). The second is that

OH-mediated base peroxyl
radicals more selectively abstract hydrogen atoms from the
sugar (base-to-sugar radical transfer, BSRT) than the native
base radicals, yielding more sugar radicals and thus
ultimately more strand breaks (1, 13, 16–18).
A Monte Carlo-based algorithm was developed to predict
DNA damage from physical and chemical tracks through a
cell nucleus simulated in Geant4-DNA, taking into account
1 Address for correspondence: Department of Physics, University
of Adelaide, Physics Building, Room G16, North Terrace, Adelaide,
South Australia 5005, Australia; email: Jake.Forster@adelaide.edu.
au.
2 Scholar-in-Training, Radiation Research Society.
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the effect of cellular oxygenation (pO2) on the efficiencies
of sugar radical-to- strand break conversion and BSRT from

OH-mediated base radicals. Other DNA damage models
using radiation track structure have typically focused on
simulating DNA geometry at the molecular level [e.g.,
Friedland et al. (PARTRAC) (19), Liang et al. (20),
Watanabe et al. (21), Štepán and Davı́dková (RADAMOL)
(22) and Moiseenko et al. (23)], whereas the current work
was concerned with simulating the oxygen effect. To our
knowledge, no other model for predicting DNA damage
from radiation tracks has simulated the effect of pO2 on
DNA radical chemistry. The primary objectives of this work
were: 1. to predict yields of DNA damage with reasonable
accuracy using a less sophisticated and less memory-
intensive approach than is conventional; and 2. to achieve
experimentally observed values of the oxygen enhancement
ratio (OER) for DSB induction (OERDSB) for both low- and
high-LET radiation.
FIG. 1. Flowchart illustrating the DNA damage induction algorithm for processing Monte Carlo physical and
chemical tracks generated in Geant4-DNA based on a spatial clustering approach.
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METHODS
Nucleus Irradiation Simulation
Physical tracks and subsequent chemical tracks from water
radiolysis were simulated inside a cell nucleus region using Geant4-
DNA (24–28) from the Monte Carlo Geant4 toolkit (version 10.3
patch-03) (29–31). The nucleus material was approximated by water
with mass density 1 g/cm3. To simulate the direct-type effects of
radiation, the positions of direct events with energy deposition  (Emin
¼) 10.79 eV (the ionization threshold of liquid water) were recorded.
Then, as described in the next section, if such an event coincided with
DNA or its primary hydration layer, it induced a DNA radical and
subsequently DNA damage. There is evidence that sub-ionization
energy electrons can induce DNA sugar radicals (and thus strand
breaks) by resonant attachment (32), but this was neglected. For
comparison, 10.79 eV was the energy threshold for strand break
induction by direct events on the sugar moiety used by previous
iterations of PARTRAC (33, 34) and more recently by Liang et al.
(20). The current model differs in that a direct event may lead to a
sugar radical but then the probability that the sugar radical is converted
to a strand break depends on the pO2 (next section). The physical
processes constituting direct events for electrons were electron
ionization, electron excitation, electron vibrational excitation and
electron attachment. If protons were used, there was also proton
ionization, proton charge decrease (electron capture), proton excita-
tion, hydrogen ionization and hydrogen excitation. If alphas were
used, there was also alpha ionization, alpha charge decrease, alpha
excitation, alphaþ ionization, alphaþ charge decrease, alphaþ excita-
tion, helium ionization and helium excitation.
To simulate the indirect effect of radiation,

OH species were
diffused for tOH¼ 2.5 ns before they were assumed to interact (unlike
modeling a scavenging probability for each

OH along each time step).
Spatial coordinates of

OH interactions were recorded.

OH interac-
tions that spatially coincided with DNA induced DNA radicals and
subsequently induced DNA damage (next section). This

OH lifetime
corresponded to a scavenging capacity of 4 3 108 s–1, which is similar
to estimates for the cellular environment (35, 36). For diffusion in 3D,
the root-mean-square displacement (RMSD) in time t is (37):
RMSD ¼ r2
 1=2
¼ 6Dtð Þ1=2; ð1Þ
where D is the diffusion coefficient. Geant4-DNA uses

OH
diffusion coefficient DOH ¼ 2.8 3 10–9 m2 s–1 (28). Thus, the
RMSDOH before interaction was 6.48 nm. This is consistent with
most experimental estimates for the diffusion distance of

OH in
biological material, which include , 8.6 nm (38), ;5.4 nm (39), ,
2.6 nm (40) and 6–9 nm (41).

OH was the only species that




– (8, 42). Reactions between radiolytic
species and oxygen during the chemical stage (10–12 to 10–6 s) were
not simulated. This was deemed acceptable because pO2 has been
shown to have only a small or negligible effect on the

OH yield in
experimental (43) and theoretical models (22, 44–46). In one such
model by Štepán and Davı́dková (22), the

OH yields under pO2s of
0 and 760 mmHg only began to diverge after approximately 10 ns,
which is after we assume they interact (2.5 ns).
DNA Damage Induction Algorithm
The current model algorithm, developed using MATLABt version
R2016b (MathWorkst Inc., Natick, MA), predicted DNA damage
from the Geant4-DNA physical and chemical tracks. It simulated the
DNA dimensions and biochemical processes after irradiation. The
algorithm proceeded as follows (illustrated schematically in Fig. 1 and
visualized in Results):
1. The positions of direct events (with energy deposition 10.79 eV)
and

OH interactions were imported from the Geant4-DNA
simulation.
2. The in-built MATLAB function ‘‘clusterdata’’ (47) with ‘‘com-
plete’’ linkage was used to spatially cluster these events into
‘‘minor clusters’’. Complete linkage ensured any two events in the
same minor cluster were not farther apart than some distance, d1,
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set by the user; otherwise the events were allocated to different
minor clusters. The following expression was used for this




2 þ DDNA þ 2Thyd
 2q
: ð2Þ
Here, LDSB is the maximum separation between two strand breaks
on opposite strands of DNA that constitutes a DSB and is
conventionally taken to be 3.4 nm, corresponding to 10 base pairs
(bp) or one turn of the DNA double helix (33). DDNA¼ 2 nm is the
diameter of DNA and Thyd is the thickness of the first hydration
layer of DNA. Estimations for this thickness include 0.4–0.8 nm
(48), 0.3 nm in experiments (49, 50) and 0.5 nm in theoretical
simulations (51–53). Here it was taken to be 0.3 nm, choosing the
low end of estimates because it was assumed that direct event-
mediated radicals in the first hydration layer were transferred to
DNA with 100% efficiency (5, 6), neglecting possible processes in
which the radical is not transferred to DNA (54). Thus, this
maximum separation between events in the same minor cluster
was d1 ’ 4.28 nm. This represents the limiting case for DSB
production by two direct events located on opposite boundaries of
the first hydration layer, 10 bp apart.
3. For each minor cluster, a cylinder of 1.3 nm radius representing a
segment of DNA and its first hydration layer were placed through
the center of the minor cluster with a random orientation. The
cylinder was as long as necessary to contain as many events in
the minor cluster as possible for the given cylinder orientation,
with a maximum length of d1 ’ 4.28 nm. Direct events in the
DNA (radius R , 1 nm from the cylindrical axis) or in the first
hydration layer (1 , R , 1.3 nm) and

OH interactions in the
DNA each induced a modified base (MB), modified sugar (MS),
MS þ MB, SB or SB þ MB (next section). If the number of
strand breaks in the minor cluster, nSB, was 2, the minor cluster
was classified as a ‘‘DSB minor cluster,’’ provided not all strand
breaks were on the same strand, i.e., the probability of a DSB
minor cluster was:
P nSBð Þ ¼ 1 2 0:5
nSBð Þ ð3Þ
4. If a minor cluster contained an event less than (LDSB,DSB ’) 4.28 nm
from an event in another minor cluster, the minor clusters were
separated by too few undamaged bp (less than approximately 10)
and were considered to be a part of the same ‘‘major cluster’’. This
minimum DSB separation of ;10 bp was used by Štepán and
FIG. 3. OER([pO2]) from Carlson et al. (69), defined as the ratio of
cell killing under full oxia (pO2 of 760 mmHg) to the cell killing under
pO2, and the oxygen function OF([pO2]) derived from OER([pO2]).
OF([pO2]) was used to map the probabilities of sugar radical-to-strand
break conversion and BSRT from

OH-mediated base radicals from
their minimum values under anoxia to their maximum values under
full oxia.
FIG. 4. Alpha (12 MeV) tracked for 10 keV of energy loss in Geant4-DNA. The alpha is shown in magenta, secondary electrons in red and

OH





þ) are not shown.

OH species diffused for tOH¼ 2.5 ns before they
were assumed to interact.
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Davı́dková (RADAMOL) (22), but other models have used larger
values [e.g., 25 bp in PARTRAC (19)]. To group minor clusters into
major clusters, the MATLAB function ‘‘clusterdata’’ with ‘‘single’’
linkage was used. To begin with, single linkage grouped events into
major clusters, ensuring any two events in different major clusters
were not closer together than (LDSB,DSB ’) 4.28 nm, otherwise the
events were allocated to the same major cluster. Since d1¼LDSB,DSB ’
4.28 nm, events in the same minor cluster belonged to the same
major cluster, thus minor clusters were grouped into major clusters.
A major cluster containing N DSB minor clusters was scored as a
single DSB with multiplicity N. A DSB was classified as ‘‘complex’’
if it contained more than two strand breaks in total. If a major cluster
did not contain a DSB minor cluster, all strand breaks within were
scored as SSBs and all MBs and MSs were scored as ‘‘isolated’’ (in
the sense that they were not part of a DSB).
5. The DNA damage yields were reduced by a factor that may be
interpreted as the volume proportion of DNA in the nucleus, since
it was assumed that all minor clusters coincided with DNA. This
volume proportion has been estimated to be from 0.3% to 2% in
yeast cells (55). In practice, this factor was tuned to bring the DSB
yield into line with the DSB yield obtained by Štepán and
Davı́dková (22) (see Results).
6. A spatial distribution of SSBs, DSBs, MBs and MSs was output.
pO2-Dependent DNA Damage
The pathways to various forms of DNA damage by direct events
and

OH interactions are shown in Fig. 2.
Experiments conducted by Purkayastha et al. (4) using hydrated
plasmid DNA films showed that a direct event in DNA or its first
hydration layer produced an electron or hole that was trapped on the
sugar, forming a (neutral) sugar radical, 11% of the time and on a base,
forming a (neutral) base radical, the remainder of the time. The probability
of sugar attack (SA) by a direct event in DNA or its first hydration layer is
denoted by PSA,dir¼0.11. Experiments conducted by Scholes et al. (56, 57)
on aqueous solutions of DNA and simulations by Chatterjee et al. (58),
both found that

OH interactions with DNA occurred with the sugar,
producing a sugar radical 20% of the time (PSA,OH ¼ 0.2) and the
remainder of the time with a base, producing a base radical.
FIG. 5. Visualization of the spatial clustering approach used to estimate DNA damage, applied to the tracks in
Fig. 4. Panel A: Sites of direct events (magenta) and

OH interactions (green). Panel B: A subsection of the
tracks. Panel C: Direct and indirect events are spatially clustered into minor clusters. Events in the same minor
cluster are shown in the same color. Panel D: DNA segments and their first hydration layers are placed. Direct
events are shown with spheres and

OH interactions are shown with cubes. Panel E: Events that induced a DNA
radical and subsequently caused a modified base, modified sugar, modified sugar and modified base, strand
break or strand break and modified base. Events that caused a strand break are shown with cubes and events that
did not are shown with spheres. One of the DNA segments contains a DSB and constitutes a DSB minor cluster.
Panel F: Nearby minor clusters separated by less than 4.28 nm are joined to form major clusters. Minor clusters
belonging to the same major cluster are shown in the same color. The major cluster containing a DSB minor
cluster is called a DSB major cluster. The DNA damage yields are then reduced according to the volume
proportion of DNA in the nucleus.
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Each base radical resulted in a modified base. In addition, there was
a small, pO2-dependent chance for an

OH-mediated radical on a base
to be transferred to the sugar moiety to form a sugar radical. This
probability, PBSRT([pO2]), was made to increase from 0 to 0.03 for
increasing pO2 from 0 to 760 mmHg, so that the contribution from this
mechanism to strand breakage was at most 7% (see Results), an upper
limit indicated by experiments with single-stranded DNA (59, 60).
Each sugar radical resulted in either a strand break or a modified





OH attacking the sugar or by

OH attacking the
base followed by BSRT) were converted to a strand break with
separate pO2-dependent probabilities PSB,SR ,d i r([pO2]) and
PSB,SR,OH([pO2]), respectively. The efficiency of strand break induction
by direct events in DNA and its first hydration layer, PSB,dir([pO2]), and
the efficiency of strand break induction by

OH interactions with
DNA, PSB,OH([pO2]), can be expressed as:
PSB;dir pO2½ ð Þ ¼ PSA;dirPSB;SR;dir pO2½ ð Þ ð4Þ
PSB;OH pO2½ ð Þ ¼ PSA;OHPSB;SR;OH pO2½ ð Þ
þ ð1 PSA; OHÞPBSRT pO2½ ð ÞPSB;SR;OH pO2½ ð Þ
ð5Þ
The OER for cell killing by direct-type effects can be measured
experimentally from the ratio of cell survival in air and a high
concentration of

OH scavenger to cell survival in nitrogen and a
high concentration of

OH scavenger. Estimates from the literature
include 1.32 (AA8 cells) and 2.01 (CHO cells) (61), 1.66
(glutathioneþ haploid yeast cells) (62), 1.9 (CHO cells) (63), 1.8
(V79-379-A cells) (64) and 1.6 (V79-379-A cells) (35). The OER
for cell killing by the indirect effect has been estimated in
experiments to be 4.11 (AA8 cells) and 3.75 (CHO cells) (61) and
4.24 (glutathioneþ haploid yeast cells) (62). As a first approxima-
tion, equate the OER for cell killing by direct-type effects with the
OER for the probability of strand break induction by a direct event
in DNA or its first hydration layer. Similarly, equate the OER for
cell killing by the indirect effect with the OER for the probability of
strand break induction by an

OH interaction with DNA [recall that,





PSB;dir 760 mmHgð Þ
PSB;dir 0 mmHgð Þ
¼
PSB;SR;dir 760 mmHgð Þ
PSB;SR;dir 0 mmHgð Þ
ð6Þ
OERindir ¼
PSB;OH 760 mmHgð Þ
PSB;OH 0 mmHgð Þ
¼
PSA;OHPSB;SR;OH 760 mmHgð Þ
þ 1PSA;OHð ÞPBSRT 760 mmHgð ÞPSB;SR;OH 760 mmHgð Þ
PSA;OHPSB;SR;OH 0 mmHgð Þ
þ 1PSA;OHð ÞPBSRT 0 mmHgð ÞPSB;SR;OH 0 mmHgð Þ
¼
0:2ð ÞPSB;SR;OH 760 mmHgð Þ
þ 0:8ð Þ 0:03ð ÞPSB;SR;OH 760 mmHgð Þ
0:2ð ÞPSB;SR;OH 0 mmHgð Þ
: ð7Þ
Taking an approximate OERdir of 5/3, an approximate OERindir of
4, and assuming sugar radicals from both direct events and

OH
interactions are converted to strand breaks with 100% efficiency
under full oxia, i.e., PSB,SR,dir(760 mmHg) ¼ PSB,SR,OH(760 mmHg) ¼
1, Eqs. (6) and (7) were applied to obtain PSB,SR,dir(0 mmHg) ¼ 0.6
and PSB,SR,OH(0 mmHg) ¼ 0.28. Note that under anoxia the majority
of

OH-mediated sugar radicals were not converted to strand breaks.
From Eqs. (4) and (5), the efficiency of strand break induction by
direct events in DNA and its first hydration layer increased from
6.6% to 11% for pO2 from 0 to 760 mmHg and the efficiency of
strand break induction by

OH interactions with DNA increased
from 5.6% to 22.4% for pO2 from 0 to 760 mmHg. Experimental
estimates for this efficiency for

OH range from 11–44% in DNA
(65–67) and 41% in the polynucleotide poly(U) (68).
As for the functional form of the pO2 dependency in probabilities
PSB,SR,dir([pO2]), PSB,SR,OH([pO2]) and PBSRT([pO2]), a goal of this work
was to make these probabilities vary with pO2 in the same manner as
experimentally observed cell killing. An ‘‘oxygen function’’ OF([-
pO2]) was defined with domain (0,760) mmHg and range (0,1) to map
these probabilities from their minimum values under anoxia to their
maximum values under full oxia:
FIG. 6. Calculated yields of strand breaks from direct-type effects
and the indirect effect under full oxia (pO2 of 760 mmHg; filled
symbols) and anoxia (pO2 of 0 mmHg; unfilled symbols).
TABLE 1
Summary of Model Parameters
Model parameter Value Refs.
Emin 10.79 (20, 33, 34)
tOH/RMSDOH 2.5 ns/6.48 nm (35, 36)/(38–41)
LDSB 3.4 nm (10 bp) (33)
Thyd 0.3 nm (48–53)
LDSB,DSB 4.28 nm (22)
PSA,dir 0.11 (4)
PSA,OH 0.2 (56–58)
PBSRT([pO2]) 0 ! 0.03 for pO2 from 0 ! 760 mmHg (59, 60)
PSB,SR,dir([pO2]) 0.6 ! 1 for pO2 from 0 ! 760 mmHg To achieve OERdir of 5/3 (35, 61–64)
PSB,SR,OH([pO2]) 0.28 ! 1 for pO2 from 0 ! 760 mmHg To achieve OERindir of 4 (61, 62)
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PSB;SR;dir pO2½ ð Þ ¼ PSB;SR;dir 0 mmHgð Þ
þ OFð pO2 Þ ½PSB;SR;dir 760 mmHgð Þ

PSB;SR;dir 0 mmHgð Þ ð8Þ
PSB;SR;OH pO2½ ð Þ ¼ PSB;SR;OH 0 mmHgð Þ
þ OFð½pO2 Þ ½PSB;SR;OH 760 mmHgð Þ
 PSB;SR;OH 0 mmHgð Þ ð9Þ
PBSRT pO2½ ð Þ ¼ OF pO2½ ð ÞPBSRT 760 mmHgð Þ: ð10Þ
OF([pO2]) was derived from experimentally measured OER([pO2]) for
cell killing, defined as the ratio of cell killing under full oxia to the cell
killing under oxygenation pO2 (in units of mmHg). The following
formula for OER([pO2]) was presented by Carlson et al. (69) as a good
fit to experimental data from Spiro et al. (V79 cells) (70):
OER pO2½ ð Þ ¼
5:13 mmHgð Þ þ pO2½ 
1:9 mmHgð Þ þ pO2½ 
: ð11Þ
To obtain OF([pO2]) from OER([pO2]), one may subtract the OER of 1
(let f¼OER; f! f – 1), invert (f! fmax – f) and then normalize (f! f/
fmax; OF ¼ f), thus obtaining Eq. (12):
OF pO2½ ð Þ ¼
1:0025 pO2½ 
1:9 mmHgþ pO2½ 
: ð12Þ
OER([pO2]) and OF([pO2]) are plotted in Fig. 3. As with cell killing,
OF([pO2]) and thus, these probabilities, vary most from 0.1 to 10
mmHg.
The key model parameters are summarized along with their values
in Table 1.
Simulations and Analysis
Using Geant4-DNA, electrons, protons and alphas with various
initial energies and LET values (Table 2) were tracked for 10 keV of
energy loss before simulating radiolysis. Depending on the LET, this
corresponded to track lengths from approximately 66 nm to 54 lm.
Since the purpose of this work was to verify the DNA damage
induction algorithm, it was assumed that the entire length of the track
was inside a nucleus region. N ¼ 100 tracks were generated for each
particle/energy combination (n ¼ 13).
For each track, the DNA damage induction algorithm was applied n
¼ 1,000 times. This combination of sample sizes was sufficient to
produce vertical error bars, equal to the SEM of the dependent
variable, that were not visible in plots. For the thousand runs of the
algorithm for track i of particle/energy combination p/E, the means
(meanp,E,i) and standard deviations (SDp,E,i) of, for example, the number
of SSBs, DSBs, MBs and MSs were recorded. This was repeated for
different pO2. To obtain the mean and standard deviation of the ratio






















The means and standard deviations of the n¼ 100 tracks for particle/


















Note that OERDSB compared full oxia (pO2 of 760 mmHg) with
anoxia (pO2 of 0 mmHg). For the plotted figures in this report, the
LET plotted was (initial LET þ final LET)/2, with error bars equal to
(final LET – initial LET)/2. The error bars for the dependent
quantities were equal to the SEM. Statements of statistical
significance were from statistical analysis (linear regression)
performed in MATLAB.
Equipment
Simulations were performed on the Phoenix supercomputer cluster
(University of Adelaide, Adelaide, Australia). Each track of 10 keV
TABLE 2
Particles, Energies and LET Simulated in Geant4-
DNA
Particle Initial energy Initial (final) LET (keV/lm)
Electron 999 keV 0.186 (0.187)
100 keV 0.41 (0.439)
30 keV 0.962 (1.312)
15 keV 1.64 (3.874)
Proton 10 MeV 4.59 (4.59)
5 MeV 8 (8.01)
2 MeV 16.26 (16.32)
1 MeV 26.94 (27.13)
Alpha 12 MeV 47.57 (47.6)
8 MeV 64.31 (64.37)
6 MeV 78.79 (78.88)
4 MeV 102.79 (102.95)
2 MeV 151.02 (151.39)
TABLE 3
Contributions (%) to the Calculated Strand Break Yield by Different Mechanisms for Low- and High-LET Radiation
under Full Oxia and Anoxia
999 keV electron (0.19 keV/lm) 2 MeV alpha (151 keV/lm)
760 mmHg 0 mmHg 760 mmHg 0 mmHg
Direct 34.1 52.5 52.9 66.5
Quasi-direct 5.7 8.8 12.0 15.0

OH-attacked sugar 53.8 38.7 31.4 18.5

OH-attacked base and BSRT 6.4 0 3.8 0
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energy loss in Geant4-DNA (n ¼ 13 3 100 ¼ 1300) took less than 2
min on a single core with 1 GB of RAM. The DNA damage induction
algorithm was run millions of times, taking a total of approximately 15
h using parallel processing with 12 cores and at most 14 GB of RAM
total.
RESULTS
The approach used to estimate DNA damage from
physical and chemical tracks through a nucleus involved
spatially clustering direct events (that deposited at least
10.79 eV) and

OH interactions (Figs. 4 and 5).
The strand break yields due to different mechanisms are
shown in Fig. 6. Similar to the PARTRAC model (19, 71),
the strand break yield due to direct-type effects was
approximately the same for all LETs simulated, while the
strand break yield from the indirect effect decreased with
increasing LET (water radiolysis products were generated
closer together, so more chemical reactions occurred and
there were fewer

OH to react with DNA). The LET at
which direct-type effects and the indirect effect contributed
equally to the strand break yield was approximately 36 keV/
lm under full oxia, while direct-type effects were dominant
for all LETs under anoxia [in PARTRAC this LET was 70
keV/lm for protons and 140 keV/lm for alphas (19)]. The
strand break yield from the indirect effect was more
sensitive to pO2, by design (see Methods). The relative
contributions of the different mechanisms to the total strand
break yield are presented quantitatively in Table 3 for the
lowest and highest LETs. The strand break contribution by
direct-type effects was 40% for the lowest LET under full
oxia, in agreement with the 35–40% in PARTRAC (19, 71).
The ratio of the calculated SSB and DSB yields under full
oxia was reasonably consistent across all LETs with
experimental data in the literature and results from other
theoretical models (Fig. 7). Pooling the experimental data
together, there was a significant negative correlation
between SSB/DSB and LET (one-sided P value 0.0002
using linear regression). The calculated SSB/DSB decreased
from approximately 38 to 12 for increasing LET from 0.2 to
150 keV/lm.
Figure 8 shows the calculated yields of different types of
DNA damage. The yield reduction factor, interpreted as the
volume proportion of DNA in the nucleus (see Methods),
was adjusted to 0.1% to best match the DSB yield with that
of Štepán and Davı́dková (RADAMOL) (22). This value is
similar to estimates of 0.3% to 2% for the volume
FIG. 7. Ratio of calculated SSB and DSB yields under full oxia,
compared with experimental data in the literature and results from
other theoretical models. Most experiments used DNA in aqueous
solution with an

OH scavenger such as Tris, glycerol or dimethylsulf-
oxide (DMSO) (36, 72–75). In such experiments, SSB/DSB decreased
with increasing concentration of

OH scavenger (73), so the data
shown are for cell mimetic scavenging capacities of approximately 4 3
108 s–1 (35, 36). Data are also shown from experiments with DNA in
cells (73, 75, 76). The theoretical data were from the models by Liang
et al. (20), and Watanabe et al. (21) as well as from RADAMOL (22)
and PARTRAC (71).
TABLE 4
Contribution (%) of Direct-Type Effects to the
Calculated SSB Yield for Low- and High-LET





760 mmHg 0 mmHg 760 mmHg 0 mmHg
Direct-type 36.6 59.5 13.8 35.0
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proportion of DNA in the nucleus of a yeast cell (55). As in
RADAMOL, the DSB yield peaked at an LET of
approximately 30 keV/lm. The peak is due to DSB
clustering, wherein DSBs separated by less than 4.28 nm
were scored as a single DSB.
The calculated OERDSB was in reasonable agreement with
experimental data in the literature (Fig. 9). The calculated
OERDSB was 3.0 for low LET up to approximately 15 keV/
lm, then decreased with increasing LET to 1.3 at 150 keV/
lm. Therefore, the additional strand breaks produced under
full oxia, compared to under anoxia, did not produce
additional DSBs as often for high LET as for low LET. The
experimental OERDSB data were highly scattered, but when
pooled together, there was a significant negative correlation
with LET (one-sided P value , 0.0001 using linear
regression).
The variation of DNA damage yields with pO2 is shown
in Fig. 10. The variation was caused by the pO2-dependent
probabilities of sugar radical-to-strand break conversion and
BSRT from

OH-mediated base radicals. Thus, the yields
varied in the same way as these probabilities, which were
constructed to vary like cell killing (see Methods), i.e., most
of the change occurred between pO2s of 0.1 and 10 mmHg.
SSB, DSB and complex DSB yields increased with
increasing pO2. Conversely, the modified sugar yield
decreased with increasing pO2 as more sugar radicals were
converted to strand breaks. The (isolated) modified base
yield also decreased with increasing pO2, particularly for
high LET, as more modified bases were a part of DSBs.
As previously mentioned, the DSB yield peaked at
approximately 30 keV/lm due to DSB clustering. This was
evident by the mean DSB multiplicity increasing from
unity at around this LET (Fig. 11A). If DSBs in clusters
were counted separately, the DSB yield would continue to
rise, as shown in Fig. 11B. The OER for the mean DSB
multiplicity varied with LET inversely to OERDSB. In
PARTRAC (19), the mean DSB multiplicity was 2 for low
LET and began to increase after approximately 100 keV/
lm for alphas. This discrepancy may be due in part to
PARTRAC combining DSBs separated by less than 25 bp,
whereas the current work combined DSBs separated by
less than approximately 10 bp. PARTRAC reported only a
small increase in mean DSB multiplicity for alphas at 200
keV/lm.
The indirect effect contributed to SSBs more than direct-
type effects under full oxia, but the situation was reversed
FIG. 8. Calculated DNA damage yields under full oxia (pO2 of 760
mmHg; filled symbols) and anoxia (pO2 of 0 mmHg; unfilled
symbols). The calculated SSB and DSB yields from RADAMOL (22)
are shown for comparison.
FIG. 9. Calculated OERDSB, compared with experimental data
found in the literature. Experimental data were for DNA in cells,
typically irradiated in vitro under 95% air vs. 95% nitrogen (76–84),
except for the in vivo experiment by Hirayama et al. (85), which used
clamping to achieve hypoxia.
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under anoxia for all but the highest LET (Fig. 12 and Table
4). The direct-type contribution to SSBs of 36.6% under full
oxia for low LET is comparable to values of 40% from
Liang et al. (20) for 60Co and 32% from Moiseenko et al.
(23) for 137Cs. Liang et al. found the direct-type contribution
remained approximately 40% for LETs from 5 keV/lm to
170 keV/lm, whereas it decreased with increasing LET in
the current work.
If DSBs were classified according to whether direct-type or
indirect effects produced their strand breaks, the results are
shown in Fig. 13A and B. For low LET, the majority of DSBs
contained strand breaks from direct-type effects only. For high
LET, the majority of DSBs contained strand break contribu-
tions from both direct-type and indirect effects. However, the
fraction of DSBs that required an indirect contribution
decreased with increasing LET (a DSB was said to require
an indirect contribution if every DSB minor cluster in the
DSB contained less than 2 SBs from direct-type effects).
Therefore, the increasing indirect contribution to DSBs with
increasing LET was associated with increasing DSB
complexity, rather than the formation of additional DSBs.
The DSB fractions according to all elementary damage sites
in the DSB, rather than just strand breaks, are shown in Fig.
13C and D. The majority of DSBs contained damages from
both direct-type and indirect effects and this fraction increased
with increasing LET. Moiseenko et al. (23) reported that 39%
of DSBs for 137Cs were from direct-type effects only and 30%
were from the indirect effect only. These fractions are smaller
in the current work. Watanabe et al. (21) found that the direct-
type-only fraction increased with increasing LET, whereas it
decreased in the current work.
DISCUSSION




and O– by oxygen during the
chemical stage (10–12 to 10–6 s). They found negligible
oxygen enhancement of DSB induction (OERDSB , 1.2) as
a result. In the current work, the effect of pO2 was simulated
on DNA radical chemistry processes, in particular, on the
efficiencies of sugar radical-to-strand break conversion and
BSRT from

OH-mediated base radicals. In doing so, the
values of OERDSB obtained were consistent with experi-
mental data in the literature, including a negative correlation
with LET. To our knowledge, this is the first model to
simulate the effect of pO2 on DNA radical chemistry in the
context of predicting DNA damage from radiation track
structures.
The main sources of uncertainty in the current oxygen
effect modeling were:
1. The OER for the probability of SB induction by a direct
event in DNA or its first hydration layer was assumed to
FIG. 10. Variation in calculated DNA damage yields with pO2 for
low-LET radiation (999 keV electrons).
FIG. 11. Panel A: Mean DSB multiplicity. Recall that the DSB
multiplicity is the number of DSB minor clusters contained in the DSB
major cluster. Panel B: Yield of DSB minor clusters. This would be the
DSB yield if nearby DSBs were not counted as a single DSB.
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be equal to the experimentally measured OER for cell
killing by direct-type effects [Eq. (6)]. Likewise, the
OER for the probability of SB induction by an

OH
interaction with DNA was assumed to be equal to the
experimentally measured OER for cell killing by the
indirect effect [Eq. (7)]. The experimental data (taken
from the literature) were for cells in vitro and varied
with cell type.
2. The probability that a sugar radical, from either direct
event or

OH interaction, was converted to a SB was
assumed to be 100% under full oxia (pO2 of 760
mmHg).
3. The probabilities of sugar radical-to-SB conversion and
BSRT [Eqs. (8)–(10)] were assumed to vary with pO2 in
the same way as cell killing in experiments performed
by Spiro et al. on V79 cells (70).
4. The theoretical fit [Eq. (11)] to this experimental data
was performed by Carlson et al. (69) and carries some
uncertainty.
The developed DNA damage algorithm spatially clustered
direct events and

OH interactions in volumes representing
10-bp segments of DNA to generate the initial DNA radical
distribution. This approach differed from the one typically
used in models of DNA damage induction by radiation (19,
21–23). The conventional approach is to first superimpose
the physical tracks with a molecular DNA geometry. Direct
events located within one van der Waals radius of a water
molecule in the first hydration layer or a molecule
FIG. 12. Calculated yields of SSBs from direct-type effects and the
indirect effect under full oxia (pO2 of 760 mmHg; filled symbols) and
anoxia (pO2 of 0 mmHg; empty symbols).
FIG. 13. Contribution of direct-type effects and the indirect effect to DSBs. DSB fractions according to strand
break content under full oxia (panel A) and anoxia (panel B). DSB fractions according to all elementary damage
content (SBs, MBs and MSs) under full oxia (panel C) and anoxia (panel D).
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belonging to the sugar moiety may induce strand breaks.
Then the physicochemical and chemical stages are simulat-
ed amidst the DNA geometry. If an

OH species diffuses to
within one van der Waals radius of a sugar molecule then it
reacts and may induce a strand break. Models that take this
approach have used increasingly rich geometrical structures
to represent the contents of the cell nucleus. This approach
may be too memory intensive (with current hardware) to use
in track structure simulations of thousands to millions of
cells. The developed spatial clustering approach has low
memory requirements and may be suitable for this kind of
task, having now validated the DNA damage yields using
both experimental data and results from other theoretical
models. Since the algorithm also simulates the oxygen
effect, it could foreseeably be applied to radiation tracks
through a large cluster of cells with nonuniform pO2. This is
an important situation to model, since many tumors contain
microscopic regions of hypoxia, which impacts the efficacy
of radiotherapy.
CONCLUSION
An algorithm was developed to predict DNA damage
from physical and chemical tracks through a cell nucleus
simulated in Geant4-DNA, taking into account the effect of
pO2 on DNA radical chemistry processes. An experimen-
tally viable OERDSB was achieved for both low- and high-
LET radiation. DNA damage yields were verified using
experimental data in the literature and results from other
theoretical models. The developed algorithm was based on a
spatial clustering approach. While this approach is a first
order approximation, it is useful for radiation track structure
simulations with large cell clusters due to its low memory
requirements.
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6. Monte Carlo Simulation of the Oxygen Effect in DNA Damage Induction by
Ionizing Radiation 101
6.2.4 Discussion and Conclusion
An algorithm was developed to translate track structure through nucleus material
into DNA damage. The algorithm used a spatial clustering approach, wherein direct
events (e.g. ionisations and excitations) and indirect events (•OH interactions)
were spatially clustered into volumes that each represented 10 base pairs of DNA.
Direct events on DNA and its first hydration layer and indirect events on DNA
produced DNA sugar and base radicals. The oxygen effect was simulated by making
two biochemical processes depend upon the cellular pO2: i) the chance for a base
radical from an indirect event to transfer to a sugar radical and ii) the chance
for a sugar radical to convert to a strand break.
It was remarkable that this model achieved not only the correct relationship for
OERDSB with LET, but also approximately correct values of OERDSB, i.e., OERDSB
was 3.0 for low-LET and decreased with increasing LET to 1.3 at 150 keV/µm.
For comparison, a model by Stewart et al [94] introduced a “chemical repair”
variable which was a function of LET in order to produce the LET-dependence of
OERDSB. This was equivalent to making the efficiency of DNA radical-to-strand
break conversion depend upon LET, which there is no evidence or theoretical basis
for, that I know of. The current model achieved the correct LET dependence of
OERDSB naturally as a by-product of the spatial clustering approach.
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Stochastic multicellular modeling of x-ray
irradiation, DNA damage induction, DNA
free-end misrejoining and cell death
The unpublished and unsubmitted manuscript [95] forms the basis of this chapter:
Forster JC, Douglass MJJ, Phillips WM, Bezak E. Stochastic multicellular
modeling of x-ray irradiation, DNA damage induction, DNA free-end misrejoining
and cell death. 2018 Oct; Manuscript in preparation.
7.1 Introduction and Motivation
An entire multicellular tumour is now irradiated and tracks are simulated in Geant4
using the Geant4-DNA physics and chemistry modules. The DNA damage algorithm
was used to translate tracks through cell nuclei into DNA damage. But the bulk of
this paper is concerned with another topic: how can we predict the likelihood that
a cell survives, given its DNA damage? This question is explored and a stochastic
algorithm is developed to simulate DNA free-end misrejoining and subsequent cell
death. The algorithm is applied in a multicellular tumour following simulation
of Monte Carlo tracks and DNA damage induction.
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7.2 Statement of Contribution
7.2.1 Conception
Jake Forster conceived of the method of voxelisation to import the multicellular
tumour into Geant4, the way of using Geant4-DNA physics and chemistry in
the context of a multicellular tumour, and the idea to simulate DNA free-end
misrejoining and predict cell death from it, under the supervision of Michael
Douglass, Wendy Phillips and Eva Bezak.
7.2.2 Realisation
Jake Forster developed the model (i.e. wrote the code), wrote the code to run
the simulations to acquire data, wrote the code to run the simulations on a
supercomputer, ran the simulations on a supercomputer, analysed the data and made
the plots for visualising data. The manuscript was evaluated by Eva Bezak, Wendy
Phillips and Michael Douglass for data accuracy, critical appraisal, conclusions
reached and general structure and flow.
7.2.3 Documentation
The manuscript was primarily written by Jake Forster, who also prepared the
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Abstract
The repair or misrepair of DNA double-strand breaks (DSBs) largely determines whether a cell
will survive radiation insult or die. A new computational model of radiation-induced cell death was
developed and used to investigate the contribution of DNA free-end misrejoining to cell killing by
low-LET radiation. A randomized cellular tumor of 1224 squamous cells in a cubic volume of side
length 0.2 mm was irradiated with 6 MV x-rays using the Monte Carlo toolkit Geant4 and the low-
energy Geant4-DNA physics and chemistry modules. DNA damage including DSBs were simulated
from the tracks through cell nuclei, with the cellular pO2 affecting the efficiency of DNA radical-to-
strand break conversion. DNA free-ends produced by complex DSBs (cDSBs) were able to misrejoin
and produce exchange-type chromosome aberrations. The misrejoining probability was modeled
as a negative exponential of the initial distance between the cDSBs with scale parameter r0 (e.g.
0.7 µm). It was assumed there were no unrejoined ends (i.e. no terminal deletions or incomplete
exchanges). The cell survival probability from misrejoining was then predicted by assuming each
misrejoining independently had a probability Pnlmr (e.g. 0.5) of producing an asymmetric (lethal)
exchange-type chromosome aberration. A sensitivity analysis was performed for model parameters
DSB yield, r0 and Pnlmr, observing the dose response up to 1 Gy of the number of misrejoinings
per cell and the mean cell survival probability from misrejoining. Conditions of full oxia and
anoxia were simulated. The linear component of cell killing from misrejoining was consistently
small compared to values in the literature for the linear component of cell killing for head and
neck squamous cell carcinoma (HNSCC). This indicated that misrejoinings involving DSBs from
the same x-ray (including all associated secondary electrons) were rare and that other mechanisms
(e.g. unrejoined ends) may be important. The quadratic component of cell killing from misrejoining
was much larger than values in the literature for the quadratic component of cell killing for HNSCC.
This was likely due to modeling the nuclei too small. Ignoring the contribution by the indirect effect
toward DNA damage caused the DSB yield to drop to a third of its original value and the cDSB
yield to drop to a tenth of its original value. As an application, DNA damage and misrejoining were
simulated in all 135306 viable cells of a 1 mm3 tumor of HNSCC, that had a tumor oxygenation




One of the tasks of radiobiological modeling is to predict whether a cell that received ioniz-
ing radiation will ultimately die from the initial radiation-induced DNA damage, consisting
of DNA double-strand breaks (DSBs), single-strand breaks, modified bases and modified
sugars. Cell death (defined by the loss of replicative potential) after irradiation mainly oc-
curs in the form of mitotic catastrophe, meaning it results from, or follows, aberrant mitosis
[1–3]. This occurs when a chromosome aberration (CA) is present that is “asymmetric”,
preventing a large amount of the genetic material from being replicated.
This paper presents a new computational model of CA production and cell death from
ionizing radiation. First, some background is provided on the mechanism of CA production
by DSB misrepair and the relationship between CAs and cell death. Some other computa-
tional models of radiation-induced CAs and cell death from the literature are then reviewed
in order to establish the gap (in the literature) that will be addressed by the current model.
A. Mechanism of CA production by DSB misrepair
CAs are formed by the misrepair of DSBs. Each DSB causes a break in a chromo-
some, producing two DNA free-ends (a.k.a. “sticky” ends). Unrelated (incongruent) DNA
free-ends produced by different DSBs can be misrejoined (illegitimate/incorrect reunion or
exchange), resulting in an exchange-type CA [4–7]. A DSB can also have both ends left
unrejoined, resulting in a terminal deletion, or have one end misrejoined and the other end
left unrejoined (an incomplete exchange) (Figure 1) [8].
“Simple” exchange-type CAs are those that are possible with just two DSBs (Figure 2)
[9]. If the two DSBs are on different chromosomes, a symmetric translocation or a dicentric
(plus an acentric fragment) can form. Two DSBs on opposite arms of a chromosome can
give rise to a centric ring (plus an acentric fragment) or a pericentric inversion. If the two
DSBs are on the same arm, an acentric ring (plus an interstitial deletion) or a paracentric
inversion can occur. A plethora of “complex” exchange-type CAs are possible with three or
more DSBs on two or more chromosomes.
Of the simple exchange-type CAs, dicentrics and rings (centric and acentric) are asym-



















FIG. 1. DSB misrepair can be in the form of complete exchanges, incomplete exchanges and
terminal deletions.
mitosis, they are unstable (lethal). On the other hand, symmetric translocations and inver-
sions (pericentric and paracentric) are symmetric and stable (non-lethal). Large deletions
due to unrejoined ends are also lethal.
The main repair pathway for DSBs in all cell cycle phases for mammalian cells is
canonical-non-homologous end-joining (c-NHEJ) [6, 10–12]. There are two types of c-NHEJ
in G0/G1: one fast (2-4 hrs) and one slow (> 8 hrs). The fast one is resection-independent
and the slow one is resection-dependent (and Artemis-dependent). The slow one is more
error prone. For example, in G1 human cells, resection-independent and resection-dependent
c-NHEJ repaired 80% and 20% of DSBs, respectively, but each was responsible for half of
the misrejoinings after a 7 Gy dose of 90 kV x-rays [13]. In G2, resection-independent
c-NHEJ is active but not resection-dependent c-NHEJ. The slow repair pathway in G2 is
homologous recombination (HR), which is error-free. HR is also active in S. There is also
the alternative-NHEJ (alt-NHEJ) pathway, which involves enzymatically-driven resection.
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FIG. 2. Simple exchange-type CAs. Complete exchanges are shown.
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contribute to repair in G0/G1-phase human cells (though it does appreciably in mice) [10].
Since DNA free-ends must spatio-temporally co-localize to either rejoin or misrejoin, it
appears that the slowness of resection-dependent c-NHEJ and alt-NHEJ is what makes them
more error-prone than resection-independent c-NHEJ, which is fast: the DNA free-ends have
more time to move away from their initial location (possibly with Brownian motion [14])
and meet incongruent DNA free-ends. It follows that a misrejoining is more likely to occur
if the DSBs are initially closer together.
The complexity of a DSB appears to affect the choice of repair pathway. Complex DSBs
are repaired by slow pathways and simple DSBs by fast pathways [15, 16], though it is
unclear why this is the case [11, 17]. Accordingly, DNA free-ends from complex DSBs are
more likely to be misrejoined.
The average number of CAs per cell, Nca, is typically linear-quadratic with dose [4, 7]:
Nca = αcaD + βcaD
2 (1)
The linear component receives contributions from misrejoinings involving DSBs produced
by the same primary (e.g. the same x-ray, including all associated secondary electrons) and
from terminal deletions. The quadratic component corresponds to misrejoinings involving
DSBs produced by two different primaries (thus it depends on dose rate and fractionation).
Let f ≤ 1 be the fraction of lethal CAs, so the average number of lethal CAs per cell is:
Nlca = fNca (2)
If the fraction of lethal CAs is independent of dose and lethal CAs are Poisson distributed in
cells (the latter assumption may become less valid with increasing dose [18]), the surviving








Thus the surviving fraction inherits the linear-quadratic dependence from the CA yield
[2]. The linear-quadratic model generally provides a good fit to experimental data from a
clonogenic cell survival assay for doses up to about 10 Gy per fraction [19].
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It is important to emphasise that Slca is the contribution to the surviving fraction from
the mechanism of lethal CA-driven mitotic catastrophe. While this appears to be the main
mechanism of radiation-induced cell death for mammalian cells [1–3], there is evidence for
additional sources of cell death. Sensitivity to apoptosis is often reduced in cancer compared
to normal tissue [20], but apoptosis may be an important contributor to radiosensitvity in
some tumors [1]. Apoptosis can occur in response to DNA damage [21]. In addition, damage
to mitochondria (which can be enhanced by gold nanoparticles) can trigger cell death by
apoptosis [22]. There are also non-targeted effects (bystander and cohort effects), i.e. signals
emitted from nearby cells, that can elicit apoptosis [23]. In the approximation that the
different mechanisms contribute independently (i.e. no synergistic or antagonistic effects),
the overall surviving fraction is given by the product of all the contributions:
S = SlcaS2S3... (6)
Macroscopic cell death is the convolution of many microscopic processes. By modeling
a microscopic process such as the production of CAs, its contribution to cell death can be
investigated in isolation.
B. Computational models of radiation-induced CAs and cell death
Deterministic models of DSB repair and misrepair in the literature include [24–26]. There
are also stochastic models, which stochastically generate a spatial distribution of DSBs in the
nucleus (e.g. from Monte Carlo track structure) and then simulate the fate of each individual
DSB using stochastic methods. The model in the current work is stochastic. Examples of
stochastic models in the literature include the model by Henthorn et al [27], Friedland and
Kundrát’s model [28, 29], “BIophysical ANalysis of Cell death and chromosome Aberrations”
(BIANCA) [30–32] and Brenner’s model [33].
Brenner’s model simulated track segments using the Monte Carlo code PROTON. A
track was generated and then a cell nucleus was randomly superimposed over the track to
score a segment of the track in the nucleus. This was repeated for a number of tracks (a
certain number of tracks were expected to pass through the nucleus for a given dose), then
it was assumed 1 in 1500 ionizations produced a DSB. The model simulated time-dependent
diffusion and distant-dependent interaction of the DSBs to form exchange-type CAs, in
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competition with faithful DSB repair.
The BIANCA model simulated cluster lesions (CLs), which were effectively DSBs whose
free-ends were able to misrejoin, in a single cell nucleus. For sparsely-ionizing photons, the
CLs were placed at random in the nucleus. For protons and alphas, there was an expected
number of nucleus traversals (based on dose) and an expected number of CLs from each
traversal (based on LET). Line segments representing traversals were randomly simulated
through the nucleus and CLs were randomly distributed along the line segments. For higher
LETs, some of the CLs were placed radially with respect to the line segments to account
for high-energy secondary electrons. Proximity-based misrejoining of the DNA free-ends
from CLs was simulated. The nucleus contained interphase chromosome territories and
chromosome-arm domains, making it possible to determine the types of CAs produced (e.g.
dicentrics, centric rings, etc.).
Friedland and Kundrát’s model simulated Monte Carlo tracks through a single cell nu-
cleus using the code PARTRAC (PARticle TRACks) and superimposed the tracks with a
multiscale DNA target model to generate DNA damage. Spatio-temporal motion of DNA
free-ends was simulated in addition to mechanistic modeling of NHEJ to achieve DSB repair
and misrepair. The types of CAs produced were known due to modeling of chromosome
territories in the nucleus. The model by Henthorn et al also simulated DNA free-end motion
with mechanistic modeling of c-NHEJ. The DSBs were generated from Monte Carlo tracks
simulated in Geant4 [34–36] using Geant4-DNA [37–39], using a spatial clustering approach.
Chromosome territories were not modeled.
Compared with these other stochastic models, the current model has two unique proper-
ties: i) Monte Carlo tracks were simulated through a multicellular tumor volume (as opposed
to a single cell nucleus) and ii) variable cellular pO2 conditions were simulated. A multicel-
lular tumor of head and neck squamous cell carcinoma (HNSCC) was irradiated with tracks
using the Monte Carlo toolkit Geant4 (version 10.4) [34–36]. The physics and chemistry
modules of Geant4-DNA [37–39] were used to accurately simulate low-energy physical inter-
actions and the chemical tracks from water radiolysis. The tracks through cell nuclei were
translated into spatial distributions of DNA damage, including DSBs, by spatially clustering
the direct and indirect events into simulated DNA volumes. The DNA damage from the
tracks was subject to the cellular pO2: a higher pO2 produces more efficient DNA radical-to-
strand break conversion. Proximity-based DNA free-end misrejoining was simulated. Cell
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death was predicted from the presence of lethal CAs.
The purpose of this work was two-fold: First, to present new stochastic modeling of
radiation-induced CA production and cell killing, that befits a different purpose than other
models in the literature. Namely, the simulation of a multicellular tumor and variable
pO2 conditions makes this model uniquely apt to be used as part of a radiotherapy model.
Radiotherapy models often take the approach of simulating each cell in the tumor, but
they typically simulate the radiation effect using the Linear-Quadratic equation or a vari-
ant thereof [40–45]. Greater accuracy and utility may be achieved if instead the radiation
effect is simulated starting from Monte Carlo tracks. With improved accuracy and utility,
radiotherapy models may find greater use in radiotherapy planning, helping to further indi-
vidualize radiotherapy treatments to account for patient-specific radiobiology. The second
aim of this work was to use the model to investigate the contribution of DNA free-end
misrejoining to CA production and cell death by low-LET radiation for HNSCC.
II. MATERIALS AND METHODS
A. Model methods
A computational model was developed in-house to simulate a fraction of dose to a multi-
cellular tumor of HNSCC, followed by DNA damage induction, DNA free-end misrejoining
and cell death from misrejoining. The flowchart in Figure 3 summarises the components of
the model, which are described in more detail below.
1. Tumor cell placement in 3D
A cubic volume of side length 0.2 mm was filled with 1224 non-overlapping cells (a
tumor-mimetic density [46] of 1.53× 108 cells/cm3) using a previously developed algorithm
(Figure 4(a)) [47, 48]. The cells were ellipsoid-shaped with random orientations and major
axis lengths between 14 and 20 µm, representative of FaDu HNSCC cells [49]. Cells contained
a concentric nucleus that occupied 8% of the cellular volume [50].
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FIG. 3. Basic flowchart of the model. Psurv(mr) is the probability of cell survival by the mechanism
of misrejoining.
2. Tumor voxelization
In order to import the multicellular tumor (1224 cells) into Geant4 (version 10.4), it was
first voxelized. Voxels were cubic volumes of side length 2 µm representing either nucleus,
cytoplasm or intercellular material (Figure 4(b)). Voxelization was performed using an
algorithm written in Matlab (R2016b, MathWorks R© Inc., Natick, MA). The distance from
the center of a voxel to the center of a cell was used to determine whether the center of the
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(a) (b)
FIG. 4. Example of a multicellular tumor with a small number of cells for demonstration. (a)
Randomized ellipsoidal cells containing nuclei. (b) The corresponding voxel representation, showing
nucleus and cytoplasm voxels.
voxel was located within the nucleus or cytoplasm of the cell (accounting for the ellipsoid-
shaped cell and nucleus and their rotation). Voxels were assigned as nucleus or cytoplasm
based on this criteria.
For the cubic volume of side length 0.2 mm, there were 100 × 100 × 100 = 106 voxels.
Two 3D arrays of size 100 × 100 × 100 called voxelType and voxelCell were introduced.
The element ~i = (i, j, k) of these arrays (where i, j and k took integer values from 0 to 99)
corresponded to the voxel whose center had spatial coordinates:
~X = −99 + 2~i (µm) (7)
The voxelType array contained the flag identifying the voxel type (0 for intercellular, 1 for
nucleus and 2 for cytoplasm) and voxelCell contained the flag identifying the cell that the
voxel belonged to (0 for intercellular voxels, 1-1224 for nucleus and cytoplasm voxels).
3. Tumor irradiation with track structure
The voxelized multicellular tumor (1224 cells) was imported into Geant4 as follows. A
cubic volume (soon to accommodate the tumor) of side length 0.2 mm was placed in Geant4










FIG. 5. Irradiation set-up in Geant4: the voxelized multicellular tumor encased in water.
and intercellular materials were defined equivalent to “G4 WATER” (as is required to use
Geant4-DNA) with density 1 g/cm3. The voxels were then assigned to nucleus, cytoplasm
or intercellular material using the voxelType array.
X-rays with an energy distribution from a 6 MV linac model developed in the Philips
Pinnacle treatment planning system were fired from a square 4.2 mm × 4.2 mm source
with parallel beam, placed 1.3 cm from the tumor (Figure 5). The tumor was encased in
water to achieve a uniform dose to tumor (see Results, Section III A). Relative to the beam
direction, there was 1.3 cm of water in front of the tumor to achieve electronic equilibrium
in the tumor (for 6 MV x-rays the mean electron energy is ∼ 2 MeV, which has a range
of ∼ 1 cm in liquid water using the continuous slowing down approximation [51]), 2 mm of
water either side of the tumor for lateral scattering and 1 mm of water behind the tumor to
provide back scatter medium (MV x-rays mostly scatter forward).
Geant4-DNA physics models, which accurately simulate physical interactions down to
eV energies, were used to simulate electron interactions in the tumor for electron energies
< 1 MeV (the models were not defined ≥ 1 MeV). The Livermore physics list (which is
low-energy but not as low as Geant4-DNA) was used in the tumor for electron energies ≥ 1
MeV and for photon and positron interactions (Table I). Outside the tumor, Livermore
physics was used exclusively (there was no need to simulate very low-energy physics outside
the tumor) (Table II). For physical interactions in nucleus voxels that deposited ≥ 10.79
eV (the ionization energy for liquid water), the spatial coordinates of the interaction were
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TABLE I. Physics interactions simulated in the tumor.
Particle Interaction Energy rangea Model
e− multiple scattering ≥ 1 MeV Urban
elastic scattering (7.4 eV, 1 MeV) DNA Champion
ionization ≥ 1 MeV Møller-Bhabha
[10 keV, 1 MeV) DNA Born
[11 eV, 10 keV) DNA Emfietzoglou
excitation [10 keV, 1 MeV) DNA Born
[8 eV, 10 keV) DNA Emfietzoglou
vibrational excitation (7.4 eV, 100 eV) DNA Sanche
attachment (7.4 eV, 11.2 eV) DNA Melton










a Energies relevant to this application with 6 MV x-rays. Active for all relevant energies if not specified.
recorded, along with the flag identifying the cell in which it took place (via voxelCell). The
total energy deposited in each voxel was also recorded.
Geant4-DNA chemistry was used to simulate water radiolysis following Geant4-DNA
physics, but only inside nucleus voxels to save computation time (Figure 6). It was as-
sumed that •OH molecules interacted after 2.5 ns of diffusion. This corresponded to an •OH
scavenging capacity of 4 × 108 s−1, and a root-mean-square displacement of 6.48 nm with
the •OH diffusion coefficient of 2.8× 10−9 m2s−1 used in Geant4-DNA chemistry, which are
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TABLE II. Physics interactions simulated outside the tumor.
Particle Interaction Energy rangea Model
e− multiple scattering Urban
ionization ≥ 100 keV Møller-Bhabha




a Energies relevant to this application with 6 MV x-rays. Active for all relevant energies if not specified.
b Same as in the tumor (Table I).
mimetic of the cellular environment [52–57]. When the virtual time of the chemistry simula-
tion reached 2.5 ns, for each •OH molecule inside a nucleus voxel, the spatial coordinates of
the •OH were recorded (taken to be the position of an •OH interaction) along with the flag
identifying the cell it was located in. The chemistry simulation was ended after a virtual
time of 2.5 ns to save computation time.
4. DNA damage induction algorithm
A spatial distribution of DNA damage including DSBs, single-strand breaks, modified
bases and modified sugars was generated in each tumor cell nucleus from the track struc-
ture, using an algorithm that has previously been described [58]. Briefly, the algorithm
spatially clustered the physical interactions that deposited ≥ 10.79 eV (direct events) and
•OH interactions (indirect events) in the nucleus into cylindrical volumes representing 10
base-pair segments of DNA. Direct events on DNA and its first hydration layer and indi-
rect events on DNA produced DNA sugar radicals and base radicals, some of which were
subsequently converted to strand breaks with pO2-dependent probabilities. Two or more
strand breaks within 10 base-pairs constituted a DSB. If two DSBs were separated by less
than 10 undamaged base-pairs, they were classified as the same DSB. Thus DSBs acquired
a multiplicity. Only the spatial distributions of DSBs were used hence.








FIG. 6. Visualization of a few cells irradiated with 1 MeV electrons. (a) The electron tracks are
not drawn, but their passage through cell nuclei is dotted by •OH tracks (green) (Geant4-DNA
chemistry was only simulated in nucleus voxels). The three scale bars are mutually orthogonal
and each 10 µm long. (b) A closer view (100 nm scale bars) shows the •OH tracks generated
sporadically along the electron tracks (magenta). (c) A closer view again (5 nm scale bars) shows
an •OH track in more detail, depicting 2.5 ns of diffusion by Brownian motion.
ns in the current work. In the previous work [58], in which the DNA damage induction
algorithm was developed and verified, the chemical stage was continued to 1 µs. As a result,
the relatively small number of •OH molecules formed during the chemical stage (by the
reaction e–aq + H2O2 −−→ OH– + •OH, as opposed to during the physicochemical stage) were
neglected in the current work. This was predicted to have a negligible effect on the DSB
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yield, since these •OH molecules are typically formed away from the electron track and thus
rarely contribute to clusters of damage (e.g. DSBs).
The DNA damage induction algorithm includes a parameter which may be interpreted as
the volume proportion of DNA in the nucleus (DNA volume for short). The DNA damage
yields, including the DSB yield, were scaled down according to this parameter. This meant
that a fraction of the DSBs within the whole nucleus volume were removed from each cell,
chosen at random and irrespective of DSB complexity. Estimates in the literature of the
DNA volume in yeast cells vary from 0.3 to 2% [59]. In the current work, the DNA volume
was adjusted to achieve realistic DSB yields. Experiments in the literature indicate that the
DSB yield increases linearly with dose in the clinically relevant dose range < 100 Gy and
is generally 20-40 /cell/Gy for mammalian haploid cells [7, 60–63]. For low-LET radiation
and human HNSCC cell lines (in vitro) in particular, Saker et al [64], using colocalization
of γH2AX and 53BP1 foci, measured an average of 36 DSBs/cell after 1 Gy with 200 kV
x-rays for UTSCC15, FaDuDD and UTSCC14. El-Awady et al [65] with 220 kV x-rays
measured a DSB yield of approximately 20 /cell/Gy for SCC4451 using graded-field gel
electrophoresis. We aimed to achieve these yields; the current work includes a sensitivity
analysis (see Section II B) using DSB yields of approximately 20, 30 and 40 /cell/Gy, which
were achieved with DNA volumes of 13.3%, 20% and 26.7%, respectively (see Discussion for
the likely reason for high DNA volumes).
5. DNA free-end misrejoining and cell death
In our simulation, DNA free-ends from complex DSBs (cDSBs) were able to participate
in misrejoining events. To obtain a cDSB yield that was approximately 10% of the DSB
yield (and therefore similar to the CL yields in the BIANCA model for x-rays, e.g. 4.0
/Gy/cell for a monolayer-shaped fibroblast and 3.1 /Gy/cell for a lymphocyte [32]), cDSBs
were defined as DSBs with > 15 elementary damages (strand breaks, modified bases and
modified sugars).
The probability of a misrejoining, Pmr, between two incongruent free-ends was modeled
as a negative exponential function of the initial distance, d, between the two cDSBs that
produced them (note that a negative exponential was used in the BIANCA model and the
simulated CA yields for low-LET radiation achieved good agreement with experimental data
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for i = 1 → N ; for j = (i+ 1) → N
free-end 1 free-end 2







FIG. 7. Schematic of the stochastic, proximity-based DNA free-end misrejoining algorithm, based
on the method in the BIANCA model [32]. A successful misrejoining event removed two free-ends
from the pool. N is the total number of cDSBs, dij is the initial distance between cDSBi and
cDSBj , Pmr(dij) is the probability of a misrejoining between a free end of cDSBi and a free-end of
cDSBj .
for a monolayer-shaped fibroblast and a lymphocyte [32]):
Pmr = e
−d/r0 , (8)
where r0 is the characteristic interaction distance, which was an adjustable parameter
(e.g. [32] used 0.7 µm for a monolayer-shaped fibroblast and 0.8 µm for a lymphocyte
in BIANCA). For a nucleus containing N cDSBs (cDSB1, cDSB2, ..., cDSBN), misrejoining
was simulated as follows (Figure 7): The first free-end of cDSB1 had a chance (with prob-
ability Pmr) to misrejoin with the first free-end of cDSB2, then with the second free-end of
cDSB2. Then the second free-end of cDSB1 had a chance to misrejoin with the first free-end
of cDSB2, then with the second free-end of cDSB2. Then the first free-end of cDSB1 had a
chance to misrejoin with the first free-end of cDSB3, then with the second free-end of cDSB3,
and so on. In general, each free-end of cDSBi had a chance to misrejoin with each free-end
of cDSBi+1, cDSBi+2, ..., cDSBN (i.e. each combination of free-ends was tried only once).
Successful misrejoinings removed free-ends from the “pool” of candidates.
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To predict cell death from misrejoinings, the following assumptions were made:
1. No terminal deletions: cDSBs with both ends unrejoined were rejoined faithfully/correctly.
2. No incomplete exchanges: For cDSBs with only one end misrejoined, assume the other
end misrejoined with the same cDSB as the first, or if that cDSB has no free ends,
with the other available end in the misrejoining “chain” (e.g. if cDSB1 and cDSB2
each have an end misrejoined with an end from cDSB3, then the remaining end of
cDSB1 was assumed to misrejoin with the remaining end of cDSB2).
3. If two cDSBs misrejoined both of their ends together during the original misrejoining
simulation, the second misrejoining was not counted, as this was assumed (from the
previous assumption).
With these assumptions in place, each counted misrejoining independently had a 50% chance
of resulting in an asymmetric exchange-type CA and thus causing cell death (Appendix).
Accordingly, the probability of cell survival from misrejoining, Psurv(mr), was related to the
total number of counted misrejoinings, Nmr, by (similar to Brenner’s model [33]):
Psurv(mr) = 0.5
Nmr (9)
In the sensitivity analysis (see Section II B), values other than 0.5 were also considered for
the probability that a misrejoining was non-lethal, Pnlmr; in which case:
Psurv(mr) = (Pnlmr)
Nmr (10)
The parameter r0 (from Equation 8) was also included in the sensitivity analysis.
B. Simulations performed
1. Sensitivity analysis
Doses to the tumor (1224 cells) of up to 1 Gy were simulated (1 mGy, 3 mGy, 10 mGy,
30 mGy, 60 mGy, 0.1 Gy, 0.3 Gy, 0.5 Gy, 0.7 Gy and 1 Gy). For each dose, DNA damage
induction and DNA free-end misrejoining were simulated in all 1224 cells under conditions
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of full oxia (pO2 of 760 mmHg) and anoxia (pO2 of 0 mmHg). The number of DSBs per cell
vs dose and the number of cDSBs per cell vs dose were fit (using Matlab) to:
NDSB = mDSBD (11)
NcDSB = mcDSBD (12)
The number of misrejoinings per cell vs dose was fit to:
Nmr = αmrD + βmrD
2 (13)
If αmr < 0, the fit was reperformed to:
Nmr = βmrD
2 (14)
The mean probability of cell survival from misrejoining was fit to:
Psurv(mr) = e
−αkilling(mr)D−βkilling(mr)D2 (15)
If αkilling(mr) < 0, the fit was reperformed to:
Psurv(mr) = e
−βkilling(mr)D2 (16)
The oxygen enhancement ratios (OERs) for DSB and cDSB induction were obtained by:
OERDSB =
mDSB(pO2 of 760 mmHg)
mDSB(pO2 of 0 mmHg)
(17)
OERcDSB =
mcDSB(pO2 of 760 mmHg)
mcDSB(pO2 of 0 mmHg)
(18)
The surviving fraction from misrejoining after a dose of 2 Gy, SF2(mr), was obtained by ex-
trapolation using the fit for Psurv(mr). The OER for cell killing by misrejoining was measured
as:
OERkilling(mr) =
D10(pO2 of 0 mmHg)
D10(pO2 of 760 mmHg)
(19)
where the dose to achieve 10% survival, D10, was obtained by extrapolation using the fit for
Psurv(mr).
A sensitivity analysis was performed for the model parameters DSB yield ∈ {20.1, 30.1,
40.2} /cell/Gy, r0 ∈ {0.5, 0.7, 0.9} µm and Pnlmr ∈ {0.25, 0.5, 0.75}, using the endpoints
OERDSB, OERcDSB, αmr, βmr, αkilling(mr), βkilling(mr), SF2(mr) and OERkilling(mr).
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Simulations were performed on the Phoenix supercomputer (University of Adelaide, Ade-
laide, Australia). To irradiate the tumor (1224 cells) with tracks to a uniform dose of 1 Gy
required 637 runs of 5×107 x-rays each. Each run required 5 cores sharing 30 GB of memory
for 1.25 hours (4000 core hours total). The amount of resources required to run the the DNA
damage induction algorithm was non-linear with dose. For a dose of 1 Gy, the DNA damage
algorithm required 1 core with 35 GB for 8 hours, followed by 5 cores sharing 110 GB for
32 hours, once for full oxia and once for anoxia (328 core hours total). For comparison, for
a dose of 0.7 Gy, it used 1 core with 25 GB for 3 hours, followed by 5 cores sharing 50 GB
for 13 hours, once for full oxia and once for anoxia (29 core hours total). The misrejoining
algorithm required almost no resources.
2. Isolation of the indirect effect
DNA damage induction and DNA free-end misrejoining were repeated for each dose, but
without including the indirect effect (•OH interactions with DNA) in the induction of DNA
damage. A DSB yield of 30.1 /Gy/cell, r0 of 0.7 µm and Pnlmr of 0.5 were used. Without
the indirect events, the DNA damage algorithm required approximately half as many core
hours and GB of memory.
3. HNSCC tumor of volume 1 mm3
The voxelized tumor (the cubic volume of side length 0.2 mm containing 1224 cells)
was replicated 125 times to form a cubic volume of side length 1 mm3 containing 1224 ×
125 = 153000 cells. A previously developed model for cellular HNSCC tumor growth with
angiogenesis [47, 66] was used to generate a connected network of blood vessels through
the 1 mm3 tumor and then assign each cell with a pO2 according to its proximity to blood
vessels.
The relevant model parameters were the relative vascular volume (RV V ), the blood
oxygenation (p0) and the distance from a vessel to the onset of necrosis (ND). While
HNSCC can have RV V from 2-10%, p0 from 20-100 mmHg and ND from 80-300 µm [67], a
typical HNSCC is very hypoxic, requiring these parameters to take values near their lower
limits [66]. In order to achieve a typical HNSCC oxygenation (see Results; Section III C),
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an RV V of 2.1%, p0 of 30 mmHg and ND of 130 µm were chosen.
The same physical and chemical tracks through the original 1224 cells from 1 Gy were
used for all 125 “copies” of the (0.2 mm)3 tumor. The positions that were occupied by viable
cells (as opposed to necrotic cells or blood vessel units) and their pO2 values differed between
copies. Stochastic DNA damage induction and subsequent DNA free-end misrejoining were
simulated for each viable (non-necrotic) cell in each copy. While the spatial distributions
of direct and indirect events in nuclei were the same between copies, the DNA targets were
moved each time, affecting which direct and indirect events hit the DNA. Furthermore, the
same event on DNA may have produced the DNA radical on the sugar moiety one time and
on a base the next. Most importantly, a higher cellular pO2 made it more likely for a DNA
radical to be converted to a strand break. For all of these reasons, the spatial distribution
of DSBs in each nucleus was different between copies.
For the 1 mm3 tumor of HNSCC, bivariate frequency distributions were generated of i)
the cellular pO2 and the number of DSBs in the nucleus, ii) the cellular pO2 and the number
of cDSBs in the nucleus, iii) the cellular pO2 and the number of misrejoinings in the nucleus
and iv) the cellular pO2 and the cell survival probability from misrejoining.
The DNA damage algorithm required 1 core with 35 GB for 8 hours, followed by 5 cores
sharing 110 GB for 32 hours for each of the 125 copies (20,008 core hours total).
III. RESULTS
A. Sensitivity analysis
Variations with dose of the number of DSBs per cell, the number of cDSBs per cell, the
number of misrejoinings per cell and the cell survival probability from misrejoining, under
full oxia and anoxia, are shown in Figure 8. These results used a DSB yield of 30.1 /Gy/cell,
r0 of 0.7 µm and Pnlrm of 0.5. The number of misrejoinings per cell and the cell survival
probability from misrejoining were mostly quadratic with dose under full oxia (αmr = 0.02
Gy−1 and βmr = 0.37 Gy−2; αkilling(mr) = 0.02 Gy−1 and βkilling(mr) = 0.17 Gy−2) and purely
quadratic under anoxia (βmr = 0.03 Gy
−2; βkilling(mr) = 0.02 Gy−2).
The results of a sensitivity analysis for the parameters DSB yield, r0 and Pnlrm are
presented in Tables III-V, respectively. The amount of misrejoining and hence cell killing
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FIG. 8. (a) Number of DSBs per cell vs dose. (b) Number of cDSBs per cell vs dose. (c) Number
of misrejoinings per cell vs dose. (d) Cell survival probability from misrejoining vs dose. The mean
values for n = 1224 cells were plotted with error bars equal to the SEM. The model parameters
used were a DSB yield of 30.1 /Gy/cell, r0 of 0.7 µm and Pnlrm of 0.5.
increased with increasing DSB yield and r0 while the amount of cell killing decreased with
increasing Pnlrm, as expected. Note that misrejoining and cell killing consistently had small
linear components (i.e. the αmr and αkilling(mr) values). Also consistently observed were
OERcDSB < OERDSB and OERkilling(mr) < OERDSB. For the remainder of the results, a DSB
yield of 30.1 /Gy/cell, r0 of 0.7 µm and Pnlrm of 0.5 were used.
For the 1 Gy irradiation, the dose to the tumor was uniform to within 1% (Figure 9(a))
































































































































































































































































































































































































































































































































































































































































TABLE IV. Effects of varying the characteristic interaction distance, r0 (from Equation 8). A DSB

















0.5 0.01/0.17 (0f/0.01) 0.01/0.08 (0g/0.01) 0.71 (0.97) 3.5
0.7 0.02/0.37 (0f/0.03) 0.02/0.17 (0g/0.02) 0.49 (0.94) 3.4
0.9 0.04/0.54 (0f/0.04) 0.03/0.24 (0g/0.02) 0.36 (0.92) 3.4
a Fit to Nmr = αmrD + βmrD
2.
b Fit to Psurv(mr) = e
−αkilling(mr)D−βkilling(mr)D2 .
c Using Pnlmr = 0.5.
d Using the fit to Psurv(mr) and extrapolating to 2 Gy.
e Using OERkilling(mr) = D10(pO2 of 0 mmHg)/D10(pO2 of 760 mmHg), where D10 was obtained by
extrapolating the fit to Psurv(mr).
f The fit gave −0.01 . αmr < 0, so the fit was reperformed to Nmr = βmrD2.
g The fit gave −0.01 < αkilling(mr) < 0, so the fit was reperformed to Psurv(mr) = e−βkilling(mr)D
2
.
standard deviation of 1.00±0.06 Gy (Figure 9(b)).
Frequency distributions of the number of DSBs in nuclei, the number of cDSBs in nuclei,
the number of misrejoinings in nuclei and the cell survival probability from misrejoining,
under full oxia and anoxia, are shown in Figure 10 for the 1 Gy dose.
Figure 11 provides information about the complexity of the DSBs induced under full oxia
and anoxia. While there were fewer DSBs under anoxia, the DSBs were on average more
complex in terms of the number of elementary damages (strand breaks, modified bases and
modified sugars). Given how cDSBs were defined (DSBs with > 15 elementary damages),
this is consistent with OERcDSB < OERDSB. Almost all DSBs had unit multiplicity (98.3%
of DSBs under full oxia and 99.6% of DSBs under anoxia).
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TABLE V. Effects of varying the probability that a misrejoining was non-lethal, Pnlmr (from
Equation 10). A DSB yield of 30.1 /Gy/cell (cDSB yield of 2.9 /Gy/cell) under full oxia and r0 of













0.25 0.03/0.25 (0d/0.02) 0.35 (0.91) 3.3
0.5 0.02/0.17 (0d/0.02) 0.49 (0.94) 3.4
0.75 0.01/0.09 (0d/0.01) 0.69 (0.97) 3.4
a Fit to Psurv(mr) = e
−αkilling(mr)D−βkilling(mr)D2 .
b Using the fit to Psurv(mr) and extrapolating to 2 Gy.
c Using OERkilling(mr) = D10(pO2 of 0 mmHg)/D10(pO2 of 760 mmHg), where D10 was obtained by
extrapolating the fit to Psurv(mr).
d The fit gave −0.01 < αkilling(mr) < 0, so the fit was reperformed to Psurv(mr) = e−βkilling(mr)D
2
.
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FIG. 9. (a) Spatial dose profiles for the 1 Gy irradiation, using voxel slices in the X, Y and Z
directions. The mean dose for n = 104 voxels in a voxel slice was plotted with vertical error bars
equal to the SEM (which were smaller than the markers). (b) Frequency distribution of dose to
nuclei (n = 1224) for the 1 Gy irradiation, with a normal distribution fit overlaid.
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FIG. 10. Frequency distributions in n = 1224 cells for 1 Gy dose, under full oxia and anoxia: (a)
Number of DSBs in nuclei. (b) Number of cDSBs in the nuclei. (c) Number of misrejoinings in the
nuclei. (d) Cell survival probability from misrejoining.
B. Isolation of the indirect effect
If the indirect effect was not taken into account in the induction of DNA damage, the
DSB yield was reduced to approximately a third of its original value and the cDSB yield to
a tenth of its original value (Table VI).
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FIG. 11. Frequency distributions for 1 Gy dose, under full oxia and anoxia: (a) Number of strand
breaks in DSBs. (b) Number of elementary damages (strand breaks, modified bases and modified
sugars) in DSBs. The total number of DSBs in 1224 cells was n = 187518 under full oxia and
n = 40886 under anoxia. The frequency distributions were normalized for ease of comparison
between full oxia and anoxia.





Da+Ib 30.1 / 2.9 4.6 3.9
Da only 12.3 / 0.3 2.6 2.2
a Direct-type effects
b Indirect effect
C. HNSCC tumor of volume 1 mm3
A 1 mm3 tumor was generated (Figure 12(a)) with a cellular pO2 distribution (Fig-
ure 12(b)) characteristic of HNSCC [66]: the mean cellular pO2 was 9.4 mmHg, the median
cellular pO2 was 8.2 mmHg, the HP10 (proportion of viable cells with pO2 < 10 mmHg) was

























FIG. 12. (a) Section (thickness 20 µm) of the 1 mm3 tumor of HNSCC, showing blood vessel
units (red), normoxic cells (pO2 > 10 mmHg) (black) located near the blood vessels, hypoxic
cells (pO2 ≤ 10 mmHg) (green) located further from the blood vessels and necrotic cells (brown)
located further than ND = 130 µm from a blood vessel. It can be seen how the 1 mm3 tumor
was constructed by replicating the (0.2 mm)3 tumor. (b) Frequency distribution of pO2 for viable
(non-necrotic) cells (n = 135306) in the 1 mm3 tumor of HNSCC.
Figure 13 shows, for 1 Gy dose, bivariate frequency distributions of the cellular pO2 and
the number of DSBs in the nucleus, the cellular pO2 and the number of cDSBs in the nucleus,
the cellular pO2 and the number of misrejoinings in the nucleus and the cellular pO2 and
the cell survival probability from misrejoining.
IV. DISCUSSION
DNA free-end misrejoining and its contribution to cell killing for MV x-rays was inves-
tigated. The linear components of misrejoining (αmr) and cell killing from misrejoining
(αkilling(mr)) were consistently small in the sensitivity analysis. For example, for a DSB yield
of 30.1 /Gy/cell, r0 of 0.7 µm and Pnlmr of 0.5, αkilling(mr) was 0.02 Gy
−1 under full oxia
(and zero under anoxia). For comparison, a typical αkilling for HNSCC is 0.3 Gy
−1 [68–73].




FIG. 13. Bivariate frequency distributions in n = 135306 viable cells of the 1 mm3 HNSCC tumor
for 1 Gy dose. (a) Cellular pO2 and the number of DSBs in the nucleus. (b) Cellular pO2 and the
number of cDSBs in the nucleus. (c) Cellular pO2 and the number of misrejoinings in the nucleus.
(d) Cellular pO2 and the cell survival probability from misrejoining.
occurrence, which is in agreement with deterministic modeling by Carlson et al [25], and
ii) other mechanisms may be chiefly responsible for the linear components of CA produc-
tion and cell killing by low-LET radiation for HNSCC. Unrejoined DNA free-ends (terminal
deletions and incomplete exchanges) are likely candidates. It has been estimated that ap-
proximately 5% of DSBs end up as either terminal deletions or incomplete exchanges for
low-LET radiation [8].
On the other hand, the quadratic components of misrejoining (βmr) and cell killing from
misrejoining (βkilling(mr)) were consistently large in the sensitivity analysis. For the afore-
mentioned {DSB yield, r0, Pnlmr}, βkilling(mr) was 0.17 Gy−2 under full oxia (0.02 Gy−2 under
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anoxia), whereas a typical value of βkilling for HNSCC is 0.03 Gy
−2 [68–74]. This indicates
that too much misrejoining was simulated (which makes the small linear component of cell
killing by misrejoining look even smaller). This is to be expected given that the SF2(mr) under
full oxia was already 49% without simulating terminal deletions and incomplete exchanges
as sources of cell killing.
The amount of misrejoining could be reduced by decreasing the model parameter r0 below
0.5 µm. However, this may not be optimal, since the BIANCA model obtained good results
for the CA yields in a monolayer-shaped fibroblast using an r0 of 0.7 µm and in a lymphocyte
using an r0 of 0.8 µm [32]. Alternatively, misrejoining could be reduced by increasing the
size of the nuclei. This may be wise given that large DNA volumes from 13.3 to 26.7% were
required to obtain DSB yields from 20 to 40 /Gy/cell (for reference, estimates of the DNA
volume in yeast cells vary from 0.3 to 2% [59]). Increasing the nucleus volume would require
a proportional decrease in the DNA volume to obtain the same DSB yield. The average
nucleus volume in the current work was 142 µm3 for squamous cells. For comparison, the
fibroblast in the BIANCA model had a nucleus volume of 628 µm3. Note that the fibroblast
was modeled as monolayer-shaped and this reduced the amount of misrejoining compared
to a more spherical shape.
It is also possible that some misrejoinings were counted that should not have been. If
a group of N ≥ 3 breaks involved N explicitly simulated misrejoinings (the maximum
number), a value of Nmr = N was mistakenly used in Equation 9 (or Equation 10) for the
cell survival probability; the true probability in this case is obtained by using a value of
Nmr = N−1 (Appendix). However, for the largest dose simulated (1 Gy), only 1.7% of cells
(22/1224 cells) under full oxia (and no cells under axoia) contained 3 or more misrejoinings
(Figure 10(c)). Therefore, these erroneous cases could not have contributed appreciably to
the current results. This oversight will be rectified in future iterations of the model, as it will
be important for simulating hypofraction doses and high-LET proton and carbon beams,
which are planned for future work.
A limitation of the model was the assumption of no incomplete exchanges. The model also
did not simulate terminal deletions. There would be greater cell killing if these mechanisms
were accounted for. Another limitation was that a negative exponential function was used to
model the probability of misrejoining (Equation 8). This was an approximation of complex
DSB repair processes (e.g. c-NHEJ), which involve a cascade of a large number of DNA
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repair proteins [13]. Additionally, there can be DNA damage from non-targeted effects [23],
which was not considered. The model also neglected cell death by apoptosis, when apoptosis
is not a consequence of lethal CA-driven mitotic catastrophe [1, 21–23].
This work presented a new stochastic model of radiation-induced CA production and
cell death that addressed a gap in the literature. Rather than focussing on simulating a
complex DNA target model (e.g. Friedland and Kundrát’s model [28, 29], the BIANCA
model [30–32]), or the motion of DNA free-ends (Friedland and Kundrát, the model by
Henthorn et al [27], Brenner’s model [33]), or mechanistic modeling of NHEJ (Henthorn
et al, Friedland and Kundrát), the current model uniquely simulated Monte Carlo tracks
through a whole multicellular tumor volume, and converted the physical and chemical tracks
in nuclei into DNA damage in a pO2-dependent fashion. These novel properties make the
model suitable for future amalgamation into a spatio-temporal multicellular radiotherapy
model [47, 66], that simulates the radiation effect starting from whole-tumor Monte Carlo
tracks and accurately simulates the effects of tumor hypoxia.
V. CONCLUSION
The current work achieved the stochastic simulation of i) x-ray irradiation of a multicel-
lular tumor, ii) pO2-dependent DNA damage induction from the tracks, iii) proximity-based
DNA free-end misrejoining and iv) cell death from misrejoining. The model was used to
investigate the contribution of misrejoining to cell killing in isolation for MV x-rays. A
sensitivity analysis was conducted for the model parameters DSB yield, characteristic in-
teraction distance and probability that a misrejoining was non-lethal. As an application,
DNA damage and misrejoining were simulated in 135306 viable cells in a 1 mm3 HNSCC
tumor for a uniform dose of 1 Gy. The near absence of linear components of misrejoining
and cell killing from misrejoining suggests that terminal deletions and incomplete exchanges
may be important mechanisms for the linear components of CA production and cell killing
by low-LET radiation for HNSCC, under the assumptions of the current model.
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Appendix: Prediction of cell death from DNA free-end misrejoining
This appendix provides the justification for Equation 9:
Psurv(mr) = 0.5
Nmr
The assumptions that were made in this model are:
1. No terminal deletions: cDSBs with both ends unrejoined were rejoined faithfully/correctly.
2. No incomplete exchanges: For cDSBs with only one end misrejoined, assume the other
end misrejoined with the same cDSB as the first, or if that cDSB has no free ends,
with the other available end in the misrejoining “chain” (e.g. if cDSB1 and cDSB2
each have an end misrejoined with an end from cDSB3, then the remaining end of
cDSB1 was assumed to misrejoin with the remaining end of cDSB2).
3. If two cDSBs misrejoined both of their ends together during the original misrejoining
simulation, the second misrejoining was not counted, as this was assumed (from the
previous assumption).
Let the number of breaks (DSBs, or cDSBs in the current work) in the nucleus be N ∈
[2,∞). The number of misrejoinings involving these breaks is Nmr ∈ [0, N ]. It will be
demonstrated that this equation for Psurv(mr) is true (given the assumptions above) for
N = 2 and all Nmr ∈ {0, 1, 2} and for N ≥ 3 provided Nmr 6= N . For N ≥ 3 and Nmr = N ,
one of the misrejoinings was counted that should not have been, i.e., Psurv(mr) would have
been correct if a value of Nmr → Nmr − 1 had been used in the formula instead. Thus, the
cell killing was overestimated in these cases (though they did not contribute appreciably in
the current work - see Discussion). Lastly, it will be shown that the equation for Psurv(mr)
extends to a nucleus containing multiple independent groups of breaks with misrejoinings.
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1. N = 2
a. 2 breaks on 2 chromosomes (1 break on each chromosome)
If there were no misrejoinings (Nmr = 0), both breaks were rejoined faithfully (assumption
1) and Psurv(mr) = 1, which the formula gives for Nmr = 0.
If there was 1 misrejoining (Nmr = 1), the options are:
• 1 dicentric (with no sticky ends) and 2 acentric fragments (each with 1 sticky end) (1
way)
• 1 acentric fragment (with no sticky ends) and 2 centric fragments (each with 1 sticky
end) (1 way)
• 1 symmetric translocation (with no sticky ends), 1 centric fragment (with 1 sticky
end) and 1 acentric fragment (with 1 sticky end) (2 ways)
A second misrejoining was then assumed (assumption 2), giving either:
• 1 dicentric (no sticky ends) and 1 acentric fragment (no sticky ends) (2 ways)→ lethal
• 2 symmetric translocations (no sticky ends) (2 ways) → viable
Thus there were 2 equally likely outcomes (2 ways each): 1 lethal and 1 viable. Therefore
Psurv(mr) = 0.5, which the formula gives for Nmr = 1.
If there were 2 misrejoinings simulated explicitly, the situation was described above and
Psurv(mr) = 0.5. However, because the 2 simulated misrejoings were between the same 2
breaks, only the first misrejoining was counted toward Nmr (assumption 3), i.e., Nmr = 1
was used in the formula and thus the correct answer of Psurv(mr) = 0.5 was obtained.
b. 1 break on each arm of a chromosome
If Nmr = 0, same as in the previous example.
If there was one misrejoining (Nmr = 1), the options are:
• 1 centric ring and 2 acentric fragments (each with 1 sticky end) (1 way)
• 1 acentric fragment (no sticky ends) and 1 centric fragment (2 sticky ends) (1 way)
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• half of a pericentric inversion, giving 1 centric fragment (1 sticky end) and 1 acentric
fragment (1 sticky end) (2 ways)
A second misrejoining was then assumed (assumption 2), giving either:
• 1 centric ring and 1 acentric fragment (no sticky ends) (2 ways) → lethal
• pericentric inversion (2 ways) → viable
Lethal and viable outcomes were equally likely (2 ways each), so Psurv(mr) = 0.5, which the
formula gives for Nmr = 1.
As in the previous example, if the 2 misrejoinings were simulated explicitly, the second
misrejoining was not counted toward Nmr (assumption 3), so Nmr = 1 and the formula
correctly gives Psurv(mr) = 0.5.
c. 2 breaks on the same arm of a chromosome
If Nmr = 0, same as above.
If there was one misrejoining (Nmr = 1), the options are:
• interstitial deletion, giving 1 acentric fragment (2 sticky ends) and 1 centric fragment
(no sticky ends) (1 way)
• 1 acentric ring, 1 centric fragment (1 sticky end) and 1 acentric fragment (1 sticky
end) (1 way)
• half of a paracentric inversion, giving 1 centric fragment (1 sticky end) and 1 acentric
fragment (1 sticky end) (2 ways)
A second misrejoining was then assumed (assumption 3), giving either:
• interstitial deletion, with 1 acentric ring and 1 centric fragment (no sticky ends) (2
ways) → lethal
• paracentric inversion (2 ways) → viable
Lethal and viable outcomes were equally likely (2 ways each), so Psurv(mr) = 0.5, which the
formula gives for Nmr = 1.
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As above, if the 2 misrejoinings were simulated explicitly, the second misrejoining was not
counted toward Nmr (assumption 3), so Nmr = 1 and the formula correctly gives Psurv(mr) =
0.5.
2. N ≥ 3
a. 3 breaks on 3 chromosomes (1 break on each chromosome)
If there were no misrejoinings (Nmr = 0), all 3 breaks were rejoined faithfully (assumption
1) and Psurv(mr) = 1, which the formula gives for Nmr = 0.
If there was 1 misrejoining (Nmr = 1), the options are:
• 1 dicentric (no sticky ends), 1 centric fragment (1 sticky end) and 3 acentric framgents
(each with 1 sticky end) (3 ways)
• 1 acentric fragment (no sticky ends), 3 centric fragments (each with 1 sticky end) and
1 acentric fragment (1 sticky end) (3 ways)
• 1 symmetric translocation (no sticky ends), 2 centric fragments (each with 1 sticky
end) and 2 acentric framgents (each with 1 sticky end) (6 ways)
A second misrejoining was then assumed between the same two breaks as the first (assump-
tion 2), giving options:
• 1 dicentric (no sticky ends), 1 acentric fragmemt (no sticky ends), 1 centric fragment
(1 sticky end) and 1 acentric fragment (1 sticky end) (6 ways)
• 2 symmetric translocations (no sticky ends), 1 acentric fragment (1 sticky end) and 1
centric fragment (1 sticky end) (6 ways)
The break that was not involved in any misrejoinings was rejoined faithfully (assumption
1), giving options:
• 1 dicentric (no sticky ends), 1 acentric fragmemt (no sticky ends) and 1 repair (6 ways)
→ lethal
• 2 symmetric translocations (no sticky ends) and 1 repair (6 ways) → viable
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Half of the outcomes are lethal and half are viable, giving Psurv(mr) = 0.5, which the formula
gives for Nmr = 1.
Now consider if 2 misrejoinings were simulated explicitly. If the second misrejoining was
between the same pair of breaks as the first, then the situation was described above, with
Psurv(mr) = 0.5. However, because the second misrejoining was between the same pair of
breaks as the first, the second misrejoining was not counted toward Nmr (assumption 3), so
Nmr = 1 and the formula correctly gives Psurv(mr) = 0.5.
If the second misrejoining was not between the same pair of breaks as the first (Nmr = 2),
then the options are (after the third misrejoining; by assumption 2):
• 1 dicentric (no sticky ends), 1 symmetric translocation (no sticky ends) and 1 acentric
fragment (no sticky ends) (36 ways) → lethal
• 3 symmetric translocations (no sticky ends) (12 ways) → viable
There are 36 ways for a lethal outcome and 12 ways for a viable outcome, giving Psurv(mr) =
0.25, which the formula correctly gives for Nmr = 2.
If the 3 misrejoinings were simulated explicitly, the situation is as described above, with
Psurv(mr) = 0.25. In the current algorithm, the third misrejoining was mistakenly counted
(Nmr = 3), so the formula incorrectly gave Psurv(mr) = 0.125. This will be fixed in future
iterations of the algorithm.
3. Independent groups of breaks in a nucleus
Consider a nucleus containing one group of breaks withNmr,1 and corresponding Psurv(mr),1





For the cell to be viable, both groups of breaks must have a viable outcome:




So Psurv(mr) is given by the same formula but using the total number of misrejoinings in the
nucleus.
[1] B. G. Wouters, in Basic clinical radiobiology, edited by M. C. Joiner and A. van der Kogel
(CRC Press, Boca Raton, 2009) 4th ed., Chap. 3, pp. 27–40.
[2] E. J. Hall and A. J. Giaccia, Radiobiology for the radiologist, 7th ed. (Lippincott Williams &
Wilkins, Philadelphia, 2012) pp. 41–42.
[3] M. N. Cornforth and J. S. Bedford, Radiat. Res. 111, 385 (1987).
[4] M. N. Cornforth, DNA Repair (Amst) 5, 1182 (2006).
[5] M. S. Sasaki, Int. J. Radiat. Biol. 85, 26 (2009).
[6] M. Durante, J. S. Bedford, D. J. Chen, S. Conrad, M. N. Cornforth, A. T. Natarajan, D. C.
van Gent, and G. Obe, Mutat. Res. 756, 5 (2013).
[7] E. J. Hall and A. J. Giaccia, Radiobiology for the radiologist, 7th ed. (Lippincott Williams &
Wilkins, Philadelphia, 2012) pp. 25–34.
[8] B. D. Loucas and M. N. Cornforth, Radiat. Res. 179, 393– (2013).
[9] R. K. Sachs, A. M. Chen, and D. J. Brenner, Int. J. Radiat. Biol. 71, 1 (1997).
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7.2.4 Discussion and Conclusion
Cell death was predicted using the initial spatial distribution of complex DSBs
(cDSBs) in the nucleus, which was obtained from the track structure. The distance
between 2 cDSBs was used to predict the likelihood that a DNA free-end from
one cDSB was misrejoined with a DNA free-end from the other cDSB. After
running the misrejoining algorithm, assuming there were no unrejoined ends, the
cell survival probability could be predicted: each misrejoining event had a 0.5
chance of producing an asymmetric chromosome aberration that would cause the
cell to die via mitotic catastrophe.
Someone familiar with Michael Douglass’ work may wonder why the multicellular
tumour was imported into Geant4 in a voxelised representation, rather than using
parameterised volumes, as Michael Douglass did. Since version 10 of Geant4, it
is no longer possible to parameterise a volume plus its daughter volume (e.g. the
cell membrane plus the cell nucleus). The voxelisation approach was devised as
an alternative. The voxelisation approach happens to have some advantages over
volume parameterisation. In particular, the voxel array was imported using a
“Nested Parametersiation”, which allows for fast particle navigation and reduces
memory requirement.
In future work, a modeller could aim to grow out the multicellular tumour spatio-
temporally, so that the cells have different types (stem, transit and differentiated),
before delivering a dose fraction. Considerable computation time could be saved
by only simulating DNA damage, DNA free-end misrejoining and cell death from
misrejoining in stem cells. Then the surviving stem cells can regrow the tumour in
the time before the next dose fraction is delivered. Thus fractionated radiotherapy
can be simulated. Future work should also endeavour to account for incomplete
exchanges and terminal deletions as sources of cell death, for the possibility that a




Comprehensive application of radiobiology is underutilised in standard practice
radiotherapy. There are well-established predictive biomarkers (e.g. hypoxia [33])
and many more that are promising (e.g. p53-status, HPV-status and a multitude
of others [25, 27, 29, 37]), that are generally not taken into consideration during
standard clinical radiotherapy planning [96]. These markers vary between patients
and (by definition) indicate the response to a treatment. By taking them into
account, patient outcomes could be improved (higher tumour control probabilities
and reduced side-effects). The problem: it is not clear precisely how a given set of
evaluated markers will interact to produce the overall effect (tumour response) for
a particular fractionation schedule, type of cancer, radiation quality, combination
of chemotherapy drugs, and so on. This is the large hurdle that must be overcome,
i.e., patient-specific radiobiology must be predicted reliably before it can be used
to further individualise radiotherapy treatment (and justify the expense of using
biomarkers). Clinical trials are essential, but they are time-consuming and expensive
and many of them will be required to consider the large number of variables involved.
It is hoped that radiobiological modelling will help provide the answers and drive
more individualised radiotherapy planning forward.
The complexity of radiobiology in radiotherapy, involving the interplay of
physical, chemical and biological processes, demands increasingly complex radio-
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biological models: from purely deterministic models to models that incorporate
stochastic elements; from temporal models to spatio-temporal models. It may be
possible to meet the demand with increases in computational power as a result
of technological advancements.
This thesis set out to develop a new radiobiological model of HNSCC radiotherapy
that would achieve a higher degree of complexity than previous models. In particular,
the aim was to develop a model with the following unique combination of properties:
1. It would be a spatio-temporal model in which each tumour cell was modelled
individually.
• With the spatial component, each cell would have a physical volume of
space that it occupied.
• With the temporal component, each viable non-differentiated cell would
progress through cell cycles and undergo cell division, thus growing the
tumour spatio-temporally.
2. A tumour vasculature would grow (angiogenesis), from which cells would
acquire their pO2.
3. Finally, Monte Carlo particle tracks would be simulated through the cellular
tumour to deliver the dose.
The developed model ultimately achieved all of this and more. Each component
of the model was developed and verified as described in the thesis.
8.1 Summary of main findings
The literature review of tumour angiogenesis and the vasculature morphology in
HNSCC in Chapter 2 [56] influenced the way the tumour vasculature and tumour
hypoxia were modelled later in Chapter 4, which was a primary focus of the model.
In particular, this review led to the formulation of model parameters: relative
vascular volume (RV V ), blood oxygenation (p0) and necrosis distance (ND), for
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which lower and upper limits were obtained for HNSCC (2-10%, 20-100 mmHg
and 80-300 µm, respectively) using clinical notes and data from the literature. It
was envisioned that these parameters, combined with a stochastically generated
tumour vasculature, would give rise to the tumour oxygenation.
A key feature of the tumour growth model developed in Chapter 4 [91] was
the “pathway”-based approach. Specifically, the randomised cell positions were
grouped into i) “curvy” pathways to generate the connected, branching and chaotic
tumour vasculature and ii) radial pathways to transport cells outward following
a cell division and inward following a cell death. Other main features of the
tumour growth model include:
• Cell positions within a distance ND of a vessel were viable; others were
necrotic.
• Viable cells were assigned a cell type in the epithelial cell hierarchy (stem,
transit and differentiated cells), a pO2 based on their distance to the nearest
blood vessel and a cell cycle time based on their pO2.
• The probability for stem cells to undergo symmetric division was a parameter
that could be increased to simulate accelerated repopulation.
Chapter 5 [92] rigorously explored and documented the behaviour of the tumour
growth model. It was found that relatively small values of the model parameters
RV V , p0 and ND (e.g. 2.1%, 30 mmHg and 130 µm, respectively) were required
to achieve the typical tumour oxygenation of HNSCC, which is very hypoxic. A
notably large stem cell symmetric division probability of 50% (corresponding to
stem cell proportions from 30 to 35%) was required to achieve doubling times from
2.3 to 6.1 days (from well oxygenated to severely hypoxic HNSCC), characteristic
of an accelerated repopulation phase.
Geant4 [38–40] and Geant4-DNA [41–43, 86] were used to simulate low-energy
physics interactions and the chemical tracks from water radiolysis. In Chapter 6
[93], an algorithm was developed to predict DNA damage from the track structure.
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Direct events (ionisations and excitations) and indirect events (•OH interactions) in
cell nucleus material were spatially clustered into cylindrical volumes representing 10
base-pair segments of DNA. Since tumour hypoxia was a major focus of the model,
the mechanism of the oxygen enhancement effect was reviewed (see Introduction of
[93]) to gain a sense of how to model it. The result was to model pO2-dependent
probabilities of DNA base radical-to-DNA sugar radical transfer and DNA sugar
radical-to-strand break conversion. The resulting DNA damage yields and oxygen
enhancement ratio (OER) for double-strand break (DSB) induction were verified
for LETs up to 150 keV/µm. In particular, the OER for DSB induction was 3.0
for low-LET radiation up to approximately keV/µm and then decreased to 1.3 at
150 keV/µm. An important finding was that while the OER for DSB induction was
close to unity at 150 keV/µm, there was oxygen enhancement of DSB complexity
at this high LET, which was quantified.
The last Chapter 7 [95] reported on simulations of multicellular irradiation with
track structure followed by DNA damage induction, DNA free-end misrejoining and
cell death. The cellular tumour geometry was voxelised, imported into Geant4 and
irradiated with 6 MV x-rays using Geant4-DNA physics and chemistry modules.
The physical and chemical tracks through nuclei were translated into DNA damage,
taking into account cellular pO2, and then stochastic, proximity-based DNA free-end
misrejoining was simulated, from which cell survival probabilities were obtained. The
results indicated that the linear components of chromosome aberration production
and cell survival are from unrejoined DSBs rather than from misrejoinings between
DSBs produced by the same primary x-ray. For a 1 mm3 tumour with oxygenation
typical of HNSCC, DNA damage and misrejoining were simulated in all 135306
viable cells, following a uniform dose to the tumour of 1 Gy.
In this way, a new and unique computational radiotherapy model was developed
and verified; one that is spatio-temporal, models each tumour cell individually,
includes tumour angiogenesis and delivers dose to the tumour volume via Monte
Carlo particle tracks, as required. Novel achievements are:
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• the mechanism of cellular movement to accommodate new cells from prolifer-
ation and to remove cells after they die;
• stochastic growth of a connected and chaotic tumour vasculature, producing
realistic spatial distributions of chronic hypoxia and necrosis;
• multicellular irradiation with Monte Carlo track structure, including low-
energy physical interactions and chemical tracks from water radiolysis;
• stochastic conversion of track structure to spatially distributed DNA damage
in each cell’s nucleus in a way that takes into account the cell’s pO2; and,
• using the DSBs and their complexities, stochastic simulation of proximity-
based DNA free-end misrejoining in each cell’s nucleus to determine the
likelihood of cell survival.
The added complexity of the model provides greater utility and potential for
new radiobiological insights. However, it comes at the cost of greater computational
load. A very large computation time would be required to grow a tumour to a
clinically relevant diameter of ∼ 1 cm with pre-treatment cell kinetics (i.e. 2%
symmetric stem cell division). Tumour irradiation in Geant4 would also be much
more computationally efficient if Geant4-DNA physics was only simulated in nucleus
voxels, rather than in all voxels, which is currently the case. This is not possible to
achieve in the current version (10.4) of Geant4. The current model does not model
DNA in complex geometries, such as nucleosome, chromatin and chromosome, as this
was not appropriate/feasible for a multicellular tumour model. The DNA damage
algorithm used a spatial clustering approach to work around this. While we can
predict the event of a chromosome aberration, the absence of explicit chromosome
structures meant that the specific type of chromosome aberration can not be known;
one can only estimate the likelihood that it is lethal.
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8.2 Future research
The ground work has now been laid and there is future work anticipated that will
benefit from the framework that has been developed. The model can be extended
in many directions. In the next work expected to follow, the dose fraction module
(shorthand for irradiation, DNA damage induction, DNA free-end misrejoining and
cell death components) will be combined with the cellular tumour growth model.
After a dose fraction, the tumour will shrink (surviving cells will fall in along the
radial pathways) and surviving stem cells will regrow the tumour, with or without
the loss of asymmetric division, until the next dose fraction is delivered. Thus,
fractionated radiotherapy treatments will be simulated. Different fractionation
schedules may be simulated to investigate which are the most effective at combating
tumour hypoxia and accelerated repopulation [97].
There are many options for further research applications using the S2RT model.
High fractional doses (i.e. hypofractionation and stereotactic body radiotherapy)
could be simulated to probe the contribution of vascular damages to the tumour
response. The current model is equipped to address this topic because of the
connected tumour vasculature; damage to a single blood vessel unit can cause the
inactivation of the entire length of the vessel and thus cause hundreds of surrounding
cells to die by necrosis. Experimental data will be required to model the effects
of vascular damage. Experiments that use a 3D vasculature would be particularly
valuable, as the morphology may affect the radiosensitivity. For example, endothelial
cells (e.g. human umbilical vein endothelial cells; HUVECs) could be grown and
irradiated in 3D (e.g. using a tube formation assay [98] or 3D bioprinting [99])
followed by a clonogenic cell survival assay.
Since tumour irradiation is performed using track structure methods, the model
can easily be extended to simulate hadrontherapy, including high-LET radiation.
In particular, protons and carbon ions are well supported by Geant4-DNA. The
DNA damage induction algorithm was demonstrated to have reasonably accurate
behaviour up to 150 keV/µm [93]. As a first step, the simulations and analysis in
[95] could be repeated with protons instead of MV x-rays.
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Cancer types other than HNSCC could be simulated with minor modifications
to the model. This may include changes to the size and shape of cells and nuclei,
the cell hierarchy, the tumour oxygenation (RV V , p0 and ND), the cell cycle times,
the stem cell symmetric division probability, the cellular radiosensitivity (r0), and
so on. Similar adjustments could be made to model secondary cancers (which are
typically more radioresistant than primary cancers) and normal tissue toxicity.
The code is currently written in Matlab for all components of the model other
than the tumour irradiation in Geant4 (which is in C++). This includes: 4D cellular
tumour growth with angiogenesis, tumour voxelisation, DNA damage induction
and DNA free-end misrejoining (plus cell death). Matlab is excellent for developing
models. It has robust in-built routines and toolboxes and enables convenient
visualisation of data, making it easy to convert ideas into model methods and then
verify the model behaviour. In the future, some time will be spent looking for
opportunities to further vectorise the Matlab code in order to reduce computation
time [100]. Some of the code may be translated into C++ to further improve
computational performance.
There has recently been interest expressed from radiation oncology manufacturers
to amalgamate and translate several radiobiological models, including this one,
into a commercial product for clinical application. This product would be a tool
that assists in identifying the optimal treatment (fractionation, radiation quality,
chemotherapy drugs, etc.) for a given cancer patient and their tumour based on
various predictive markers (e.g. hypoxia, p53-status, HPV-status, etc.). This is
something radiobiological modelling has long been building towards. As computation
time is a factor in the current model, a first approach could be to perform
benchmarking and then interpolate for a given patient’s tumour. There would also
need to be a graphical user interface (GUI) developed for a commercial product.
The field of radiobiological modelling, and in particular radiotherapy modelling,
is at an exciting stage and brimming with opportunities. There is much work left
to do, but we are now beginning the process of translating models into clinical
tools that will better individualise and optimise radiotherapy treatments. The
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current lack of patient-specific radiobiological considerations in standard practice
radiotherapy limits potential clinical benefit to patients. It is understandable if
clinicians were hesitant in the past to go down this path, for example, due to
limitations of deterministic models [66]. But with the more accurate and reliable
stochastic approaches in newer models, and speed improvements to make them
clinically viable, perhaps there can be a larger investment made into pursuing
the integration of new and innovative radiobiology-based radiotherapy planning





Parallel and high performance computing
with Matlab and Geant4
This work made extensive use of parallel computing. This appendix provides
practical tips for using parallel computing in Matlab and Geant4 and running
parallel Matlab code and Geant4 applications on a supercomputer.
A.1 Parallel computing
Some computational tasks consist of performing a similar subtask many times, with
each subtask independent of the others. In parallel computing, such subtasks are
executed simultaneously on multiple workers (e.g. cores in multicore processing).
A.1.1 Matlab
In Matlab, the parallel analogue of the for-loop is the parfor-loop. A parfor-
loop can be used instead of a for-loop if the iterations are capable of running
independently. A call to parfor will automatically create a “parallel pool”, unless
one is already active. The parallel pool contains the workers that will execute
the parfor-loop iterations in parallel. Parallel pools can be manually created
and deleted (Listing A.1).
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Listing A.1: Parallel pools in Matlab (Matlab code)
nworkers = 4 ; % dec l a r e a va r i ab l e f o r the number o f workers in the
p a r a l l e l pool
poo lob j = parpool ( nworkers ) ; % c r ea t e a p a r a l l e l pool with nworkers
delete ( poo lob j ) % de l e t e the p a r a l l e l pool
parpool ( nworkers , ' IdleTimeout ' , Inf ) % c r ea t e a p a r a l l e l pool that
never t imes out due to i n a c t i v i t y
poo lob j = gcp ( ) ; % get cur rent pool
A.1.2 Geant4
Primary particles (events) are independent, so they can be simulated in parallel
on different workers (event-level parallelism). Geant4 offers this capability with
“multithreaded mode” (Listing A.2). Note that to use multithreaded mode, when
installing Geant4 the Geant4 library must be built with the CMAKE option:
-DGEANT4_BUILD_MULTITHREADED=ON
Listing A.2: To run a Geant4 application in multithreaded mode, create a multithreaded
run manager in the main file (C++).
#ifde f G4MULTITHREADED // was the Geant4 l i b r a r y bu i l t with
mult i threaded opt ion ?
G4MTRunManager ∗ runManager = new G4MTRunManager ; // c r e a t e
mult i threaded run manager
runManager−>SetNumberOfThreads (4 ) ; // use e . g . 4 co r e s
runManager−>SetNumberOfThreads (G4Threading : : G4GetNumberOfCores ( ) ) ;
// use a l l the co r e s you have
#else
G4RunManager ∗ runManager = new G4RunManager ; // otherwi se c r e a t e
s e r i a l run manager
#endif
It is recommended to score data in Geant4 simulations using G4AnalysisManager,
which is thread-safe (i.e., compatible with multithreaded mode) [101]. The data is
written in the form of “ntuples”, which are like the rows of a table. For example,
an ntuple may be generated for an event (or track or step) and the elements of
the ntuple (i.e., the columns of the table) contain information about the event (or
track or step). Listings A.3, A.4 and A.5 show how to create an ntuple, score data
in it and properly close the output file, respectively. Several output formats are
available including CSV (comma-separated values) and ROOT. Listing A.6 shows
how to specify the output format. Note that in multithreaded mode, each thread
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writes its ntuples on a separate output file (e.g. “output_nt_output_t0.csv” for
thread 0, “output_nt_output_t1.csv” for thread 1, etc.). Examples of analysis
manager can be found at <g4src>/examples/extended/analysis.
Listing A.3: Create an ntuple in the RunAction constructor (not in BeginOfRunAction)
(C++)
#include " Ana lys i s . hh "
. . .
// Create an a l y s i s manager
auto analys isManager = G4AnalysisManager : : In s tance ( ) ;
// Create ntuple
analysisManager−>CreateNtuple ( " output " , "my t i t l e " ) ; // f i l e name ,
t i t l e o f the f i l e
analysisManager−>CreateNtupleIColumn ( " f l a gP a r t i c l e " ) ; // I f o r in t ege r
, column name
analysisManager−>CreateNtupleIColumn ( " f l a gP ro c e s s " ) ;
analysisManager−>CreateNtupleDColumn ( " tota lEnergyDepos i t " ) ; // D f o r
double p r e c i s i o n
analysisManager−>FinishNtuple ( ) ;
Listing A.4: Score data in an ntuple (C++). This is usually in a user action class, e.g.
in the UserSteppingAction of SteppingAction.cc.
#include " Ana lys i s . hh "
. . .
// Create an a l y s i s manager
auto analys isManager = G4AnalysisManager : : In s tance ( ) ;
// F i l l the ntuple
analysisManager−>Fil lNtupleIColumn (0 , f l a gP a r t i c l e ) ; // column index
s t a r t s at 0
analysisManager−>Fil lNtupleIColumn (1 , f l a gP r o c e s s ) ;
analysisManager−>FillNtupleDColumn (2 , Edep ) ;
analysisManager−>AddNtupleRow ( ) ;
Listing A.5: Close the output file properly in the EndOfRunAction in RunAction.cc
(C++)
#include " Ana lys i s . hh "
. . .
// Create an a l y s i s manager
auto analys isManager = G4AnalysisManager : : In s tance ( ) ;
analysisManager−>Write ( ) ; // For ROOT histogram output , merges thread
histograms in to a s i n g l e histogram
analysisManager−>Clo s eF i l e ( ) ;
Listing A.6: In the “include” folder of your application, you need an “Analysis.hh” file
that specifies the output format (C++).
#ifndef Analysis_h
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#define Analysis_h 1
#include " g4csv . hh " // f o r CSV output
//#inc lude " g4root . hh " // f o r ROOT output
#endif
A.2 High performance computing
You get the most out of parallel code by using a high performance computer (HPC)
(a.k.a a supercomputer). HPCs provide access to many more cores and much
higher memory than a personal computer.
A.2.1 Job script
Code and software are ran on a HPC in the form of “jobs”. A job is submitted to
a HPC using a job script. The job script includes details of the resources to be
assigned to the job, set-up of notifications and execution of the code (Listing A.7).
The cores in a HPC are grouped into “nodes”. If you only use one node, the
number of cores is limited to the number of cores in one node. If you want to
use more than one node, you should check that your software/code can do that.
A job is then submitted with the command:
sbatch my_job_script.sh
Listing A.7: Example of a job script (bash).
#!/ bin /bash
#SBATCH −p batch # pa r t i t i o n ( o the r s : t e s t , highmem)
#SBATCH −N 1 # number o f nodes
#SBATCH −n 1 # number o f co r e s
#SBATCH −−time=0−01:00 # time a l l o c a t i o n ( format D−HH:MM)
#SBATCH −−mem=30GB # memory pool f o r a l l c o r e s
# No t i f i c a t i o n c on f i gu r a t i on
#SBATCH −−mail−type=END # Send emai l when the job ends
#SBATCH −−mail−type=FAIL # Send emai l when the job f a i l s
#SBATCH −−mail−user=jake . f o r s t e r@ade l a i d e . edu . au # Email address
# Execute the s c r i p t
module load matlab /2016b # Load the Matlab module
matlab −nod i sp lay −nodesktop −r " t ry run ( ' my_script .m' ) ; catch ; end ;
qu i t " # Execute a Matlab s c r i p t
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A.2.2 Matlab
The last part of the above job script (Listing A.7) shows how to execute a sequential
Matlab script. Listing A.8 shows how to execute a sequential Matlab function with
variables. In each case, the Matlab module is loaded prior to calling the Matlab
file. The Matlab file is called with the options -nodisplay, -nodesktop and -r,
which are suitable for running a job in batch mode on a HPC. The try/catch
wrapper ensures that a Matlab error is recognised as such by the HPC (a Matlab
error is reported as a successful job otherwise). To run a parfor-loop in parallel
on a HPC, modify the job script as shown in Listing A.9. Make no reference to
the parallel pool in the Matlab file; simply call parfor.
Listing A.8: Executing a Matlab function in the job script (bash).
# Execute the s c r i p t
VAR1=3 # va r i a b l e s f o r the Matlab func t i on
VAR2=5
module load matlab /2016b
matlab −nod i sp lay −nodesktop −r " t ry my_matlab_function ($VAR1,$VAR2) ;
catch ; end ; qu i t "
Listing A.9: Executing a parallel Matlab script in the job script (bash).
. . .
NCORES = 5 # va r i ab l e f o r the number o f co r e s
#SBATCH −n $NCORES # number o f c o r e s
. . .
# Execute the s c r i p t
module load matlab /2016b
matlab −nod i sp lay −nodesktop −r "max_pool=$NCORES; parpool (max_pool , '
IdleTimeout ' , I n f ) ; p=gcp ( ) ; t ry run ( ' my_para l l e l_scr ipt .m' ) ;
catch ; end ; qu i t "
A.2.3 Geant4
To use Geant4 on a HPC, you may have to request it to be installed (Geant4 is not
as popular as Matlab), in which case notify the HPC user support staff of which
version of Geant4 to install and ensure that they install it with the flags:
-DGEANT4_INSTALL_DATA=ON -DGEANT4_BUILD_MULTITHREADED=ON
The module will have a name like “Geant4/10.04-foss-2016b”. Here the version is
10.04. The “foss-2016b” part refers to the toolchain used to build the software. If you
have a problem with Geant4 on the HPC, one thing to try is a different toolchain.
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Normally to compile a Geant4 application (in a build directory located inside











Listing A.10 shows how to modify the job script for a Geant4 application.
The application will then run in multithreaded mode with NCORES (1 core works
too). The G4FORCENUMBEROFTHREADS line prevents the job from using more cores
than are allocated.
Listing A.10: Job script modifications for Geant4 (bash)
. . .
NCORES=5 # va r i ab l e f o r the number o f co r e s
#SBATCH −n $NCORES # number o f c o r e s
. . .
# Execute the s c r i p t
module load Geant4/10.04− f o s s −2016b
module load CMake/3 . 4 . 3




Code can sometimes be modified to run more efficiently on a HPC. This is because
a HPC is ran analogous to a game of Tetris: jobs that request less cores, memory
and time start quicker because the resources are more readily available and these
jobs are given higher priority by the Slurm Workload Manager.
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One way to take advantage of this is to use a job array instead of a parfor-loop
in Matlab, so that each iteration of the parfor-loop is submitted as a separate
job. Because a job for a single iteration of the parfor-loop requires less resources
(cores/memory/time) than a job for the entire loop, the job array method is more
optimised for running on a HPC.
Listing A.11 shows how to modify the job script for a job array. The elements
of the job array are called “tasks”, equivalent to the iterations of the parfor-
loop in this example. The variable SLURM_ARRAY_TASK_ID serves as the original
parfor-loop index. Note that the time and memory specified in the job script
are for individual tasks in the job array.
Listing A.11: Job script modifications for a job array (bash).
. . .
#SBATCH −−array=3−8 # run ta sk s 3 to 8 o f the job array
. . .
# Execute the s c r i p t
module load matlab /2016b
matlab −nod i sp lay −nodesktop −r " t ry my_matlab_function (
$SLURM_ARRAY_TASK_ID) ; catch ; end ; qu i t "
A.2.5 Slurm dependencies
You may want to submit multiple jobs to a HPC that depend upon each other.
For example, you may want one job to only start running after another job has
completed successfully. Slurm dependencies can be used to achieve this. A job
can be submitted with syntax:
sbatch --dependency=<TYPE> my_job_script.sh
where <TYPE> can be:
• after:<JOBID>[:<JOBID>...] - the job can start after these jobs have
started.
• afterany:<JOBID>[:<JOBID>...] - the job can start after these jobs have
ended.
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• afternotok:<JOBID>[:<JOBID>...] - the job can start after these jobs have
failed.
• afterok:<JOBID>[:<JOBID>...] - the job can start after these jobs have
completed successfully.
• singleton - the job can start if there are no jobs currently running with the
same name by the same user.
Slurm dependencies can be used to build “pipelines” in a bash script (Listing A.12).
Listing A.12: A bash script to build a simple pipeline with a slurm dependency (bash).
Note that the variable “jid1” is a string of the form “Slurm-1234567”. The “-7” is to get
only the job ID part.
#!/ bin /bash
j i d 1=$ ( sbatch job_scr ip t1 . sh )
j i d 2=$ ( sbatch −−dependency=a f t e r ok : ${ j i d 1 : −7} job_scr ip t2 . sh ) # job
s c r i p t 2 can only s t a r t running a f t e r job s c r i p t 1 has completed
s u c c e s s f u l l y
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